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ABSTRACT
The study explores price transparency in the healthcare system. With the increase in
healthcare spending resulting in advent of high deductible plans, consumers have been exposed
to the high healthcare cost. Despite of being burdened with outrageous and extravagant bills,
studies have shown that the consumers are not using price transparency tools to their benefit.
The literature review reveals that the major stakeholders in the healthcare industry have
never been studied together to understand the research question on ‘Why is there lack of price
transparency in the healthcare system?’ and that there is no theory that explains such a
phenomenon.
This study undertakes a 360-degree, exhaustive view of all the major stakeholders
involved in healthcare in aims to understand the reasons behind the lack of price transparency in
the healthcare system and what is holding the industry back.
The study followed a grounded theory methodology approach, utilizing the data from 78
semi structured interviews. The 78 professionals and executives representing the major
stakeholders in the healthcare industry contributed in providing information to uncover the key
factors for an opaque healthcare industry.
Eighty-five hours of interviews resulted in 1,686 transcribed pages that provided insights
and discernment to understanding the complexities and intricacies in the healthcare industry that
prevent it from becoming fully transparent. The results provide richness of data for an emergent
theory that explains the actions taken by major stakeholders to reduce healthcare spending based
on their intrinsic interests and their perceptions of complexities of the healthcare industry.
vii

The study presents practical implications on how a complex industry is slow to evolve
and that a change is not possible unless it is deconstructed layer by layer to recognize the root
cause. The change has to start for the core by simplifying the complexities that are created over
time by the stakeholders who have always looked to optimize their motivations and have had no
incentives to make the industry efficient.
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PREFACE
Dissertation option 2, per the “USF DBA Dissertation Proposal” guidelines, includes a
collection of articles/papers. This dissertation consists of three papers, presented as three
chapters for this dissertation. Two of the three papers have been submitted for publication with
an anticipation that the third one will also be submitted following completion of the dissertation
requirements. All the three papers are standalone readings with their own executive summary
and conclusion. An overview of each paper is given below and a synopsis of all the three papers
combined is presented in the abstract.
Paper 1 / Chapter One: Why is there a Lack of Price Transparency for Healthcare Services
across the U.S. Healthcare System
This paper utilized the research question review template format from the Muma
Business Review (MBR). It is a review of literature to discern what the what has been already
researched on the proposed research question of ‘Why is there lack of price transparency in the
U.S. healthcare system.’ The body of the literature research is consolidated into tables that focus
on the needs and opportunities of having price transparency, the advantages and disadvantages of
having price transparency, the ways and barriers in creating price transparency and price
transparency in action. The article lays a foundation on price transparency in the healthcare
industry and can point a reader toward future research opportunities.

ix

Paper 2 / Chapter Two: Deafening Silence: A Grounded Theory Study on the Healthcare
Problem Nobody is Talking About
This paper utilized the Research Method Review template format from the Muma
Business Review (MBR). It is an in-depth review on the research method ‘The Grounded Theory
Methodology (GTM)’ that was used for the research on “Price transparency in healthcare
system.” The paper discusses why and when GTM should be adopted, how to undertake and
accomplish this type of research. It also discusses the advantages and disadvantages of using
GTM, the three major GTMs, the challenges faced, and lessons learned during the process. It has
a list of helpful resources and articles that can help a reader to comprehend GTM concepts.
Paper 3 / Chapter Three: A Simple Complexity: Deconstructing the Healthcare
Transparency Issue
This paper discusses the exploratory research done for this dissertation. It briefly touches
on impetus of this research, the research design and data collection, a pilot phenomenological
study and the major results and findings of an exhaustive grounded theory methodology study of
the major stakeholders in the healthcare industry. It provides insights into the thinking and
mindset of the payers, the providers, the patients and policy influencers and makers. The study
resulted in creation of a proposed theory that explains the actions of strong stakeholders, each
with their intrinsic interests pulling the complex, multifaceted industry in opposite directions.
All Three Papers as Part of the Traditional Dissertation
The sequence of papers followed a logical path towards the completion of the
dissertation. Figure A explains the three papers in relation to the various components of a
traditional dissertation. The research process started with a paper one, the literature review of the
research question. It was followed by paper two, a deep dive in the exploratory grounded theory
x

methodology employed for the research study. Finally, the paper three brought it all together
with detailed insights into the depth and richness of the 78 interview participants. The paper
deliberates the findings, results, discussion and conclusions with a culmination of a complete
picture of the complexities in healthcare industry and an emergent theory showing the actions as
a result of the complexities. All the three papers provide a consistent approach to answering the
primary research question of the dissertation: Why is there a Lack of Price Transparency for
Healthcare Services across the U.S. Healthcare System.

Figure A. Traditional Dissertation and Collection of Articles
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CHAPTER ONE:
WHY IS THERE A LACK OF PRICE TRANSPARENCY FOR HEALTHCARE
SERVICES ACROSS THE U.S. HEALTHCARE SYSTEM? 1
Tagline
Despite being the foci of the U.S. healthcare industry, consumers are not empowered to
make informed decisions about the healthcare services they consume. Lack of price transparency
for various healthcare services impedes informed decision making, creating price discrimination
and inefficient markets.
Keywords
Healthcare, Price Transparency, Price Opacity, Cost of Care, Price Discrimination,
Competitive Market, United States of America, Consumerism, Consumer-Directed Healthcare,
High Deductible Plans.
Executive Summary
The United States of America has the highest total spending per person per year on
healthcare in the world (WHO, 2012). The national health expenditure grew to $3.2 trillion in
2015, or $9,990 per person. Half of the $3.2 trillion spending was spent to pay for services
provided by hospitals and physicians (CMS.gov, 2015). Despite the relatively high level of per
capita expenditure on health, the U.S. ranks 50 out of 55 countries in life expectancy behind

This chapter has been accepted for publication by the MUMA Business Review, a publication of MUMA College of
Business, University of South Florida.
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countries like Algeria and Cuba (Lisa Du 2016). In 2014, 33% of Americans (up from 19% in
2001) reported delaying or forgoing medical care due to high prices (Riffkin, 2014).
Approximately 11% of Americans remained uninsured in 2016 (Marken, 2016).
Uninsured Americans are billed exorbitantly high prices for services and procedures, while those
with insurance pay significantly less for the same (Austin & Gravelle, 2007). Though millions
have received coverage under the Affordable Care Act, as of 2016, 92% are enrolled in high
deductible plans with deductibles as high as $6,000 for an individual and $12,000 for families.
High deductible plans keep affordable healthcare out of the financial reach of most Americans.
Unfortunately, 2017 brought even higher premiums and deductibles to all Healthcare
Marketplace plans, further blurring the lines between being financially assured of healthcare and
being uninsured (HealthPocket.com, 2016; KFF, 2016b; Walsh et al., 2015).
Healthcare price transparency is a state where the information on the total price a patient
has to pay to a provider for healthcare service is readily available before the service is provided.
This information should be pertinent, meaningful, and accurate. It should enable the consumer to
compare and choose providers based on price, anticipate cost, reduce unexpected expenses, and
make an informed decision. The price should reflect the out-of-pocket responsibility of a
consumer based on the insurance plan (private or public) and self-pay rates. This information
should be presented alongside other relevant details such as quality, customer satisfaction scores,
customers’ reviews, and ratings etc., to help define the value of the service and help consumers
choose a provider with the desired value. Price transparency would empower consumers to select
affordable alternatives, reducing their financial burden and overall healthcare costs. Efforts are
currently underway, although the successful implementation of such initiatives depends on
removing hurdles, shifting attitudes and engaging and involving all the stakeholders.
2

Introduction
Healthcare is the fastest growing market segment of the U.S. economy (Danzon, 1993). It
is projected to grow 1.3% faster than the gross domestic product (GDP) per year over a period of
10 years (2015–2025). This means healthcare spending will account for nearly 20% of the GDP
or one-fifth of the U.S. economy by the year 2025. Out of pocket spending grew to $338 billion
in 2015 or 11% of the total National Health Expenditure (CMS.gov, 2015). Enrollment in the
high deductible plan and out of pocket expenses for the consumers is increasing. For example,
from 2006 to 2016, the percentage of covered workers enrolled in high-deductible employersponsored health plans increased from 4% to 29%. In 2006, 55% of the covered workers had an
average annual deductible of $303 whereas, by 2016, 81% of covered workers had an average
annual deductible of $1,478 for single coverage. The cost for the consumers does not end there.
Consumers may also face substantial out of pocket expenses, even after reaching out of pocket
deductibles. Sixty-four percent (64%) of covered workers had coinsurance for hospital
admissions after meeting their deductible (KFF, 2016a). Consumers without any health insurance
have to bear the full burden of the cost of care, without a third party to negotiate on their behalf.
And to make matters worse consumers are not aware of their healthcare costs until after having
received the service (GAO, 2011).
Patients/consumers are paramount to this industry, yet they are confined not only due to
their medical condition but also due to their inability to choose the quality and price of their
medical services. In most circumstances, consumers remain unaware and uninformed of the vast
price differences that exist between various providers, insurances, and self-pay rates.
Furthermore, a higher price for care does not translate to higher quality. Morally and ethically,
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the healthcare industry should prioritize better healthcare outcomes over profits. Awareness,
empowerment, and engagement of the consumers are critical to reducing healthcare costs.
Consumers have been complacent in the poor state of the American healthcare system.
They have historically accepted the fact that complexity in healthcare creates opacity, which
further prevents them from finding the cost of care before they receive it. Providers, on the other
hand, have been complacent to the lack of transparency because they benefit from it. The
complexity of the healthcare system and the complexity of a human body is a huge barrier to
creating price transparency. Several types of research have been conducted to address the
problem of opacity in the healthcare system and studies have presented ways that price
transparency can be created successfully despite the barriers. Research is still underway to
provide simplified, actionable solutions to resolve this complexity. Price transparency will assist
consumers in becoming more aware of the financial liabilities of their care, facilitate better
decision making, and improve the affordability of care. To ensure that consumers can find value
care (better healthcare at a lower price), they have to be educated, empowered, and evolved!
Protocol
Using the University of South Florida online library and Google, research on the general
healthcare industry was done. Then, using the aforementioned resources, a general literature
search was conducted to ascertain previous studies on the lack of price transparency for various
healthcare services. The general databases, i.e., Google Scholar, ABI-Informs, and JSTOR were
used with specific keywords for this research. Queries were also tried in specific healthcare
databases like PubMed Central which contains literature from MEDLINE; National Institute of
Health, the nation’s medical health agency. Additional research was conducted in medical
journals such as the Journal of the American Medical Association, Health Affairs, New England
4

Journal of Medicine, etc. Reports and healthcare information from the Government
Accountability Office, National Conference of State Legislatures, Library of Congress, National
Academy of Science, Institute of Medicine, Healthcare Laws, Legislations, Catalyst for Payment
Reform, U.S. Department of Health and Human Services, Kaiser Family Foundation,
PricewaterhouseCoopers Health Research Institute, Healthcare Financial Management, etc., were
also reviewed. After reviewing about 400 articles for rigor, a summary of about 75 relevant
articles was prepared. The summary was structured to address the research question and
understand the current landscape of price transparency in healthcare. Though each article
covered many issues, they were separated into six broad categories. The categories have related
articles, though many articles had overlapping material.
Literature Summary
The literature review was divided into six categories (with some overlaps in some
categories) to understand the concept of the price transparency in the healthcare industry. It was
also discerned that the terms consumers and patients has been used interchangeably in the
literature. It is important to recognize that all patients are consumers, but all consumers are not
patients. Consumers make choices for healthcare but become patients only when they receive
care (Beckers Hospital Review, 2015).

5

Table 1. Needs and Opportunities for Price Transparency
Source
Reinhardt, U. E. (2014).
Health care price
transparency and economic
theory.

Findings
•

When identical service is sold to different buyers at different
prices it is called price discrimination. This price discrimination is
part of the U.S. health system. In U.S. every private health
insurance negotiates prices with every healthcare practitioner.
Large public health insurances like Medicaid and Medicare does
not pay full fees to cover the full cost of treating patients and selfpaying patients are asked to pay whatever can be pulled out from
them sometimes with the help of debt collectors and the judiciary.
(Reinhardt, 2014)

Porter, M. E., & Teisberg, E.
O. (2007). How physicians
can change the future of
health care.

•

Consumer-driven healthcare relies on the power of informed and
engaged consumer, but currently they are uninformed and
uninvolved. Choices of providers should be based on the value
(price and quality). Consumers don’t have the capability and the
information to drive the system or get value out of it. Thus they
benefit from providers and medical teams’ involvement to help
them make best choices for their health. (Porter & Teisberg, 2007)

Beck, M. (2014). How to
bring the price of health care
into the open.

•

Price transparency is a simple yet radical idea. After the
establishment of the Affordable Care Act, there is an impetus to
change from consumers as well as from the insurance companies.
This is a new territory in the healthcare industry because doctors
and hospitals have never competed over price because the industry
benefits from keeping the profit margins and cost muddy. The
negotiation between the provider and payer have traditionally been
proprietary. Neither the provider nor the payer wants the
competition to know what they are willing to settle for. Most of
the health plans offer some sort of transparency online tools for
their members to address the demand in the healthcare industry.
Consumers should be given the price and the quality data together
otherwise they could assume higher prices mean better quality.
Some experts believe that without consumer education price
transparency will confuse rather than empower consumers and the
price transparency efforts could backfire and result in high prices.
If providers see that their competitors are paid more by the
insurance companies, they too might increase their rates. (Beck,
2014)

•
•

Brown, E. C. F. (2014).
Irrational hospital pricing.

•

The hospital prices are opaque and irrational and have no
relationship with the cost of providing services. The services could
be marked up from 100–1000%. Providers especially hospitals
have incentives to inflate their prices for those with the least
bargaining power and ability to pay, e.g. uninsured, out of network
or high deductible patients thus resulting in higher overall cost in
the market. They leverage their bargaining power against the
payers. (Fuse Brown, 2014)
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Table 1 (Continued)
Source
Brown, E. C. F. (2015).
Resurrecting health care rate
regulation.

Findings
•

•

•

•

•

The U.S. spends more on healthcare than any other wealthy and
developed nation. This is mostly because of high healthcare prices.
Hospital services are the most expensive services bought by
consumers and yet they don’t shop for it like for any other
expensive products.
Healthcare is expensive because of a number of undisciplined
market forces. The overlapping of these multiple categories results
in market failure.
Lack of information on pricing and non-competitive marketplace
results in increased pricing, creates monopolies and debts,
bankruptcies and foreclosures for the society.
Healthcare market inefficiencies can be solved by price
transparency, but it does not address the non-competitive hospital
market, who can still command high prices.
Consumer Directed Health Care (CDHC), through the highdeductible plan, make the consumer aware of the healthcare cost
and addresses the moral hazard problem by rationing the services
through sensitization to price. Even with price information
available, consumers will not or cannot bargain with hospitals
because traditionally they have let the providers’ advice and
prescribe what is good for them. (Fuse Brown, 2015)

Leape, L. et al. (2009).
Transforming healthcare: A
safety imperative.

•

Progress in the healthcare marketplace has been extremely slow.
To move with the fast-paced era and have any meaningful
improvement, five fundamental endeavors have to be achieved.
Two fundamental attempts are to create transparency and engage
consumers in making the decision for their own health. (Leape et
al., 2009)

Porter, M. E., & Teisberg, E.
O. (2004). Redefining
competition in health care.

•

The increase in healthcare cost but not the quality is the result of
reduced competition, failure of reforms (wrong strategies,
structure, and incentives) and lack of consumer awareness. This all
can be changed to create a competitive marketplace by changing
major ingredients like focusing on preventive healthcare, reforms
to create competition, accessible information, and transparent
pricing. (Porter & Teisberg, 2004)

Hall, A. (2014). Financial
side effects: Why patients
should be informed of costs.

•

The cost of the treatment is obscure to the patient until after the
treatment itself. Under informed consent, out of pocket cost should
be presented to a patient before treatment takes place. This should
be done as a part of disclosures like diagnoses, prognosis, and
purpose of treatment, risk, and benefits, alternates. The cost to the
patient is a part of bioethics and should be the moral foundation of
disclosure and informed consent.
In the U.S. healthcare system the medical and financial interest are
inseparable and if the systems cannot disclose the cost to the
patient then it is unsustainable both morally and financially. (Hall,
2014)

•
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Table 1 (Continued)
Source
Sands, D. Z., & Wald, J. S.
(2014). Transforming health
care delivery through
consumer engagement, health
data transparency, and
patient-generated health
information.
Riggs, K. R., & DeCamp, M.
(2014). Providing price
displays for physicians.

GAO. (2011). Meaningful
price information is difficult
for consumers to obtain prior
to receiving care.

Findings
•

Ease of availability of communication technology has the capacity
to provide effective information in healthcare. There is an
untapped market so opportunities exist for us to harness this
market for better decision making and self-improvement in the
healthcare marketplace. (Sands & Wald, 2014)

•

With price transparency in focus, attention is given to increase
consumer awareness, but less attention has been given to increase
provider/physician awareness. Engaging providers is as important
as engaging consumers. Research demonstrates that display of
prices to the physician has been well received. When they are
aware of the cost, they in-turn can help patients get cost-effective
and high-value care. The physician generally has insufficient
knowledge of the prices but this information will assist physicianpatient shared decision making about treatment options and out of
pocket cost. (Riggs & DeCamp, 2014)

•

Price transparency is relevant to consumers who can plan services
in advance. To be meaningful price transparency should be easily
and timely available, credible, and easy to understand, paired with
quality information and be actionable. Most meaningful price
transparency will provide a consumer an estimate of total cost
consumer has to pay – this will reflect any negotiated discounts,
include all the cost associated with the service and out of pocket
expenses. Healthcare industry has started to see price transparency
initiatives grow because of regulations, consumer demand,
insurances trying to get a competitive edge, and for a need for
payers to reduce cost. Some initiatives such as Health Care Blue
Book and PriceDoc were started to help consumers find fair prices
for their healthcare services.
Providers use CPT codes (current procedural terminology) to price
services. The CPT codes can be bundled together for an episode of
care. PPACA requires HHS to help create bundled payments for
an episode of care surrounding certain hospitalizations. GAO
studied the extent to which healthcare price transparency is
available to consumers. Quality information along with price
information was important for the transparency measures. This
information together can help consumers to make a better decision
in selecting the greatest value of care (high quality and low-price
provider). Research suggests that information on volume (number
of services performed), mortality rates for a specific procedure,
surgical complications or post-operation complications, average
length of stay, and the satisfaction of the could help consumers
make better decisions. The research found out that it is difficult to
predict the price of healthcare service before it is provided because

•
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Table 1 (Continued)
Source

•

Ubel, P. A., Zafar, S. Y., &
Abernethy, A. P. (2013). Full
disclosure - out-of-pocket
costs as side effects.

•

•

Findings
of various episode of care which may be provided by various
providers and most of the time even providers are unaware of the
cost off hand because of numerous insurances and their benefit
structures. Insurance companies do not have the data required for
calculating the real-time cost, prior to the patient receiving
services. Legal factors can also be a barrier to price transparency
as they prevent providers and insurers from sharing the contracted
or negotiated rates. Thus, helping the consumers to make an
informed decision. Lack of price transparency poses a serious
threat to consumers who are being asked to pay a greater share of
their healthcare cost. HHS and CMS are supporting various
initiatives to promote price transparency.
Out of the 8 initiatives, Government Accountability Office (GAO)
studies, only 2 were able to provide complete estimates because
they have access to price data, negotiated rates, and claims data.
Thus showing that despite complexities complete cost estimates
can be provided to the consumers. (GAO, 2011)
The article discusses the financial toxicity of high medical bills.
Patients unknowingly face high financial concern as a side effect
of their treatment that may deteriorate their well-being. It makes
clinical sense to disclose financial consequences as side effects
just as treatments’ side effects. Financial information is a vital
component of the decision-making process that can help the
patient 1) to seek monetary assistance before the treatment to
avoid financial distress 2) choose between equally effective but
potentially low-cost treatment alternatives.
The compromise between potential cost and benefit is ethically
charged but patient engagement is harmed if financial impact is
not discussed. But there are social and moral barriers to discussing
cost. The providers feel that it’s their job is to provide the best care
regardless of price and patients hesitate to ask because they feel
that a discussion of cost might result in inferior treatment options.
The discussion of money is not an easy discussion because of
above-mentioned reasons and social barriers. Policy makers and
healthcare stakeholders should push for price transparency to
promote high-value care to reduce cost and improve efficiency.
The article has a graph showing that as compared to private or
public insured patients, uninsured patient below age 65 have more
problem paying their medical bills or currently have a higher
amount of medical bills that they are paying overtime or have a
higher amount of medical bills that they can’t pay. (Ubel, Zafar, &
Abernethy, 2013)
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Table 1 (Continued)
Source
Phillips, K., & Labno, A.
(2014). Trend: Private
companies provide health
care price data.

Schleifer, D. (2015). How
much will it cost?

Findings
•

•

The survey showed that most Americans (71%) don’t think that
the price and quality are related. 21% believed there is a
correlation and 8% were unsure. Consumers who had compared
prices were more likely to perceive a positive association between
price and quality. This can challenge the success of price
transparency initiatives. Perceptions vary across demographic and
other subgroups of consumers. (Phillips & Labno, 2014)
The majority of Americans have looked for price information and
tried to find information before getting care. The survey suggested
that consumers with higher deductibles were more likely to seek
out price information. 21% compared prices across various
providers and believed that they saved money and will do it again.
The majority of the surveyed did not believe that higher price
implied higher quality and wanted the payers to make transparent
the amount they pay to the provider for the services. The research
also highlighted barriers that most Americans are not aware that
prices vary across the healthcare providers and are unsure where to
find the information and how to compare prices. The most
common way that consumers sought price information was by
calling providers office or insurance companies; asking friends,
relatives or colleagues; or checking the insurance companies’
websites. The majority of them would like to know the prices of
the services in advance and about 40% said that they would
choose a lower cost provider if the prices were known in advance.
(Schleifer, 2015)

Weimar, C. (2008). Doctors
say future of price
transparency appears cloudy.

•

The surveys show that majority of the physicians believe that there
is a need for price transparency and that it is long overdue but
were unsure of how the information will be presented and how the
consumers will be educated to utilize it (Weimar, 2008)

Sinaiko, A. D., & Rosenthal,
M. B. (2016). Examining a
health care price transparency
tool: Who uses it, and how
they shop for care.

•

Aetna’s Member Payment Estimator, a web tool was studied to
find out the demographic information on who was using it and for
what reasons. Users of this tool were younger and healthier
consumers with fewer comorbidities. They had higher annual
deductible spending as compared to the nonusers. The services
that were more often searched were planned, non-emergency
service (like screenings, childbirth, imaging, non-emergency
outpatient treatments etc. – called shop-able services). The
consumer does not have an incentive to shop when the cost of the
service dramatically exceeds the consumer’s deductible or when
their out of pocket expense is fixed regardless of the provider (e.g.
copays). Findings suggest that there is a need to focus on engaging
consumers to use these tools (Sinaiko & Rosenthal, 2016)
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Table 1 (Continued)
Source
Mehrotra, A. B., Tyler;
Sinaiko, Anna D. (2014). Use
patterns of a state health care
price transparency web site
what do patients shop for?

Skinner, D. (2013). Defining
medical necessity under the
patient protection and
affordable care act.

Findings
•

Several states have created price transparency website to help the
consumers shop for prices. New Hampshire’s HealthCost website,
which is at the forefront of this initiative was studied for a threeyear period for this inquiry. The utility of the website was low.
Only 1% of the state’s residents used the website. The most
common searches were for outpatient visits, imaging, scans, and
emergency department visits. (Mehrotra, Brannen, & Sinaiko,
2014)

•

Price Transparency will allow patients to know their financial
responsibilities upfront and enabled them to determine how they
want to pay. This will reduce the collection activities and the cost
associated with them.
Numerous providers are providing price transparency on their
websites just to follow the state mandate to list charges for some
of their common procedures. Though consumers are attracted to
providers with price transparency and they can differentiate
themselves by truly embracing price transparency and
understanding consumers’ need. Marketing campaigns and
consumer-centric branding can incorporate price transparency and
arrangement for payment can be made before the treatment is
rendered. (Skinner, 2013)

•

Brennan, K. B., Bonney, R.
S., Bertschinger, W., &
Banks, K. (2006). Are you
ready for pricing
transparency?

William Bertschinger, division chair, patient financial services, at
Mayo Clinic in Rochester, Minn. mentioned that price
transparency along with simplified billing will be required to
reduce the frustration and satisfy the consumer. He explains that
price transparency is not a technology issue but a cultural issue
and remarks that if the hospitals don’t come up this vision for the
future, the government will eventually take the lead and do it for
them. (Brennan, Bonney, Bertschinger, & Banks, 2006)

•

Table 2. Advantages of Having Price Transparency
Source
Kane, C. S., & Harvey, G.
(2015). Demystifying patient
price estimates. The advantages
of transparency.

Findings
•

Consumers are asking for price transparent. Providers seeking to
distinguish themselves and gain an edge should defy the secrecy
and be receptive to this request. Providers who address these
concerns proactively can be market differentiators. These future
thinking providers can create competitive advantage by
advertising their ability to provide price estimates and arrange
for practical payment plans before services are rendered. It is
indicated that patients will be attracted to these providers and are
likely to access their services and follow through with the
payment. (Kane & Harvey, 2015)
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Table 2 (Continued)
Source
Whaley, C., Schneider Chafen,
J., Pinkard, S., Kellerman, G.,
Bravata, D., Kocher, R., &
Sood, N. (2014). Association
between availability of health
service prices and payments for
these services.
Whaley, C. (2015). Searching
for health: The effects of online
price transparency.

Findings
•

Use of price transparency information resulted in lowering the
total claims payments for common medical services. The impact
was largest for advanced imaging services and smallest for
clinical office visits, implying that access to pricing information
before receiving services may result in reducing the overall
payments made for care. (Whaley et al., 2014)

•

Price transparency resulted in a 16% reduction in prices of a lab
test, 15% reduction in prices of imaging and 1% reduction in
physician office visit pricing. (Whaley, 2015)

•

An insurance-initiated price transparency program resulted in
patients choosing the lower cost facility (non-hospital) for MRI.
This prompted the higher cost facility (hospital) to respond and
resulted in a 30% reduction in price variation between the
hospital and non-hospital facilities. (Wu, Sylwestrzak, Shah, &
DeVries, 2014)

Rosenthal, J. A., Lu, X., &
Cram, P. (2013). Availability
of consumer prices from us
hospitals for a common
surgical procedure.

•

An experiment conducted to obtain the price of elective surgical
procedure (hip arthroplasty) revealed wide variation in quoted
prices (so shopping may result in considerable savings),
difficulty in obtaining information and lack of provider
knowledge to give price estimates. (Rosenthal, Lu, & Cram,
2013)

Durand, D. J., Narayan, A. K.,
Rybicki, F. J., Burleson, J.,
Nagy, P., McGinty, G., &
Duszak, J. R. (2015). The
health care value transparency
movement and its implications
for radiology.
Robinson, J. C. B., Timothy T.
(2013). Increases in consumer
cost sharing redirect patient
volumes and reduce hospital
prices for orthopedic surgery.

•

Increased transparency can reduce prices and increase
competition but including quality can reduce commoditization
and enable true value-based competition. (Durand et al., 2015)

•

Reference Pricing: A strategy where employers allow the
employees to choose the providers but set a limit on what they
would pay for a certain service. These practices lower the
bargaining power of the hospitals as providers because they try
to become a high-value provider and attract patient volume. To
reduce their expenditure, some employers have used referencepricing (allowed charges), to establish the limits they would pay
for certain procedures covered under their insurance. Employees
have to pay the difference between the prices if they choose a
higher cost provider. This encourages the employees to choose
low-cost providers and encourages providers to keep the prices

Wu, S.-j., Sylwestrzak, G.,
Shah, C., & DeVries, A.
(2014). Price transparency for
MRIs increased use of less
costly providers and triggered
provider competition.
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Table 2 (Continued)
Source

Findings
within limits to draw increased patient volume California Public
Employees’ Retirement System (CalPERS). In the first year, the
volume of knee and hip surgeries at the low-priced facilities
increased by 21% and decreased by 34.4% at high-priced
facilities. Prices charged to the members reduced by 5.6% in
low-priced facilities and by 34.3% at high-priced facilities. This
accounted for $2.8 million saving for CalPERS and $0.3 million
in lower cost-sharing for members in 2011. (James C Robinson
& Brown, 2013)

Hibbard, J. H. G., Jessica;
Sofaer, Shoshanna; Firminger,
Kirsten; Hirsh, Judith. (2012).
An experiment shows that a
well-designed report on costs
and quality can help consumers
choose high-value health care.
Duke, C. C., Smith, B., Lynch,
W., & Slover, M. (2014). The
effects of hospital safety
scores, total price, out-ofpocket cost, and household
income on consumers' selfreported choice of hospitals.

•

Austin, A., & Gravelle, J. G.
(2007). Does price
transparency improve market
efficiency? Implications of
empirical evidence in other
markets for the health sector.

•

•

•

It is expected that consumers will use healthcare price
transparency data to choose high-value providers (higher quality
and lower prices) that will help control national spending. The
survey showed most consumers associate higher cost with a
higher standard and vice versa and changing the perspective is
challenging. It was found that when quality and cost were
presented together then consumer looked at both and picked
higher quality regardless of the cost to make an informed
decision. (Hibbard, Greene, Sofaer, Firminger, & Hirsh, 2012)
As per the Journal of Patient Safety, if the consumers were asked
to shop by price only, they would pick higher price only if they
thought higher price related to better quality. Once they were
given quality and price information, they choose quality
regardless of the price, showing that quality supersedes price.
(Duke, Smith, Lynch, & Slover, 2014)
In all markets prices generally differ because of two reasons –
price differentiation and price discrimination and both of these
characters exist in the Healthcare market. Hospitals try to charge
more from uninsured patients who have lower income than
insured patients because the uninsured have lower bargaining
power.
Healthcare differs from other commodity markets and few
characters result in price discrimination and limit price
transparency These factors are: Healthcare is complicated and
affects different people in different ways. Patients don’t know
what they want. So, providers rather than consumers pick the
product to be purchased. Patients pick Physicians and physicians
pick hospitals. So, patients don’t have control over what hospital
they go to. Other peoples’ money pays for hospital care
(Hospital earns 1/3rd of revenue from Medicare, 1/3rd from
private insurances and 1/6th from Medicaid). Insurances though
protect consumers from financial consequences they also make
them insensitive to the price. Out of pocket deductible is
generally met for patients with complicated cases, so they are
fully covered and thus insensitive to the prices. In either case,
price plays little role in the choice of treatment. Payment for a
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Table 2 (Continued)
Source

•

•

•

Findings
service depends not just on the patient’s medical condition but
also on the negotiated power of the patient’s insurer. Patients
have poor or no information about hospital quality and cost
because of lack of price transparency.
Price discrimination in healthcare occurs because of two reasons:
Government policies w.r.t Medicare and Medicaid through the
bargaining power of the insurance companies (the prices are
generally set high to leave room for bargaining and discounting)
and through providing some amount of free care for the needy.
As consumers find out price differences, the prices might come
equilibrium position.
Price transparency in healthcare may improve healthcare quality.
Consumers still have difficulty finding useful price information
to make informed decisions. Some of the transparency initiatives
have shown minimal visible effect. Public pressure and the
increased competition itself have resulted in a good pricing
behavior from the providers.
The major difference between commodity and Healthcare market
is that here patients pick physicians and physicians pick
hospitals. So, consumer’s pressure to hold down the prices is
more difficult, but they can exert pressure and question
physicians. The publicity of price difference may result in
voluntary compliance. Once price transparency results in
reducing cost, it will also help hospitals to become productive.
Reduction in prices will result in a reduction of amenities in
healthcare. Lower prices could expand healthcare and increase
the demand for procedures and services, thus bringing in high
volume. Innovative providers may find ways to expand
healthcare by using efficient and more cheaper methods. (Austin
& Gravelle, 2007)

The Kaiser Family Foundation
KFF. (2006). National survey
of enrollees in consumer
directed health plans.

•

Consumer-directed health plans (CDHPs) are plans where
consumers participate actively in their healthcare. These plans
are high deductible plans (over a $1000 for single coverage). The
survey found that cost-conscious consumers are more likely to
participate in these plans. As compared to the control group they
are more likely to ask for lower cost alternatives, shop for the
cost of the visit/ service, and choose lower cost option. These
consumers feel vulnerable to high medical bills and over time
have skipped recommended treatment, opted out of the medical
care that was needed, did not fill prescriptions or took lesser
doses of prescription as compared to the control group to save on
the cost. (KFF, 2006)

Coluni, B. (2012). Save $36
billion in us healthcare
spending through price
transparency.

•

For the employer-sponsored insurance program, price
transparency can result in savings of $36 billion for the
individuals and $6.8 million for employers over a 3-year period.
(Coluni, 2012)
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Table 3. Disadvantages of Having Price Transparency
Source
Kyle, M. K., & Ridley, D. B.
(2007). Would greater
transparency and uniformity of
health care prices benefit poor
patients?
Altman, S. H., Shactman, D., &
Eilat, E. (2006). Could us
hospitals go the way of us
airlines?

Findings
•

Thought price transparency can increase competition and reduce
cost, it can also, deter businesses to enter bad markets, lower
investment in quality care and lead the poor to pay more. (Kyle
& Ridley, 2007)

•

Hospitals could become like the airline industry if price
transparency initiatives succeed. Price transparency can reduce
inefficiencies and make an industry lean but in the case of
healthcare, it can be a morally charged issue. Price transparency
would result in severe cost cutting, eliminating services, create
efficiencies. If this happens then by 2025, hospitals would no
longer be able to cross-subsidize Medicare, Medicaid and
uninsured. The institutes that have provided important and
needed services for their communities will no longer be able to
do it. Price transparency will benefit all if the political system
would be willing to pay for underfunded and needed services.
(Altman, Shactman, & Eilat, 2006)

Table 4. Ways to Create Price Transparency
Source

Findings

Cornett, B. S. (2007).
Transparency in health care:
Through a glass, dimly.

•

Incentives and rewards have to be aligned among all
stakeholders - policymakers, providers, purchasers, payers, and
patients, for any meaningful change to take place. Effective price
transparency can be created by the right attitudes and attributes,
appropriate culture, establishing effective policies and
procedures, employee training, programs and processes to
protect competitive intelligence and active communication
among important stakeholders. (Cornett, 2007)

Houk, S., & Cleverley, J. O.
(2014). How hospitals
approach price transparency:
The issue of price transparency
has become more prevalent in
health care recently, but
hospitals may have different
views of the concept depending
on their relative charge levels.

•

Hospitals were surveyed on ways to create price transparency.
All respondent recognized it to be a strategic move but
mentioned that there were challenges related to price
transparency. The article presents a 5 point checklist to prepare
for price transparency – buy-in of the leadership team, identify
the starting point i.e. lower priced, higher demand services as a
good starting point for price transparency efforts, consider how
to disseminate price transparency information, identify other
information that would help consumers assess the value of the
service provided (e.g. provide quality and safety information),
explain the healthcare pricing and why it differs from one
provider to another. (Houk & Cleverley, 2014)
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Table 4 (Continued)
Source
de Brantes, F., & Delbanco, S.
F. (2015). Getting accurate
price estimates from price
transparency tools.

Findings
•

•

•

•

One in five Americans has high deductible plans. 61% of
employees in small firms and 41% of workers overall have a
deductible of $1000. The deductible for a single coverage is
$1200, with the total average healthcare cost of $2000. Showing
that the individual pays 63% of the total healthcare expense from
out of pocket. Beyond the out of pocket cost, there is coinsurance cost. The cost sharing for an individual for healthcare
can go up to as high as $20,000/year. For insured consumers,
healthcare is becoming a retail industry, where they can shop for
prices. This need of shopping is being understood and many
employers and they are providing price information to their
employees through third-party vendors. The articles give the
definition of price transparency. Price is defined as an estimate
of the total cost for a healthcare service(s) after negotiated
discounts.
Today, most of all healthcare plans (about 98%) offer some type
of online price transparency tool. The 2013 National Scorecard
on Payment Reform shows that only 2% of consumers actually
use this tool. As a result, the healthcare plans have turned to
independent, third-party vendors in search of better tools.
Castlight Health, Truven Analytics, Change Healthcare, and
Healthcare Bluebook have been successful in developing good
price transparency tools.
Price transparency tools should provide information on price,
quality and consumer’s share of the cost. Successful vendors
claim an engagement rate as high as 60%. The article list how
the tool can be consumer-friendly (ease of use, easy to
understand, shows quality measure, allows comparison on price
and quality side by side, helps consumers understand the value,
contains information on other services e.g. pharmacy etc., help
avoid unneeded care, help find less expensive options, encourage
consumers to continue using the tool, can be customized, can
provide reports to employers on utilization, savings, etc.)
The article also mentions that even though the tools provide all
this information, most of them lack accuracy and provide
misleading or incomplete information which hurts the consumer.
Most common problems and their solutions are suggested: A.
Incomplete definitions of medical episodes (to prevent the
vendors should 1. Clearly, defining an episode of care and alert
of any additional cost. 2. Help consumers understand the
difference between typical services vs. service with healthcare
complications. 3. Have a provider score based on unplanned
admissions vs. readmissions. 4. Provide information on
outcomes for both short-term and long-term services) B.
Ignoring weather providers deliver needed vs. unneeded services
(to prevent this vendor should 1. Educate consumers on needed
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Table 4 (Continued)
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Findings
vs. unneeded services, 2. Create standard episode price based on
recommended care) C. Creating price estimates from a small
number of cases (to prevent this vendor should 1. Not show price
estimates when the sample size is small. 2. Include confidence
interval with price estimates. 3. Disclose the consumers about
the provider’s whose price information is blocked due to gag
clause by the provider) D. Not accounting for rate increases (to
prevent this vendor should ensure that the published prices are
either adjusted to reflect any recent negotiation fee or indicate
the year for which the price is published) E. Not using visuals
that are easy to understand and interpret (to prevent this vendor
should stress on ease of use and ease of interpretation of
information by the consumer). (François de Brantes &
Delbanco, 2015).

Ubel, P. A. (2014). Can
patients in the united states
become savvy health care
consumers?

•

For effective price transparency, information needs to be clear
and incorporated into clinical conversations (with providers) of
the pros and cons of healthcare services and any alternative
options. Patients trust their providers and providers can offer
information about options in a more meaningful (simpler) way to
improve shared decision making. Medical training needs to place
an emphasis on communication and empathy with patients.
Smarter and better incentives should be designed to help
consumers make smart decisions. Reference-based pricing can
be incorporated to align consumer incentives of medical and
financial decision making. (Ubel, 2014).

Donovan, C. J., Mazoh, M.,
Brown, J. P., Moore, S., &
Skalka, C. (2008). Surviving in
the age of price transparency:
A pricing model can be
designed to not only create
competitive advantage for a
healthcare organization but also
provide value to its patients.

•

To establish price transparency the first thing to do is to establish
prices for the services. For this healthcare providers need to
determine line item cost for the services. This cost should be
routinely examined. Organizations will need to invest time and
resources to develop detailed costs. Providers can work with
payers and consumers to align payment strategies. Executive
involvement and support are important.
Providers play an important role in creating trust by
communicating value and other quality markers. In order to
promote trust, many hospitals are providing consistent prices for
their services. Creating price transparency is not a quick fix but
will require strategic vision with measurable short, medium and
long-term goals. (Donovan, Mazoh, Brown, Moore, & Skalka,
2008)

•
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Findings

Decker, S. (2013). Getting in
on transparency.

•

Price transparency could transform the healthcare industry
completely. Companies like Amazon have changed the way
people shop by publishing the range of prices, customer reviews,
and the quality of each vendor. This helps consumers to find the
product that best fits their needs and budget. This transparency
allows for easy and convenient decision making by providing
information on their fingertips in one place. If this could be
carried over to healthcare space, it will educate consumers to
make an informed decision. The push for transparency is coming
from the Center for Medicare and Medicaid Services (CMS).
The U.S. senators appealed the Government Accountability
Office (GAO) to examine consumers’ accessibility to accurate
healthcare pricing information. Board of Directors of America’s
Insurance Plan (AHIP) outlined price transparency as one of the
strategies, to reduce cost and make healthcare more affordable.
A survey conducted by CICERO Group presented on the
opportunity to educate healthcare executives about transparency.
Though the push is apparent, price transparency implementation
has been weak because the tools are relatively new and lack
presentation for accurate price information. The lack of price
transparency is a result of the large investment of time and
money to gather data and to create proprietary tools to interpret
the data into useful information. Although the impact of price
transparency is still being debated, a study found that the use of a
cost estimation tool could have saved nearly $50 million had all
the members of the health plan used it for lower cost options. A
provider can differentiate based on price transparency by
communicating directly with consumers. To thrive price
transparency must be embraced to meet the needs of savvy
consumers. Despite internal and external challenges, health plans
are poised to continue with their efforts of creating price
transparency. (Decker, 2013)

PwC. (2014). Healthcare’s new
entrants: Who will be the
industry’s Amazon.com.

•

A survey done by PWC’s health research institute shows that
consumers are looking for convenient and affordable healthcare,
for example, getting a flu shot from Walgreens or buying a home
kit to diagnose strep throat or getting a flat fee physical at retail
clinics etc. These conveniences are improving the bargaining
power of the consumer and will result in a market shift towards
services that consumers can shop for. Some insurance companies
have started providing price transparency tools for their members
but still to come is national comprehensive healthcare shopping
option. The survey revealed that consumers prefer an online
healthcare shopping website to compare prices over either
calling providers/insurances or using insurance companies’
websites. To remain competitive healthcare providers will have
to think about consumers first and then work backward. They
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Findings
will have to focus on B to C (provider to consumer) rather than
B to B (provider to payer). Consumers will favor and reward
those who provide ease and affordability in healthcare lists like
online shopping for travel, entertainment, and consumer goods.
PWC predicts that within a decade heal care will look and feel
like consumer-oriented-tech industry. The obstacle to change is
the third-party payment system. But success will prevail if
consumer desires, regulatory requirements, and reimbursement
complexities are understood. (PwC, 2014)

Hammond, J. B. (2011). Cash
only doctors: Challenges and
prospects of autonomy and
access.

•

High deductible insurance has resulted in an evolution of cash
only doctors. They are the pioneer in providing the consumers
with price transparency, Prices are given an upfront and the
third-party payer is eliminated to simplify the system. These
providers have dis-enrolled from insurance plans, simplified the
process and have a B to C relationship and provide service for
cash. This practice allows the providers to better consumer
satisfaction, creating loyalty. Cash only doctors could alienate
consumers with a lower deductible. (Hammond, 2011)

Table 5. Barriers to a Successful Price Transparency
Source
Reinhardt, U. E. (2013). The
disruptive innovation of price
transparency in health care.

Findings
•

The article mentions two reasons on why Americans pay higher
prices for their healthcare services: First -the private health
sector in the U.S. is highly fragmented and this limits the
bargaining power (market power) of insurers against
consolidated hospitals; Second, the veil of secrecy surrounding
healthcare prices negotiated in private sector. (Reinhardt, 2013)

Thompson, T. G. (2007).
Advocating price transparency.

•

This article discusses various barriers to price transparency. The
first barrier to transparency is a lack of initiation from providers,
to not put the information out. The attitude has to change and the
providers have to be convinced that this is the right thing to do.
The second barrier is a lack of uniform standards to present the
information so that consumers can easily decipher it. The third
barrier is a lack of interoperability between different regions
because of the lack of uniform standards for quality and cost
comparison. The fourth barrier is a lack of accurate information
from the providers. (Thompson, 2007)

Tu, H. T. & May, J. H. (2007).
Self-pay markets in health care:
Consumer Nirvana or caveat
emptor?

•

As consumers make cost-conscious decisions, for self-pay
procedures, they will shop even less if there is a lack of urgency
or the cost of obtaining necessary information/ quotes is high,
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and if there are quality concerns. Instead of shopping, they
would just rely on word of mouth. It is argued that if there is
limited shopping for self-pay procedures, then the shopping
would be even more limited for the procedures covered by the
insurances. (Tu & May, 2007)

Chen, J., Mullins, C. D.,
Novak, P., & Thomas, S. B.
(2016). Personalized Strategies
to Activate and Empower
Patients in Health Care and
Reduce Health Disparities.

•

To remove the culture barrier in healthcare, culturally sensitive
interventions are essential to encourage patients to actively
participate in their own healthcare. These tailored strategies will
sustain patients’ involvement by imparting them knowledge and
confidence to ask questions about their healthcare. Designing
such methodologies will empower consumers to participate in
decision-making. Knowledge and transparency are critical to
creating such interventions. (Chen, Mullins, Novak, & Thomas,
2016)

Betbeze, P. (2015). Health care
Price Transparency: Patients
and Payers Versus Providers?

•

It is expected that 2/3 of the healthcare services will become
price sensitive in the next decade. Consumers and payers are
demanding price transparency but a stumbling block for
providers is to provide the exact cost of care because the
accurate pricing of healthcare service is absence. Though, it can
create efficiencies, the release of price data has put providers on
the defensive, resulting in a pushback. The high margin
procedures generally subsidize money for specialized programs,
so transparency impact these programs negatively. Rather than
pushing back, providers and payers should work together to meet
consumer demand and create price transparency. (Betbeze,
2015b)

Betbeze, P. (2015). The great
•
transparency movement? The
ability of consumers to shop for
health care services based on
price and quality won't take
hold until innovative providers
take some risk and a dose of
faith.
Caballero, A. (2015). The state •
of price transparency and
payment reform.
•

Mitka, M. (2011). Price of
health care services.

•

The complexity of healthcare procedures, health, coding,
misplaced financial incentive and consumers, who have been
historically shielded from participating in their own care are few
reasons providers have not focused their resources (time, effort
and expense) to making this process simpler. As the pressure
mounts to create price transparency, the time and magnitude it
has on the providers are unclear. (Betbeze, 2015a)
Prices for a healthcare service can vary as much as 700% within
the U.S.
Numerous health plans provide price transparency tools but a
survey in 2013 indicated that only 2% of the health plan
members are using the tools. (Caballero, 2015)
Government accountability office list barriers faced by
consumers in getting cost information, such as refusal by
insurers to share negotiated prices as this is proprietary in nature.
Of the initiatives taken to create price transparency, two of the
eight price transparency initiatives reviewed were found to give
a complete cost and rest six had are certain constraining factors
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creating a limitation to the results, not providing total and actual
cost. GAO recommends that one of this initiative, which is
administered by the department of human and health services
expands it transparency efforts to provide complete cost of
healthcare services. (Mitka, 2011)

Sinaiko, A. D., & Rosenthal,
M. B. (2011). Increased price
transparency in health care —
Challenges and potential
effects.

•

Congress passed three bills to improve healthcare transparency
in 2010. Thirty (30) states are planning to implement price
transparency for consumers. This would result in cost-conscious
shopping for a lower cost provider, thus improving competition.
If there is a weak response to comparative price information,
lower-priced providers may raise their prices to match the higher
priced provider, thus increasing the overall price level. The
belief that higher cost must be better might result in a weak
response to the transparency initiatives thus inspiring lower cost
providers to raise their prices. Lack of competition in smaller
areas with price transparency has not resulted in any cost
reduction. Quality and health complication might change the
pricing of care resulting the provider having to explain it to the
patient. (Sinaiko & Rosenthal, 2011)

Ginsburg, P. B. (2007).
Shopping for price in medical
care.

•

The taboo about consumers considering cost while deciding
about healthcare is starting to erode. Price transparency
discussion has downplayed the complexities in healthcare like
medical care, the guidance of the providers, the role of the
insurer as an agent for consumer and a purchaser in negotiating
prices with providers. Shopping for healthcare is either done
directly by the consumer or indirectly through their enrollment
plan. Though it is thought that price transparency will reduce
prices, but it could affect the quality. Lower income people will
not be able to afford providers with high quality who also have
higher prices. Also, the pressure on providers to reduce prices
will stop them invest in order to improve quality. People
considering choosing a lower cost provider might regret their
decision based on quality.
The effectiveness and quality of the data will create better price
transparency. Policy makers are pushing consumerism by
providing incentives for high-deductible plans and pushing
providers to post their prices. Price transparency will help
consumers find a better value and pressure providers to lower
their cost, slow the rising cost of healthcare and increase quality.
Some situations are more suitable for price shopping than the
others for example non-urgent services (urgent services cannot
be shopped for but if a consumer had chosen a provider before
the problem for the medical problem, the urgency can be shopable too), non-complex services (consumers have a better idea of
what they are shopping for and not worried about the variation in

•
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Merlis, M. (2007). Health care
price transparency and price
competition.

•

Findings
clinical quality e.g. immunizations, cholesterol checks or dental
cleaning, screening mammogram, colonoscopy), already
diagnosed services (after diagnosis have been made price
information on the services that need to be done is more
valuable), bundled services for episode of care (market has not
led to many bundled services when more than one provider is
involved but the average cost of an episode could be a valuable
information)and services where the insurer provides incentive to
choose a lower cost provider ( high deductible or no insurance
would increase the return on price shopping ). Health plans then
can give financial incentives to the consumers to select highperformance providers (low cost, high quality). Till now health
plans have not created any incentives to encourage consumers to
price shop.
With high deductibles and higher co-insurance price information
is becoming a priority for consumers. Reference pricing (patients
pay the difference between price negotiated with the hospital and
the price of a low-cost hospital (reference hospital) would
increase the need for price shopping. Generally, the insurance
tries to keep negotiated or contract prices with hospitals
confidential. Regulations are playing an important part in price
transparency. Policy makers at both federal and state levels have
plans to help with the collection and publication of price data
and consumer education on price shopping. Transparency efforts
have already started at these levels.
For the insured consumers, insurers are in the best position to
provide information on price differences among providers. For
highly concentrated markets publishing the prices between
providers and insurers might lead to higher than lower prices.
Posting contract pricing can result in increased prices because
the hospital will try to negotiate higher prices for services as the
other highly paid provider.
Engaging consumer directly in comparing price and quality of
the provider could reduce the cost, increase efficiency and
quality. Insurers are well positioned to facilitate the transparency
because of their ability to analyze complex information on prices
and quality and translate it into usable data for their enrollees.
The government can also help uninsured by posting prices and
quality information. (Ginsburg, 2007)
Consumers have an incentive to shop for prices because of high
deductible plans. They still cannot make informed decisions
because of the complex pricing system and the lack of publicly
available information on prices. Many initiatives are underway
from insurers, providers, state and federal agencies, and other
third-party sources. One episode of care could differ from
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•

•

•

•

O'Kane, M. et al. (2014).
Demanding value from our
health care: Motivating patient
action to reduce waste in health
care..

•

•

Findings
another because of the complexity with regards to testing
performed and other providers involved.
If all providers and insurers knew all the prices providers
received for a procedure, it could create an anti-competitive
effect of shared price information. A provider may demand more
for a service if it learned that the insurer was paying more to the
other provider for the same service, thus increasing prices.
Conversely, if an insurer learned that a provider was giving
pricing discounts to competing insurers, they might demand
same discounts, thus reducing prices. Higher bargaining power
of either the provider or the payer will dictate the rise or fall in
prices. Price transparency was previously under antitrust laws
but is becoming more open.
To create simpler standardized pricing for a service, providers
could use certain scales, or charge same uniform rates for all
purchasers (insured or uninsured). In the latter case, the
competition will be at the level of the health insurer and the
discounts they can get from the providers.
Some proponents of price transparency feel that it will result in
lowering the prices and improving quality, other says that the
impact will be limited (because healthcare decisions are
complicated and made urgently as a result consumer might not
be able to or willing to shop; the financial incentives to shop for
prices might not be strong because consumers only pay a
fraction of true cost)
Studies have shown that cost sharing led to reduced overall
spending. Price shopping may be more practical for frequent
shoppers of healthcare services, e.g. patients with chronic
conditions or for pediatric care services. Providers should
actively discuss cost with their patients to promote price
transparency. (Merlis, 2007)
(This paper was written in 2007, incentives to shop have gone
higher since because of increase in high deductible plans.)
To get value out of the healthcare system, it is important to
understand what is of value to consumers. One surveyed found
60% of people were not confident that the cost of healthcare
could be reduced by shopping around.
Studies found that consumers can make improving health are
value decisions when they are involved in their own care.
Providing information alone is not enough unless it is easy to
find and the consumers know how to use it. The challenge in
involving consumers is that they are reluctant to talk about value,
in some cases because they consider value as rationing and lesser
quality of care. (O'Kane et al., 2012)
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Danzon, P. (1993). Health care
industry.

Findings
•

Healthcare industry does not have a defined output, like a shoe
factory. The output is less defined, unpredictable, imperfect and
not understood by both producers and consumers. The output is
stochastic and dynamic. Nonetheless, healthcare industry obeys
the fundamental rules of economics. In this industry, there is
asymmetric information with consumers totally relying on the
advice of the providers to understand the risk and benefits of
treatment. The complexity arises because the provider is an agent
not only for the patient but also for the third-party payer who inturn is the ultimate agent of the patient. The government also is
pervasive in healthcare because it is the largest insurer through
Medicare and Medicaid. (Danzon, 1993)

Table 6. Healthcare Price Transparency in Action
Source
Hegwer, L. R. (2015). Case
studies in price transparency.

Whitehouse, D. (2015). Getting
ahead on price transparency: A
playbook for healthcare finance
leaders: The movement toward
transparency in pricing is
gaining steam in the healthcare
sector.

Rosenkrantz, A. B., & Doshi,
A. M. (2016). Public
transparency web sites for
radiology practices: Prevalence
of price, clinical quality, and
service quality information.
Tu, H. T., & Lauer, J. R.
(2009). Impact of health care
price transparency on price
variation: The New Hampshire
experience.

Findings
•

Case study - successful price transparency initiative at
MetroHealth System in Cleveland OH. Not only did the hospital
increase customer satisfaction but also reduced the days in
account receivable and has helped with from self-pay
collections. (Hegwer, 2015)

•

Trends to create price transparency are evident on a national and
state level. Centers for Medicare & Medicaid Services (CMS), in
2011, started publishing hospital-specific prices from Medicare
data. A few websites like ContactMyDoc.com and Guroo.com
are aimed to provide price transparency. As the trend of financial
burden is shifting towards individuals, the consumer is more
aware and cost-conscious just like payers. The healthcare
providers need to catch up with this demand to create price
transparency. Providers can distinguish themselves by defining
prices as well as delivering value. (Whitehouse, 2015)
Six of the eight websites for transparency on radiology practices
reported prices of the services. The sites also provided
information on the quality of providers. Price comparison
websites are helping consumers to choose price and quality of
services. (Rosenkrantz & Doshi, 2016)

•

•

New Hampshire is a unique market with weak provider
competition (only 30 hospitals and 3 commercial insurers). It is a
national leader in providing cost information on healthcare
services paid by public and private insurers (NH
HealthCost.com). Price transparency has resulted in an
unenthusiastic price change. But this has helped to employers
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and policy makers to focus on the price difference and has
resulted in some hospitals to moderate their demands for rate
NH was the only state to receive A grade in an annual report
card on state transparency efforts issued by Catalyst for Payment
reforms and the healthcare Incentive Improvement Institute. It
recognized as a national leader in creating price transparency
services. Consumers can look up the actual price and their outof-pocket cost. The state established a comprehensive health
information system (CHIS) is a database of all-payer claims.
Publishing the rates that insurance (both public and private) pays
to the provider has an impact on the payment negotiation
between providers and insurance. Price transparency has
encouraged consumers to seek low-cost providers and prompted
hospitals to offer lower cost care setting. Thought this website is
visited by consumers, providers and insurers have been more
involved. Employers can compare health plans premium and
benefits through NH HealthCost. Health plans have started
offering incentives to consumers for choosing a lower cost
provider. State lawmakers require the providers to publish their
charges but NH HealthCost (state website) has taken the pressure
of the providers to post their prices. (Kutscher, 2015)

Kutscher, B. (2015). New
Hampshire website reduces
sticker shock for patients.

•

Dafny, L., & Cutler, D. (2011).
Designing transparency
systems for medical care
prices.

•

Legislation introduced in 2011, mandates price transparency.
States have passed their own price transparency laws. Though 34
states are using tools for price comparison, could result in cost
reduction, it also could result in an increase in pricing especially
in the case of imperfect markets. (Dafny & Cutler, 2011)

de Brantes, F., & Delbanco, S.
(2016). Report Card on State
Price Transparency Laws

•

Many states have enacted legislation and have price transparency
laws and regulation that mandates a public website. A review of
state transparency laws conducted by Catalyst for Payment
Reform (CPR) and Healthcare Incentives Improvement Institute
(HC13) revealed that 90% of them failed to provide adequate
information to their consumers because of poor design or
inadequate functionality. Two states NH and Massachusetts
received an A. (François de Brantes & Delbanco, 2016)
Systematic Internet searches were conducted to identify patientoriented websites hosted by a state-specific institution. 62 such
websites were found, out of which about ½ were launched in
2006. Opportunities exist to enhance the usability and
effectiveness of these websites to focus on predictable nonurgent services. (Kullgren, Duey, & Werner, 2013)

Kullgren, J. T., Duey, K. A., &
Werner, R. M. (2013). A
census of state health care price
transparency websites.

Appold, K. (2016). Price
transparency: Where are we
now? New tools fuel progress.

•

•
•

Many insurance plans and third-party vendors have developed
their own price transparency tools to compare quality and price.
According to the Institute of Medicine, lack of competition and
excessive price variation results in a waste of $105 billion in
healthcare spending annually.
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•

With increased enrollment in high deductible plans, healthcare
stakeholders are becoming more price sensitive.
To be successful in transparency endeavors, robust laws and
regulation are needed that mandate provider to share the price
information of procedures. Elizabeth Mitchell, CEO and
President of Network for Regional Healthcare Improvement,
feels that strong leadership at the federal level can improve price
transparency. Medicare has started to release information on the
cost of services and what doctors get paid. Mitchell feels if
Medicare leads, others will follow. (Appold, 2016)

NCSL (National Conference of
State Legislatures). (2015).
Hospital provider charge and
actual payment data.

•

As per National Conference of State Legislatures Centers for
Medicare and Medicaid Services (CMS) have “Hospital Provider
Charge and Actual Payment” database that compares charges of
100 common inpatient services and 30 common outpatient
services in the country. The database includes the list price of
170,000 services across 3,300 hospitals as well as the actual
amount paid by Medicare. (NCSL, 2015)

Bumpass, D. B., & Samora, J.
B. (2015). Price transparency
in health care: The other half of
the value equation.

•

This price information is specific to a region and healthcare
providers and should be available both to the consumer and
third-party payer in a useable format prior to the purchase of a
healthcare service. In the digital era, the consumers are savvy
and adept at searching for maximum value for goods and
services. Policy experts believe that empowering consumers to
make value-driven choices in healthcare is the key to controlling
the escalating healthcare costs. To this extent, accurate
information on both quality and cost has to be presented.
However, with the complex nature of healthcare economics, this
goal is easier proposed than accomplished. Although
empowering consumers will help them to select high-value
healthcare if price and quality information is provided.
Currently, there are three primary sources of price transparency
data: Insurance Companies, Center for Medicare and Medicaid
Services (CMS) and State-run websites that publish all-payer
claims databases (APCDs) and hospital pricing data. The
information provided to the consumers through the Online
Decision-Making tools (via their insurers) is inconsistent, with
pricing information generally missing, privy only to the insurers’
customer base. Studies found that the current Medicaid data is
irrelevant for the purpose of providing lowest cost hospitals.
Currently, 12 states have APCDs and this information is
available to the general public. Hospitals are also complying
with the state price transparency regulations in over 35 states.
However, not all the information is clear and useable. To meet
the demand for price transparency, companies like CastLight
Health and Healthcare Blue Book, are providing better pricing

•
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Hammer, D. C. (2006).
Adapting customer service to
consumer-directed health care:
By implementing new tools
that provide greater
transparency in billing,
hospitals can decrease
collection costs while
improving consumer
satisfaction.

Findings
tools. Complexity, proprietary information on pricing data are
the barriers to achieving price transparency. If both pricing and
quality information is not available to the consumers, they might
mistake cost for quality which is not frequently true.
Collaboration between all the stakeholders (Insurers, employers,
providers, and non-governmental healthcare quality
stakeholders) and government (legislative efforts) is critical to
the success of price transparency. (Bumpass & Samora, 2015)
•

•

Kaplan, J. L., & Mills, P. H.
(2016). Price transparency in
the online age.

•

With the rise in consumer-directed, high-deductible healthcare
plans, consumers instead of payers are shouldering an increasing
amount of cost. The onus has shifted consumers and they are
facing sticker shock and confusion. This shift is creating
consumer demand for the value of healthcare, both for quality
and price. With consumers paying for most of their cost, the risk
of collection expenses shifts now to the providers. To mitigate
the risks the providers, have to improve consumer relations,
educate the consumer and share information i.e. provide price
transparency, to reduce sticker shock and meaning full billing.
Few providers and hospitals have started providing price
transparency and simplified billing through online tools to
provide meaning full information to consumers. These tools are
already paying off through increased payments, reduced cost of
mailing and collection calls, increased customer satisfaction and
loyalty. Thus, giving these providers a leadership role in the
rapidly evolving market. As the advantages become clear, more
of the providers will take a plunge to follow the price
transparency trend. (Hammer, 2006)
A study for price transparency in the field of plastic surgery
revealed reduced advertisement and consultation cost when the
surgeon's website was integrated with the price transparency
platform. Consumers had the ability to create a wish list for
plastic surgery and receive the breakdown of the price/fee for the
procedure. Without any advertisement expenditure, the website
had 208 consumers submitting 402 wish lists. On receiving the
price for procedures, Approx. 18% of the consumers came back
for consultation and 62% got the procedure done. This generated
$92,000 in revenue, repeat customers, a lead generation without
having to spend on advertisement. The price-aware consumers
were 41% more likely book a procedure as compared to nonprice aware consumers because of awareness, and reduced
sticker shock. (Kaplan & Mills, 2016)
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Discussion
Patients rarely know the total cost of care until after the care has been provided. Price
discrimination in the healthcare market is an understatement. There is so much of this
discrimination that goes unnoticed because of the consumers lack awareness. For example, table
7 shows that a hospital charges different prices for the same service depending on who is paying
for the service. Just by looking at table 7 (adapted from (Beck, 2014)), the idea of creating price
transparency in healthcare seems quite apparent because the prices for an MRI for the knee, hip
or ankle, without contrast at the same facility vary from $2,844 to $335 based on how you pay.
Table 7. One Test, Many Prices: The Cost Depends On Who's Paying*
Who Pays

Prices for the Same service

List or "chargemaster" price

$2,844

Cash price

$695

UnitedHealth care negotiated price

$1,990

Blue Cross negotiated price

$617

Aetna Negotiated price

$520

Cigna negotiated price

$341-$362

Medicare Rate

$335

*The table shows the cost of MRI for the knee, hip or ankle, without contrast, at Oakwood Health Care
System, Dearborn, MI. As collected by PricingHealth care.com - Adapted from (Beck, 2014)

On a similar note, Figure 1 (Reinhardt, 2011) shows the actual transaction prices paid by
a large New Jersey Health insurance company for a colonoscopy, by the facility where the
procedure was performed in 2007. The figure shows that for the same procedure, with the same
insurance, patients paid different prices within the facility as well as different prices among
different facilities.
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Figure 1. Price Discrimination between Providers*
*Figure shows the actual prices paid by a large New Jersey Health Insurer for a Colonoscopy, to various
facilities (Physician office, Hospital, Ambulatory surgery center) where the procedure was performedAdapted from (Reinhardt, 2011)

There is clear evidence of price discrimination among providers for the same service.
Healthcare providers, especially hospitals, have an incentive to inflate their price because they
don’t compete on prices. Hospitals have a ‘Chargemaster price’ that is overinflated and has no
cost basis. These kinds of prices hurt the uninsured, out of network, and high deductible patients.
In other words, the patients who need the most financial support are the ones that receive the
least.
Higher bargaining power of hospitals (Fuse Brown, 2014), the lack of consumer
awareness, healthcare regulations, complexity in coding, and ambiguity in health condition are
some of the factors that make price transparency in healthcare a seemingly insurmountable task.
Consumers have been sheltered to the true cost of care for so long because insurance companies
have been historically acting as an intermediary payer for their healthcare services. The thirdparty payer system was invented in 1930 to shield consumers from catastrophic bills. Since then,
consumers have been paying only about 13% out-of-pocket of all healthcare spending. Since
90% of the reimbursements came from the insurances, hospitals did not have to worry about the
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consumers (Lutz, 2007). With high deductible plans becoming the norm, employers are pushing
the cost sharing of healthcare on to their employees. Consequently, consumers have started to
demand price transparency. To meet this demand, providers have to understand the market, the
consumers, and their own cost structure and then reevaluate their pricing by re-engineering
business processes around consumers rather than the billing side of the business. They will have
to create pricing that is meaningful to the consumers. Price transparency could shift the balance
of power into the hands of the consumers instead of the providers.
Healthcare services are one of the most expensive services in a consumer’s lifetime (Jaffe
et al., 2006). It is estimated that half of personal bankruptcies and one-quarter of home
foreclosures are due to medical debt (Fuse Brown, 2014). Prices set by the providers are
arbitrary, have no relationship to the cost of providing services, and can vary widely from the
same provider (Appendix 8). To be better informed, consumers should have the ability to
compare prices to anticipate cost. This comparison will encourage providers to offer quality at
competitive prices thus reducing the overall healthcare spending. Having the information on
prices will reduce sticker shock and financial and psychological stress of not knowing the cost
and receiving large bills after the fact. Consumers will be better able to manage their healthcare
expenses if they are aware and can plan for the expenses they would incur as a result of a
healthcare service. This ability to manage the financial cost will not only reduce anxiety but also
improve the consumer experience and health outcomes.
There is a certain taboo associated with discussing prices in healthcare and both the
providers and patients shy away from it. Providers feel that it is their job to provide the best
healthcare regardless of the cost, and patients feel that the conversation of cost might result in
substandard services. There needs to be a paradigm shift in the thinking of all the stakeholders to
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understand that since consumers are shouldering a higher amount of out-of-pocket cost, financial
health is one of the important components of total health.
Conclusions
The healthcare industry has been slow to change on certain forefronts; but with changing
the regulatory landscape, higher out-of-pocket cost, emphasis on healthcare consumerism and the
advent of smart technology (cell phones, tablets, and wearable technology) that provides access
to information at the consumer’s fingertips, creating price transparency is becoming a business
necessity. Consumers will be able to shop for the best care for their money can buy before
receiving care. For all of this to flourish, all stakeholders (consumers, payers, providers, and
government), will have to come on board. Consumer awareness and consumer engagement are
critical for price clarity. Consumers want accurate, easy to comprehend, and meaningful
information that is easily available. Estimates of the total cost of the services do not matter to
consumers; they want to understand their out-of-pocket responsibility. Complexity in healthcare
and lack of efficient tools have yet to provide the consumer with the relevant price details. Price
transparency initiatives that are underway are not sufficient and do not give complete
information. Under pressure from consumers, multiple transparency initiatives (by Medicare,
private insurances, and providers) are underway and 39 states have passed some kind of price
transparency regulations. The healthcare industry has taken a step in the right direction but has
much further to go. Studies show that prices should always be presented with other data to help
consumers choose the best value for their specific healthcare needs. Additional information on
quality and customer satisfaction is important because, if not available, higher prices could be
construed as higher quality, though the prices have no correlation with the quality.
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To put the research in perspective of Malcolm Gladwell’s (2000) book “Tipping Point,”
the connectors and the mavens are already there (initial efforts introduced by private and public
entities to create price transparency). The stickiness factor because of high deductibles and a
shift in cost is there. The only thing missing is the power of context that will tip price
transparency in healthcare. Success is only a matter of time until a critical mass is achieved to
reach the tipping point.
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CHAPTER TWO:
DEAFENING SILENCE: A GROUNDED THEORY STUDY ON THE HEALTHCARE
PROBLEM NOBODY IS TALKING ABOUT 2
Tagline
Healthcare price transparency has been one of the buzzwords in healthcare for a few
years now. Though the importance of price transparency cannot be discounted, consensus on its
definition and presentation has been heavily debated. This grounded theory research attempts to
uncover the reasons and impediments on why price transparency has not been achieved and
sheds some light on what is holding the industry back.
Keywords
Price Transparency, Health Care Industry, Price Opacity, Patients, Providers, Payers,
Policy, Grounded Theory, Methodology, Research, Healthcare, Lessons, Challenges
Executive Summary
National healthcare spending has risen from 5% of the GDP in 1960 to about 18% in
2016 and is expected to be 20% or one-fifth of the total GDP in 2026. The out-of-pocket costs
shot up from $13 billion in 1960 to $353 billion in 2016 and are projected to grow in the coming
years (CMS.gov, 2018). Private sector employers paid about $665 billion in 2016 in healthcarerelated costs for their employees. (This includes both health premiums and out-of-pocket cost for
the employee) (CMS.gov, 2018). High deductible plans were created to motivate consumers to

This chapter has been submitted for review to the MUMA Business Review, a publication of MUMA College of
Business, University of South Florida.
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shop prudently. It was assumed that increased skin in the game would lead the patients and
employers to seek better prices, thus reducing high healthcare spending to create a competitive
marketplace. Theoretically, the healthcare market, like any other market, should be highly price
transparent and competitive, ultimately achieving a market equilibrium with stable prices. The
reality is that though change is inevitable, it has been slow to come. Price transparency has been
a buzzword in the healthcare industry, but the industry has managed to defend its status quo, thus
making price transparency a challenge. In fact, the healthcare industry has hardly been affected
or changed over time. The motivation behind this study was to gain insights into the underlying
reasons of price opacity of non-emergency services in the U.S. healthcare system.
The grounded theory approach was used to enable the researcher to uncover the
complexities and intricacies in the market that would have been otherwise hard to uncover
because of its sensitive nature. For this research, semi-structured interviews were conducted for
78 participants representing various sectors of the healthcare industry. The analysis of 85 hours
of interviews guided the researcher to generate an emergent theoretical model by delving the
reasons behind the lack of price transparency. The methodological approach (or model) can be
leveraged to other similar situations in multi-stakeholder industries to understand the lack of
change despite strong drivers and good intentions. The grounded theory approach is flexible for
exploring complex phenomena and addressing ambiguous problems. The salient feature of this
method is its outcome, which is either a theory or model that is grounded in the data. The
theories created from the data make the solutions specific and relevant to the phenomenon being
addressed. The grounded theory method could be a viable research approach for executives and
managers because they can benefit from gathering data from the pool of participants within their
organizations. The approach provides an excellent opportunity for the organization to create
34

solutions as a team. This paper addresses the benefits and limitations of grounded theory
methodology, as well as the lessons learned and challenges faced during the research process. It
provides some resources for managers to start a similar journey using this research methodology.
The Research Problem
Since its inception during WWII, healthcare pricing has been opaque and has been one of
the very few industries that have not advanced to empower their consumers/patients (Reinhardt,
2014). With the advent of consumerism, healthcare is one of the few areas of commerce where
consumers agree to spend out of pocket for the service without knowing the actual price. Imagine
buying a new car. Could you envision visiting a dealership, purchasing a new car without
knowing the price and then driving off only to receive a bill in the mail weeks later revealing the
actual price? Would you do that? Why would you? It seems absurd buying something without
knowing its price, but this is precisely what is happening in healthcare. Consequently, we need to
challenge ourselves to use new methods to advance our thinking and come up with innovative
solutions to promote healthcare price transparency.
Rationale for Using Grounded Theory Methodology
The research presented in this paper uses Grounded Theory Methodology (hereafter
called GTM). When existing theories may not fully explain the process, this type of research
enables the researcher to comprehend the full extent of problems before providing solutions that
might have little to no impact (Creswell, 2013). GTM is generally used for the domains of study
with little research and information or when there are nonexistent or unsubstantiated theories.
The methodology is useful to develop a better interpretation of complex problems that need
detailed explanations and more in-depth analysis. GTM allows the participants to talk at length
and candidly with the researcher especially when the information discussed is sensitive and
35

complex. Rather than verifying existing theories or models (Birks & Mills, 2015), GTM focuses
on collecting and interpreting data to conceive frameworks or theories that can be leveraged to
other similar situations in different industries (Creswell, 2013). Grounded theory methodology
(GTM) is often chosen for qualitative studies to study the technological/socio-technical changes
and behaviors in emergent research areas (Wiesche, Jurisch, Yetton, & Krcmar, 2017).
Grounded Theory Methodology for an Interpretive Research Study on Healthcare
Pricing
To elucidate price opacity in healthcare, GTM was adopted to explore and understand
complexity and sensitivity in the multifaceted healthcare industry. This methodology is
conducive for the dynamic healthcare world which is characterized by numerous pertinent and
intervening variables. It was invaluable for the researcher to hear and understand the reality from
the viewpoint of the participants who have been discussing this topic forever but who have not
been able to come up with a solution. This methodology has enabled the researcher to analyze
various perspectives, grasp the intricacies, and discover emerging patterns in data to generate a
comprehensive model to address the issue. While the complexity in healthcare system cannot be
understated, it has been fascinating to discover that all the stakeholders have varying perceptions
and opinions that deviate even within the same group. The research took a 360-degree view of
the healthcare industry by talking to the major stakeholders for a preview to determine the
underlying reasons to why consumer/patient has merely become a rubber stamp instead of being
a powerful entity controlling their health and wealth.
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Description
Grounded Theory Methodology
Grounded theory methodology is a qualitative research approach initially developed by
sociologists Glaser and Strauss (1967) in their book, The Discovery of Grounded Theory, and
used for their investigative study in social sciences. Although it was initially used in social
sciences, GTM has been used since in many disciplines including nursing, anthropology,
psychology, education, business, information systems and many more (Strauss & Corbin, 1994).
As per Glaser’s definition, grounded theory is a general methodology that analyzes the collected
data, using systematic methods to generate a theory (Glaser, 1992). As GTM is inductive, it does
not require hypothesis generation, though one can be generated during the process of theory
building. The study involves going back and forth between the data and the analysis to come up
with a theory or model (Charmaz, 2014). GTM has the advantage of being able to explore
evolving conditions and social processes to create a theory that is current and grounded in the
data collected for a specific situation. It fits the real-life research with emphasis on individuals,
their lived experience, influences and perceptions (Hallberg, 2006). As per Corbin and Strauss
(1990), the research methodology considers the non-static conditions and their influence on the
phenomenon to allow the researcher to identify concepts, build relationships among them to
develop theories, models, and explanations that can provide new insights to the research. It is
broad, with flexible guidelines (rather than rigid rules) that can be adapted to any area or subject
(Hallberg, 2006). GTM is often chosen for qualitative studies to explore the technological/sociotechnical changes and behaviors in emergent research areas (Wiesche et al., 2017). The primary
purpose of grounded theory research is to explain the core category for the specific phenomenon
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being studied. With its intuitive appeal, and its ability to address dynamic situations it stimulates
critical thinking and creativity that is ideal for the managers.
Advantages and Disadvantages of Grounded Theory Methodology
Grounded theory methodology can be very advantageous to the managers because it is
timely, specific, rigorous, and generates a theory that is grounded in the data. It provides the
researcher with the opportunity to study, analyze, and conceptualize the data to discern
phenomena that are not explained by existing theories. The objectivity and connection to the data
make this theory trustworthy and credible (Allan, 2003; Hussein, Hirst, Salyers, & Osuji, 2014).
Grounded theory can be tailored well in mixed method research (MM-GT). Using both methods
in research is gaining popularity. So, GTM can be used both for qualitative and quantitative data
(Glaser, 2003). It can also be used in conjunction with any quantitative approach to add depth
and rigor or to test a theory generated during the theory building process. Researchers who have
undertaken the two approaches together have applauded the benefits of employing MM-GT
(Guetterman, Babchuk, Howell Smith, & Stevens, 2017).
Though there are tremendous benefits of using GTM, its time-consuming nature, limited
generalizability, and flexible approach can come across as having limitations. Another potential
drawback can be the variation in cognitive thinking. In GTM, a researcher uses a cognitive
approach to explain and analyze the data, their style may seem lucid and logical to some and
incoherent and chaotic to the others (Heath & Cowley, 2004). Though not recommended, it is
acceptable to do a preliminary but noncommittal literature review at the beginning of the
research. A literature review might be needed to set a direction and orient the researcher to the
current conditions. A detailed literature review can be done during the analysis phase to confirm
any emergent findings (Birks & Mills, 2015). Another unique challenge presented by GTM is
38

that the researcher must have a clear and open mind, which is almost never possible (Urquhart &
Fernandez, 2016). A clear mind prevents any previous theories to influence the new concepts and
to prevent any preconceived ideas in the development of a new theory. Birks and Mills (2015)
recommend listing the existing ideas, perceptions, experience, and knowledge before
commencing the research. A manager should be able to discern the situations where GTM can be
valuable and situations where it cannot be used because of its limitations.
Variations in Grounded Theory Methodology
Before deciding which GTM model to use, it is imperative to be familiar with the
differences in the three major grounded theories discussed in the literature (Figure 1). Though
the definition and basic premise of grounded theory methodology are universally accepted by
researchers, the process, techniques, and rigor in data collection, handling and, analysis differ
based on the type of GTM approach chosen (Evans, 2013). There have been a few variations to
this study over the years, but the concept of having the data grounded to the theory has remained
consistent. Glaser emphasizes the approach to openness and ingenuity in the interpretation of
data in Glaserian Methods (CGT) (Glaser, 1978). Straussian grounded theory (QDA) takes a
prescriptive position and a linear approach to thinking and conceptualizing data. It differs from
CGT in data collection, data analysis, and coding structure. (Strauss & Corbin, 1994). The third,
more recent methodology, the Constructivist GTM was developed by Charmaz in 2006, This
GTM approach has flexible guidelines for data collection and analysis. This methodology states
that concepts are constructed and not discovered as mentioned in CGT (Charmaz, 2014).
Charmaz suggests a social interaction methodology that accentuates the involvement and
collaboration of both the researcher and the participants in constructing a theory (Cho & Lee,
2014). A significant source of disagreement between CGT and the other two GTM approaches is
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about having a pre-conceived question at the beginning of the research process. Glaser dismisses
having a specific research question when starting and recommends to start with an intention to
know more about the area of research (Devadas, Silong, & Ismail, 2011; Glaser, 1992) Another
major difference between the three GTMs is the use of literature. Once again Glaser prohibits the
use of literature at the beginning of the process to prevent being influenced by it, whereas
Straussians believe that it can be done at any research phase but should be non-committal, and
Constructivist GTM recommends literature review at every stage (Corbin & Strauss, 1990, 2008;
Devadas et al., 2011).
Researchers should be careful while following a methodology for grounded theory
because numerous published papers and books on GTM have not only engaged in theory mixing
or theory slurring but also seldom mention the grounded theory that is being used (Goulding,
2002; Martin, 2011). Most articles and books have been mixing up and switching among the
three methodologies and using a “method of skip and dip while collecting data” (Gynnild, 2011).
Thus, leading the novice researcher to believe that various GTMs follow a comparable path
causing misunderstandings and confusion. Learning and distinguishing between different
methodologies and similar sounding terminology can be daunting especially when different
GTMs are mixed and matched while doing research (Evans, 2013).
Nonetheless, despite the deviations in coding methods, literature use, data analysis in the
three methodologies, the core principals such as constant comparison, memo writing, theoretical
sampling, and theoretical saturation have remained constant (Kenny & Fourie, 2017). Figure 2
describes the similarities and differences between the three GTMs.
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Typical Protocol
For any research, the first step is to have a research question. Once the researcher knows
the area of study, the next step is to peruse the best possible method to complete the research. In
this section, I describe how I applied the typical protocol to my research.
Research Question
A research project starts with a research question to address a topic of interest. The
research described here emanated from the researcher’s interest in understanding the lack of
price transparency for non-emergency healthcare services across the U.S. Health Care System,
especially when consumers have been footing their bill because of the high out-of-pocket
deductible. Consequently, the research question is:
Why is there a lack of price transparency for non-emergency healthcare services across
the U.S. Health Care System?
Hypothesis
This inductive and exploratory research has no hypotheses at this time. As per GTM,
hypotheses are not formulated in advance but could be created as a part of the theory building
process and can be later tested using qualitative or quantitative measures (Evans, 2013).
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Figure 2. Comparison of the three GTMs: Similarities and Differences
Research Method
A preliminary literature review did not reveal any evidence of GTM studies undertaken
to elucidate the opacity in healthcare. The review did reveal that no existing theories explain the
phenomena of price opacity in the healthcare system. Thus, the use of GTM was appropriate to
generate concepts, ideas, and theories for understanding the opacity in the market. There were
four main reasons to use GTM: (1) to get an opportunity to interview participants to get a rich
description of their realities in the complex and social environment (Hallberg, 2006); (2) to gain
an understanding of the powerful, complex, multi-stakeholder industry with money and a strong
lobby fighting to keep the industry’s fundamental interests in place (Rappleye, 2017); (3) to
examine relationships and behaviors about the phenomenon of price transparency to develop a
theory that is grounded or rooted in the observations of the study participants (Trochim, 2006);
and (4) to delve into issues that interviewees might find sensitive or hard to explain. This
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rigorous qualitative approach assisted in creating an explanation of the factors, and reasons that
have contributed to a price opaque healthcare market. Such a theory or model with rich
explanations resulting from interviews is grounded in data collected from the leaders in
healthcare. As a result, this potential framework can be leveraged to similar conditions in this or
any other industry (Creswell, 2013).
Of the three GTM approaches, Straussian grounded theory by Corbin and Strauss was
selected for this study because it provides a systematic, well-structured and linear approach to
data analysis and theory creation (Corbin & Strauss, 1990). This approach is suited for a novice
researcher because it provides guidance and a framework for research. Its prescriptive style
specifies the steps, giving direction on how to code and structure the data. The method supports
the concept of having a research question or an idea of the concept that a researcher wants to
study. The research question can be formed through literature research or the researcher’s
experience and knowledge (Corbin & Strauss, 2008; Evans, 2013). Straussian grounded theory is
also flexible with the review of the literature at the early stages for theoretical sensitivity which
is appropriate since most researchers are aware of the literature to some level before they start
their analysis. Another reason for pursuing Strauss and Corbin’s GTM was because it was the
preference of the researcher’s [dissertation] committee and the researcher. With limited time and
no experience with grounded theory, it was agreed upon that Straussian grounded theory would
be a most appropriate approach for the researcher’s dissertation research.
Institutional Review Board (IRB) Submission
The researcher submitted for an Institutional Review Board (IRB, hereafter) approval but
was recommended by the IRB committee that an IRB was not required because the study
focused on the participants sharing professional information and opinion about the industry.
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Please note not all the studies are deemed exempt. For dissertation research, a judicial approach
of having a conversation with the committee and following their direction is recommended.
Though the IRB was not required, an IRB form was created and sent to most of the participants
to encourage their participation by letting them know formally that their name and organization
will be kept confidential.
Participant’s Selection Criteria
The target segment for this research was healthcare leaders in various organizations with
knowledge and insights on the healthcare pricing and policy landscape. Recruitment drew from
various segments of the healthcare industry (Figures 4 and 5). As the focus was to gain insights
on the opaque healthcare system, executives (CEOs, COOs, CFOs, EVPs, SVPs, VPs, Executive
and Senior Directors, business owners, etc.), professionals (consultants, physicians, researchers,
academics, journalists, lobbyist) and other key stakeholders of the industry were selected.
Seventy-eight participants with twenty-two years of average healthcare industry experience were
recruited from academics, hospitals, healthcare insurance companies, healthcare brokers,
healthcare vendors, healthcare administrators, employers, lobbyist, journalists/ reporters,
healthcare consultants, physicians, hospital association, non-profit policy organizations,
consumer advocate associations. The groups were then aggregated to represent four
sectors/sides: Provider, Payer, Patient, and Policy side (the 4 Ps hereafter). Providers, physicians,
hospital lobbyists, and hospital associations were aggregated to form the provider side; insurance
companies, brokers and benefit advisors and healthcare vendors were aggregated under the Payer
side; Consumer advocates/ authors, journalist/reporters, consultants, employers, and employer
lobbyists were aggregated under the patient side; the Policy side consisted of those who
proposed, made or evaluated healthcare pricing policies such as government employees and
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academicians studying healthcare. Figure 3 shows the distribution of participants under each of
the 4 Ps.

Figure 3. The 4 Ps of a Pie
Participants’ Enrollment
The initial selection and recruitment of individuals were done through networking
(references of family, friends, peers, professors, and acquaintances, professional and personal
circle). Of the 50 people contacted, 40 responded and 28 were interviewed. As a few interviews
progressed, recruitment looked like a daunting process. It soon became evident that the existing
process of recruiting would not result in sufficient and specific participation. The researcher
struggled initially to enroll the desired individuals in various healthcare segments for the
interviews. She requested her LinkedIn contacts to help her network. Connecting through
LinkedIn also had its challenges because most of the networking contacts that were being
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pursued were not the right candidates for the research. The researcher then reached out to the
right candidates directly, without the support of the network. She looked for leaders, executives,
and professions prominent in the targeted 4P healthcare segments. LinkedIn has a personalized
invite option under the member’s profile, that allows a 300-word introduction to connect to a
person. The researcher used this feature extensively to send messages to the desired individual
based on their profiles. The researcher used the 300 words to give the candidates a preview in the
research. Through this tool, the researcher was able to reach out to the various organizations and
individuals that she would not have otherwise been able to reach out to and connect.
The researcher used half an hour each day to send numerous invitations. She reached out
to journalists, academics, authors, consumer advocates, college professors, academic writers,
researchers, think tanks, non-profit organizations, hospitals, physicians, insurance companies,
broker firms, benefits advisors, employers, healthcare innovators, vendors, consultants, lobbyist,
government, etc. For each organization, she targeted 3–5 participants depending on the size and
relevance of the organization. Of the approximately 500 invitations, roughly 50 declined the
request. Two hundred seventy-five (275) did not respond and 175 accepted. Once connected, the
researcher texted them to find their personal preferences for communication (personal email,
administrative email, or cell phone text, LinkedIn chat). The researcher followed up with a thank
you note for accepting the invitation with a detailed informational email on the research. She
followed up again with the participants who did not reply to see if they had received the previous
information and if they have any questions on the research. On average, three correspondences
were sent to each of the 175 candidates, of whom 88 responded. On average, another three
correspondences were sent to the 88 respondents to set up and interview. Of these candidates, 50
interviews were successfully conducted. The participants could choose a phone or in-person
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interview. In some cases, multiple interviews were set up with one person in consideration of
their time.
Questionnaire and Interviews
The open-ended, generative interview questions were framed in such a way that they
were neither static nor confining (Trochim, 2006). The semi-structured interview questions
facilitated open discussion and provided the opportunity to ask follow-up questions for
clarification. Each interview on average took approximately 60–75 minutes. To triangulate and
add rigor to the GTM, interviews that were conducted included healthcare leaders from various
professions each with a different perspective of price opacity. This approach provided a holistic
view of the opacity in the healthcare system. The interviews process continued until saturation
was achieved.
The interviews were divided into three parts:
•

Part one (5 minutes): Participants were requested to provide a brief description of the
current role they play in the organization and any past role that was relevant to healthcare
pricing.

•

Part two (30–40 minutes): Questions were asked about the factors contributing to price
opacity in the healthcare system. The questions were about the general healthcare system
and the price opacity as relevant to their organization and the industry.

•

Part three: (25–30 minutes): Questions were directed on the status of the healthcare
system including their perceptions of the consumer behavior.
Data Collection
Interviews are an essential characteristic of grounded theory. They provide the data used

as a building block to create a theory. The research was an iterative process consisting of
interviews with U.S. healthcare industry leaders who are knowledgeable about healthcare pricing
and policy strategies. A total of 78 interviews (in-person and over the phone) were planned and
conducted over a seven-month period (February–August). The interviews were recorded,
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professionally transcribed and edited for accuracy before the data analysis process. Seventy-eight
interviews resulted in 85 hours of interview data, giving an average of 65 minutes per interview,
with the longest one being 168 minutes. Of the 78 interviews, 14% (n=11) were conducted face
to face, and the remaining were conducted over the phone. Of the 67 interviews conducted over
the phone, 14 interviews were conducted in parts (two or three) over a period of time. The
researcher was cognizant of the fact that some participants were too busy to devote a full hour at
one time for the interview. Being flexible in spreading the interview to two-three parts increased
the acceptance and enrollment of the participants.
Theoretical sampling. As the data was being collected during the interviews, the
analysis was being done continuously. The simultaneous process of interviewing and evaluation
of the data enables the researcher to establish theoretical sampling. Theoretical sampling is the
process of continuous selection of the participants based on the findings from previous
interviews. The initial interviews guide the researcher to the areas that need to be probed, and
sampling enables the exploration of all ideas and concepts that emerge during the interviews
(Glaser & Strauss, 1967). Theoretical sampling was done to collect data and information based
on the core concept of price opacity. As the field of healthcare is complex and layered, the
researcher talked to different players in the healthcare industry to understand people, events, and
behaviors in order to identify relationships between different variables (Corbin & Strauss, 2014).
This sampling led the researcher to various areas/sectors in the healthcare industry that aided
with the visualization of a 360-degree view of the healthcare industry. Theoretical sampling
helped to document relationships and uncover discrepancies.
Saturation. After theoretical sampling, the interview process continued until saturation
was achieved (Glaser & Strauss, 1967). The researcher continued the interviewing process till no
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more new codes were being generated. This point in the analysis where new data is confirming
what the researcher already knows, and the concepts generated are redundant the is called
saturation. At the saturation point, there was no benefit in seeking more interviews because the
researcher had heard the same information repeatedly.
Theoretical sampling and saturation are crucial in developing a theory. Not doing so can
result in missing a principal theme(s) or concept(s) leading to an incomplete analysis and hence a
weak or irrelevant theory. It is important to note that the number of interviews required to attain
saturation differs based on the area of study and the research question. A researcher should
handle this solely based on the data being gathered and on the repetitions of information being
heard during the interview process.
Data Analysis
As the researcher prepared to undertake her journey into the grounded theory process, it
was recommended that she put forth any assumptions and be vigilant of any biases she might
have (Birks & Mills, 2015). Doing this created clarity and kept the researcher grounded in the
process. Before starting the data analysis process, it is imperative for the researcher to get
familiar with the key terms (Figure 4). Knowing the concepts will reduce confusion as the
methodology progresses.
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Figure 4. GTM- Key Terms
Straussian Grounded Theory coding guidelines were followed for this research. The
interviews provided the data for coding which is the central process for all GTMs. The Straussian
Grounded Theory starts with data gathering, for in-depth analysis that facilitates insights for the
discovery of emerging patterns to generate a theory. The research process that starts with having
a research question to creating a theory is outlined in Figure 5.

50

Figure 5. Strauss and Corbin Grounded Theory Methodology
The GTM analysis begins with an iterative process of open coding and axial coding
ending with selective coding. This continuous analysis helps to identify codes, subcategories,
categories and phenomenon that helps with theoretical integration to create a theory or model
(Strauss & Corbin, 1994). On the way to creating a theory, other steps like memo writing and
constant comparison are crucial for facilitating analysis and data integration. As the analysis
continues, emerging core concepts are identified, and tentative linkages are developed between
the data and the theoretical concepts (Trochim, 2006). NVivo 12 was used for the coding
process. It is a software that helps the researcher drag and drop the codes into concepts and then
categories. It makes search functions easy and presents the data in an easy to visualize and
conceptualize form. The program can handle a lot of data in one place and is very helpful in
sorting, arranging and organizing data.
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Literature review. A non-committal literature review was conducted a few months
before the analysis process to prevent any literature influence and biases during the analysis
phase. To some extent, the literature review is essential because it helps the researcher to analyze
the condition and create an informed research question (Corbin & Strauss, 1990). Without any
knowledge of the literature, a researcher would not know of other similar studies done on the
phenomenon of interest. Thus, the literature review is important in justifying the use of GTM
(Antle, 1986). To the best of the researcher’s knowledge based on her literature review, GTM
had not been used to study price opacity in healthcare. The researcher was able to justify the
study using GTM because it would help with explaining the opacity in the complicated and
layered healthcare market.
Open coding. The researcher began by reading the transcriptions breaking it apart by
words, phrases, line by line and in some case blocks of data with relevant context (Corbin &
Strauss, 2008). This stage of coding is the most time consuming and results in numerous
concepts because the interviews can open many theoretical directions. The open coding gives a
preliminary list of concepts about the phenomenon that continues to grow with each interview. A
total of 23,038 phrases/lines or sections were coded. On average, 77 codes were created per
interview with total 6,019 open codes for the 78 interviews. Similar codes in different interviews
were consolidated to create 364 distinct open codes. Table 8 shows some open codes, the percent
of participants who talked about them and the number of times the participants mentioned them.
To give an example, the code of ‘consumer awareness’ was mentioned by 50 participants (64%)
and they talked about it in some way about 124 times. So, ‘customer awareness’ was coded 124
times under one open code.
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Table 8. Example List of Open Codes and Their Occurrences During the Interview

Open Codes

Number of
Participants
who
mentioned
this
concept

Consumer Awareness
Consumer Education Empowerment Engagement
Stuck with the plan
Difficult to find information - helpless
Historical Behavior
Opaque Billing
Patients are not Purchasers
Patient's Skin in the Game; insulated because of benefit design
Playing with house money
Consumer: lack of motivation or- desire
Unsuccessful and Cultural Slow change
Ineffective tools
Closer to home/work
Feel that there is not much of a price difference
Time
Prefer Choices
Not going to the doctors’ too often
Family support
Health foremost
Patient sickness, Lack of energy
Severity of sickness; comorbidities
Trust in the Physician
What will people say - shy - hesitant

50 (64%)
31 (40%)
15 (19%)
34 (44%)
46 (60%)
5 (6%)
56 (72%)
49 (63%)
21 (27%)
50 (64%)
26 (33%)
37 (47%)
7(14%)
4(8%)
9(18%)
4(8%)
3(6%)
5(10%)
20(40%)
12(24%)
6(12%)
42(48%)
8(16%)

Total number of
times the
concept was
coded
(mentioned by
the participants)
124
50
24
62
100
11
125
123
36
148
55
92
10
5
11
5
4
5
32
15
12
83
8

Axial code. In this coding step number of open codes are reduced by grouping similar
open codes or concepts in related categories. The aggregation creates second-level themes based
on shared properties (Corbin & Strauss, 2008). Axial coding starts the consolidation process for
the raw data to provide the pieces of a puzzle to build a theoretical model or theory. There was a
total of 67 axial codes or categories. As an example, the axial coding for patient’s emotions was
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mentioned by 64% of the participants and is shown in Table 9. The open code ‘trust in the
physician’ highlighted in Table 9 can be seen grouped under the axial code ‘patient’s emotions.’
Table 9. Example of an Axial Code with the Underlying Open Codes

Axial Code (showing aggregation of open codes)

Number of
Participants
who
mentioned
this
concept

Patient's Emotions
Closer to home/work
Feel that there is not much of a price difference
Time
Prefer Choices
Not going to the doctors’ too often
Family support
Health foremost
Patient sickness, Lack of energy
Severity of sickness; comorbidities
Trust in the Physician
What will people say - shy - hesitant

50 (64%)
7(14%)
4(8%)
9(18%)
4(8%)
3(6%)
5(10%)
20(40%)
12(24%)
6(12%)
42(48%)
8(16%)

Total
number of
times the
concept was
coded
(mentioned
by the
participants)
190
10
5
11
5
4
5
32
15
12
83
8

Selective coding. Selective coding is the last step that helps to link the categories to
create a relationship (Corbin & Strauss, 2008). In this step, the theory starts to emerge as all
categories are unified through the integration around a core category (Corbin & Strauss, 1990).
Core category is a concept that can broadly and abstractly represent the main idea of the study
(Corbin & Strauss, 2014). This concept has to be abstract to allow the linkages and connections
of various axial codes required in the explanation of the core phenomenon. Too many codes can
create panic and confusion, so it is advisable to pick only the selective codes that are relevant to
addressing the research question. The selective codes determine the vital and central processes
that enable the generation of theory relevant to the core phenomenon. For this research, the core
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phenomenon is factors affecting in price transparency in healthcare. Examples of selective codes
are shown in Table 10. Selective code of ‘Labyrinths in healthcare’ looked at relationships and
connections of similar axial codes that cause intricacies in the system. The figure shows that all
(100%) of the participants had talked about this in one way or the other. Of the 67 axial codes, a
total of four selective codes were produced, of which two were pertinent to the research question.
Table 10 shows the axial codes unified under the selective code or the core category of
‘Labyrinths in healthcare’. The axial code ‘patient’s emotions’, highlighted in figure 6 can be
seen linked to the selective code ‘labyrinth in healthcare’ in Table 10.
Constant comparison. Constant comparison is a process of comparing code constantly.
It can be within a single interview, between interviews of the same group, interviews of a
different group, the comparison in pairs in the same group or comparison in pairs with the
different group (Boeije, 2002). The researcher may pick a way of constant comparison that most
benefits theoretical sampling. Comparing different codes helped the researcher with the
theoretical sampling, with determining similarities and differences among the stakeholders and
with validating emerging categories (Corbin & Strauss, 1990).
Memo writing and diagramming. Memo writing or “memoing” is a narrative process
that helps articulate and document the grounded theory. The process is undertaken to track the
analysis and develop codes and relationships (Creswell, 2013). Memos can be written or draw
(also called diagramming). Writing and sketching helps the researcher to link concepts together
as concrete ideas. It helps with visualization of relationship to the identification of logic (Corbin
& Strauss, 2014). Memo writing should begin with the first interview and continue until the end.
The memos started as a basic expression of thought initially but towards the end had grown in
thought and complexity (Corbin & Strauss, 2014). This process helped in the development of a
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theory as the researchers wrote and sketched out ideas. About 113 memos were created, 78 on
the interviews and the remaining were a reflection on the analysis compilation of thoughts and
ideas, process flow diagrams, relationships diagrams, flowcharts, etc. The memos were written at
various points in the research to assimilated thoughts from the study. See Figure 6 for an
example of a memo.
Table 10. Example of a Selective Code with the Underlying Axial Codes
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Figure 6. Example of Memo Writing
Findings
The first thing the researcher realized while following the GTM was that she needed a lot
of patience. The grounded theory process produced an enormous data set. Going through each of
the 78 interviews, resulted in 23,038 sentences and sections that were coded to yield a total of
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6,019 codes, 364 open codes, 67 axial codes, and four selective codes. Selective codes reflect the
emerging theory by refining categories to core categories. As the selective codes were formed by
connecting and relating the categories, the researcher observed that not all the selective codes
were significant in explaining the core phenomenon. Only two selective codes were eventually
analyzed for contemplation of a theory. These selective codes helped the researcher in
reinforcing the core phenomenon of reasons for lack of price transparency in healthcare. A lot
has been written in the literature about the importance of price transparency, so it was interesting
to get the first-hand take of the four main stakeholders’ segments, the 4 Ps (provider, payers,
policy, and patient side) on the issue. It was seen that the factors in each segment were
interconnected with the factors in the other segment. Figure 7 shows several overlapping factors
that lead to opacity in healthcare. The factors highlight the labyrinth of the healthcare market. All
these, factors are associated with each other and impact not only the segments but also have and
an overarching impact on price transparency. The interviews gave the researcher an exhaustive
view of the healthcare industry and factors that result in price opacity. The next step was to
absorb and analyze the core categories to start the formulation of the theory for price opacity in
the healthcare market.
Challenges Faced, and Lessons Learned
A complete list of dos and don’ts is presented in Table 11. These are the lessons learned
by the researcher as she went through the research process.
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Figure 7. Labyrinth of Healthcare
Table 11. Personal Learnings: Dos and Don’ts
Dos
People

Don'ts

Use the professional network (LinkedIn) to find the right
candidates for the interview
At the beginning of the research, put aside 30 minutes of your
day to connect with prospects
When sending an email wait for about three days to get the
response.
Continue to follow up with a person until you get a “yes” or a
“no.” On average, 3–4 follow-ups will do the trick to get you
an answer either way. Remember, it’s better to ask twice than
to lose your way once.
Connect with the administration staff (if available). This is the
best way to schedule, reschedule, and get any relevant
document.
Try to be flexible with your time to accommodate the time of
the participant.
Sideline conversations before or after the interview can
contain some important data. Ask the participants if you can
include it in your study.
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Don't write to prospective participants (or
participants) on the weekend or Monday.
Tuesdays and Thursdays are better days to
write.
When trying to solicit interviews, reach for the
professionals. Don’t be intimidated by their
title. Per my experience, the top management is
often eager to help
Don’t give up if they don’t reply; keep on
sending them reminders
Don’t worry about rejection or getting a “no”
for an answer. It’s not personal
Don’t take the participant's anger directed
toward an issue personally. It is not you; it’s
the issue.
If you have any ideas, thoughts, don’t wait until
you grab a pen to write them down. Open the
recorder in your phone and recorder away!

Table 11 (Continued)
Dos
People
Initial interviews will be choppy and long. It's okay. Like
anything else, this is a learning process; you will quickly start
to have a flow
If the interviews seem to run over, as a courtesy, remind the
participant that their scheduled time has ended. Request to
continue the interview if they have extra time or request a
follow-up. Most participants oblige.
Always be personable, humble, and professional. Thank the
participant when done; request to keep the lines of
communication open and continue liking and commenting on
their LinkedIn feeds.
Once the participant interviews with you, it will be difficult
for you to get a response back (most not all cases) from them
because of their schedule and other commitments
So, clarify and repeat things you don’t understand. Don’t
hesitate to ask again. (this might be your last chance).
If they are interested, agree to send them the results of your
final dissertation.
Process
Understand the key terms and difference between the three
GTMs.
Pick a GTM then one of the seminal books and follow it.

Use referred articles for quick summaries and refreshing
concepts.
Have as many as possible open codes. It is easier to aggregate
than to break the codes apart.
Get interviews transcribed, read once, and then read while
coding. Highlight quotes save them separately.
If you feel burned out, take a break from the data.
Sketch a lot of diagrams. These help to conceptualize
concepts and refine your thinking in terms of relationships
and connections.
Memo writing a must. The more, the merrier. It is useful for
theory generation.
If your final product is a model and not a theory, don’t fret explain your model as the end product of the research. You
can always come back and develop your model to a theory.
Work in groups if it is an option.
Keep calm and carry on - practice patience.
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Don'ts

Don’t panic if you find that you had
accidentally coded some codes under the wrong
category. Constant comparison will enable to
identify these codes and re-code them directly.
Don’t get bogged down by the amount of data
collected or codes created. Remember to look
at them from a collective framework.
Don’t worry about the number of interviews
when you start the process. You will be doing
theoretical sampling and once you start hearing
the same information, that is your cue that you
have saturation and can stop.
Different research will have a different number
of interviews to get to saturation
Don’t throw any memos or drawings out. You
never know when you might need them.

Table 11 (Continued)
Dos
Technology
Have two recording devices (one for backup) while
interviewing.
Check transcriptions for accuracy and correctness.
Along with recording devices, write notes. Handwritten notes
help the researcher to underline and highlight any important
quotes, concepts, and ideas while speaking during the
interview.
Save the data on a password-protected cloud (never on your
hard drive).
If using a cell phone as a recording device, put it on airplane
mode, this prevents incoming calls to stop your recording.
If planning to use NVivo, learn it beforehand. It is a powerful
software and will be a huge time saver if you understand the
software to use it optimally.

Don'ts

People
As mentioned before, it was difficult for the researcher to get the right candidates through
the networks. The researcher turned to LinkedIn to look for the appropriate profiles for
recruitment. Most of the professionals have information on their work, experience, and
education. It is a powerful resource to connect to professionals of choice by sending them a 300word invitation. Though the response rate was not as good as networking response rate, it did
help the researcher to get in touch with the right people. A researcher should be open to the
schedule and convenience of the participant. On this journey, the researcher interviewed
positive-minded, cheerful, as well as brusque and curt participants. Regardless of their demeanor,
all had a passion to help and desire to get their ideas across. Some blunt candidates were bitter
because they felt that the government is doing things that do not make sense in the healthcare
market. They were not against the goal of price transparency but were opposed to the methods
being followed to get there. As a researcher, it is imperative to keep an open mind to not taking
the conversation personally or getting confrontational with the participant. Another important
fact to remember is that the interview is not over till it is over. Until the researcher is with the
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participant either on the phone or in person, the conversation continues. Many participants
continued talking when the recording devices are off, and pens are down. If the participant
makes an important point during these sideline conversations, ask for their permission to include
that point as a data point. Most participants will say “yes!”
Processes
“Keep calm and carry on” was the mantra used during the research process. A researcher
has to be flexible with time. Enrolling, communicating, scheduling, and interviewing the
candidates, as well as transcribing, and coding the data exhausted the researcher. Time was a
huge factor in this research. GTM, in general, is a time-consuming, but rewarding process. It is
advisable to work in a group to cover a project of such magnitude. For smaller research projects,
it is advisable not to procrastinate; start coding as soon as the first interview is done. Looking
back, the researcher had mixed feelings while doing this research. It was not the amount of data
that bogged the researcher down but the lack of clarity of key terms and generalization of GTM.
Most of the articles/ books researched and read mixed the terms and methodologies from all the
three GTMs; this created confusion on what was the right process to follow. Not all the books
provided structure, the information was scattered throughout and not presented very concisely.
To make matters worse, the books from the same author used different keywords in different
editions. The best way to keep such confusion at bay is to pick one edition from the author based
on the methodology that is preferred and just follow that book. The researcher also had a hard
time finding information on how to do a constant comparison. While conducting research and
collecting data, it was essential to remember that till the saturation is achieved, there would be
many possible directions a concept can go, so it is important not to get attached to an idea. Also,
there might be some information that does not seem important but as the researcher re-codes and
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does a constant comparison, the information that did not seem essential starts to make sense and
resurfaces as a concept. During the constant comparison process, the researcher noticed that she
had put certain codes under the wrong category. These errors were caught and fixed. So, another
added benefit of constant comparison is that it helps to “right the wrong” by giving an
opportunity to the researcher fix the errors in coding. During the analyzing process, the coding
went seamlessly until the researcher reached the selective coding phase. The researcher was
burnt out and did not feel like going back to the research because the coding process had
exhausted her. She stepped away for a few days to reenergize and get back on track. During
selective coding, the researcher drew a number of diagrams in multiple different ways to form a
model that made sense. It was an iterative process that continued to evolve. In GTM, models
continue to mature and evolve as more information is added. A vital virtue learned in GTM is
patience and flexibility.
Technology
Be wary of the technology. Always have two recording devices while interviewing
participants. These can be old cell phones, tablets, etc. (with apps like just press record or rev).
The researcher had some instances where one of the recording devices did not work, having two
of them saved the day. If the functional cell phone is used as a recording device, make sure put it
on airplane mode otherwise recording stops as soon as the phone receives a call. When this
happened with the researcher, she forgot to turn the recording back on. Thankfully, she had
another recording device as a backup. Another word of caution is to review the transcriptions
even though they were professionally transcribed. Not all the transcriptions were of the same
quality. It is advisable to have the recording play while reading the transcripts. The researcher
found a range of errors in 40% (n=31 of the 78) of the transcripts with six being exceedingly
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erroneous. Lastly, always save the data on a secure cloud and not on the PC. The researcher’s
laptop crashed but she was able to recover the data from the cloud.
Learn More
The researcher has tried to provide the context in which GTM can be used and the broad
difference between the three different methodologies. For more information on the basics of
GTM and difference in the three GTM the researcher has created a list of articles that helped her
the most (Figure 8, top section). Once a particular GTM has been chosen, it is recommended to
read the example cases for that specific methodology (Figure 8, bottom section). The articles will
provide the researcher with a clear understanding of how to follow a research process step by
step using the methodology. GTM has some seminal texts based on the methodology being
followed (Table 12). These texts are written by the authors and researchers who developed the
GTMs and provide information on following a specific methodology. Researchers should pick
the book based on the methodology they want to follow. If there are multiple editions of the
book, any edition will work (latest edition is preferred), but it is recommended not to use
multiple editions because the researcher has noticed some subtle (keyword) difference between
editions. For a quick overview of Straussian GTM, the researcher has compiled a list of
simplified steps ‘Cliff Notes on Straussian GTM.’ The list is not a comprehensive and exhaustive
list and is not an alternative to text, but it gives the researcher a birds-eye-view on the process.
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Use of Nvivo software
for coding and analysis

Figure 8. Similarities and Differences between the Three GTM Approaches
Table 12. Seminal Books and Reading on Different GTM Approaches*
Year
1967
1978
1987
1990
1992
1994

Author
(Glaser & Strauss, 1967)
(Glaser, 1978)
(Strauss, 1987)
(Strauss & Corbin, 1990)
(Glaser, 1992)
(Strauss & Corbin, 1994)

1995
1998

(Charmaz, 1995)
(Strauss and Corbin 1990)

2005
2006

(Clarke, 2005)
(Charmaz, 2014)

Title
The discovery of grounded theory
Theoretical sensitivity
Qualitative analysis for social scientists
Basics of qualitative research: Grounded theory procedures and techniques
Basics of grounded theory analysis
‘Grounded theory methodology: An overview’ in Handbook of qualitative
research (1st ed.)
‘Grounded theory’ in Rethinking methods in psychology
Basics of qualitative research: Grounded theory procedures and techniques
(2nd ed.)
Situational analysis: Grounded theory after the postmodern turn
Constructing grounded theory: A practical guide through qualitative
analysis

*Adapted from (Birks & Mills, 2015) Grounded Theory: A Practical Guide
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Cliff Notes on Straussian GTM
1. Start with a research question or the phenomenon of interest.
2. Write down your pre-conceived ideas or assumptions, so you can go back to these and
remind yourself not to get biased during the analysis phase.
3. Start the coding process by reading the interviews, labeling phrases/sentences/sections
(by hand or on a computer using any software or even excel). The labels can be about
anything (people, ideas, feelings, concerns, technology, processes, opinions, activities
actions – you name it, and you can label it). Start with a lot of codes (hundreds or more).
You can always consolidate them later.
4. Write memos often and after each interview or piece of data is collected. Memos are your
reflections, thoughts, ideas on the process, people or analysis. Memo writing is just like
writing a diary; its flexible but has a significant impact on theory creation. Never
discount the power of memo writing.
5. Consolidate similar codes under groups or categories. Once again, categories can
represent people, processes, technology, feelings, opinion, etc. The only difference in the
first and second level coding is an aggregation of similar codes to minimize the number
of codes.
6. Draw relationships, linkages, and anything that helps with creating a visual image.
Drawing may help in finding the missing relationships or linkages. Discuss your
drawings as this might stir conversation that would help theoretical sampling.
7. Theoretical sampling is selecting data (participant or information) that helps with an
exploration of all ideas gathered through your previous data collection. As the data
collection continues, the data gives clues about what other areas should be explored.
8. Keep an open mind. Coding can be done differently by different people. There is no
specific way, style or format for coding. Remember these are your thought on how the
idea should be represented and coded, so there is no right and wrong answer.
9. Compare interviews with one another; this also helps with theoretical sampling and recoding.
10. In the third cycle coding, aggregate the categories from the second cycle and try to create
relationships and connections. Drawing and discussing relationships and models assist in
enabling theory generation.
11. The theory might or might not come out at the end of the analysis. It is okay because
some GTM studies end at a model. You might go back again and try to come up with the
theory. Remember, it is not you; it is the process; it can be challenging and daunting.
12. Trust the process. If you stay at it, the theory will emerge, but it is okay to end with the
discovered model. There is light at the end of the tunnel, thought the tunnel might be
long.
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13. Seek help from co-workers, colleagues, support groups, professionals who know the
process, while keeping the confidentiality of the participants.
14. Brainstorm by discussing with people and drawing various categories and their
relationships.
15. All through the process, keep an open mind and don’t allow your preconceived notions to
interfere with what your data shows.
16. Patience Pays – If you feel like giving up – DON’T
17. There will be a eureka moment when the theory comes to light. This can happen
anywhere and at any time.
Conclusions
Real life is often never black and while GTM helps the researcher to understand and see
the grey and make sense of it. GTM is the ideal way to comprehend and capture the lived
experiences and appreciate that real-life situations change with time, culture and generations.
The theory presented in this article is Straussian GTM. The purpose of using this methodology
was to have a comprehensive understanding of the challenges and limitation faced by each of the
4 Ps (provider, patient, payer, and policy side) resulting in the opaque healthcare market. The
GTM enabled the researcher to put together different aspects and perspectives of the four
segments to see an interconnected picture. Through this methodology the researcher was able to
connect different concepts, to get to a model of the factors that impact price transparency in
healthcare. Upon completion of this study, the researcher expects to have a framework or a
theory to understand the challenges in creating a price transparent healthcare market.
In this article the researcher has tried to put together the types of phenomena that lend
themselves to using GTM, the justification of using GTM for studying the opaque healthcare
market, the advantages and limitation of using this methodology, the steps to be followed for
Straussian methodology, relevant texts on GTM and the challenges faced in the research process.
The key mantra while undertaking the journey of GTM is to “practice patience.” There are many
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challenges that a researcher might face, but it is important to remember that “the best things
come to those who wait,” and the final result of having your own theory is invigorating.
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CHAPTER THREE:
A SIMPLE COMPLEXITY: DECONSTRUCTING THE HEALTHCARE
TRANSPARENCY ISSUE
Abstract
If you build it, they will come—the mantra that cannot be applied to healthcare price
transparency. With the increase in high deductible plans and the consumers sharing the burden of
increased healthcare cost at the point of care, price transparency was expected to eventually
bring down healthcare spending. Though consumers are becoming increasingly inquisitive about
the prices of their healthcare services, efforts to create price transparency, in an aim to reduce
healthcare spending, have not been successful. Grounded theory research was conducted to
understand the factors that impact price transparency of healthcare services in the United States
of America. For the study, I interviewed seventy-eight professionals and executives representing
the major stakeholders in the healthcare industry. Each stakeholder segment with its independent
sets of complexities, motivations, and barriers creates a multifaceted maze in the healthcare
industry. This layered maze compounds the effect of all individual factors, subsequently leading
to the slow evolution of the healthcare system regarding price transparency. The research
uncovered the intricacies, perspectives, conflicting interests, influences of various stakeholders,
and more importantly, the explanations that keep the industry opaque.
Keywords
Price Transparency, Health Care Industry, Price Opacity, Patients, Providers, Payers,
Policy, Healthcare, Grounded Theory, High Deductible Health Plans
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Healthcare Terrain
Healthcare spending is expected to continue on an upward spiral of growth over the next
ten years. U.S. healthcare spending accounted for at 18% of the GDP in 2016 but is expected to
grow to 20% by 2026, an estimated growth rate that is one percentage point faster than the GDP.
The cost of consumer out-of-pocket for healthcare in 2016 was $353 billion, with an average
annual deductible of $3,572 for an individual, and $7,474 for a family in 2017. There were 27.6
million people uninsured, of which 45% remain uninsured because of the cost of healthcare
insurance (KFF, 2017). All of these numbers underscore the importance of price transparency in
healthcare to empower the consumers to who continue to spend more out-of-pocket every year.
Price transparency should be able to create competition, reduce healthcare spending, and
improve the affordability of care (Durand et al., 2015). It should enable consumers to be aware
of the financial liabilities of their care and facilitate better decision making (Durand et al., 2015);
thus, allowing them to make informed decisions and reduce their financial burden and overall
healthcare cost (Bumpass & Samora, 2015)
In 2001, George Akerlof, Michael Spence, and Joseph Stiglitz received the Nobel
Memorial Prize in Economic Sciences for their research related to asymmetric information.
Akerlof's seminal paper (1970), “The Market for Lemons,” states that information asymmetry in
the marketplace creates an adverse selection, leaving just “lemons” in the market and leading to a
market collapse. According to David W. Johnson, the CEO and Founder of 4sight Health,
opaque pricing is the lemon in healthcare and the information asymmetry results in unnecessary
expenditures in healthcare (Johnson, 2015). Healthy consumers with high deductibles may exit
the healthcare market leading to a market with sick consumers who will have to continue to pay
higher prices (that they might not be able to afford) to get medical coverage. To equalize the
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information gap and promote efficiency healthcare price transparency is imperative. The
transparent market will make shopping for a healthcare service less complicated and effortless. It
is a sine qua non for properly functioning markets (Reinhardt, 2014).
Price transparency, though, a very straightforward concept, has different interpretations,
with a debate on what prices to publish (Skelley & Brown). Some propose publishing price of a
service based on the chargemaster, while some want to publish price negotiated with the
insurance, and while the others want to publish average price of a service based on total hospital
claims data (Dafny & Cutler, 2011). However, to be meaningful to a consumer, price
transparency can be defined as the readily available information on the total amount a consumer
has to pay to a provider for healthcare service before the service is provided. This information
should be pertinent, meaningful, and accurate. It should enable the consumer to compare and
choose providers based on price, anticipate cost, reduce unexpected expenses, and make an
informed decision. The price should reflect the out-of-pocket responsibility of the patient based
on insurance plans (private or public) and self-pay rates. This information should be presented
with other information (like quality, customer satisfaction scores, customers’ reviews, and
ratings, etc.) to define the value of the service and aid consumers in choosing a provider with the
desired value for their specific healthcare needs (François de Brantes & Delbanco, 2015).
Price opacity, or the lack of price transparency, lends itself to creating price
discrimination, which in economic terms means selling identical services to different buyers at
different prices. The U.S. healthcare market leads the patient blindfolded into the health system.
In virtually all areas of commerce, except healthcare, consumers are aware of the price and
quality of the product they intend to buy before they buy it (Reinhardt, 2014). Price negotiations
between the private insurance companies and healthcare providers to subsidize the prices are
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confidential, and patients are clueless about the prices of the healthcare services until after the
services have been received (GAO, 2011). The disparity in the price charged to the consumers
varies widely. On the one hand, Medicare and Medicaid, the large public healthcare insurance
companies do not pay full fees for medical services; and on the other hand, the cash-pay/ selfpay patients and the uninsured patients are asked to pay the full price—or whatever can be pulled
out of them in some cases—with the help or debt collectors or courts (Reinhardt, 2014). The
issues with medical care and bills have resulted in severe social problems. In the early 1980s,
only 8% of bankruptcy cases had a medical cause (Sullivan, Warren, & Westbrook, 2000).
However, the bankruptcy rate has sharply increased, and it is estimated that half of personal
bankruptcies and one-quarter of home foreclosures are a result of medical debt (Fuse Brown,
2014).
Prices charged by the providers for healthcare services are based on the hospital’s
chargemaster. The chargemaster is merely the list of all the services and all the supplies a
hospital provides. This price list is arbitrary, and the creation and maintenance of this ad hoc list
varies between hospitals (Reinhardt, 2006). The price of a service is based on the negotiation of
insurance companies with the providers and not with the cost of providing services. The price of
a service can vary drastically with the same provider based on how the service is paid for (Figure
9). It can also vary for the same service with different providers even with the same insurance
(Figure 10). More than a dozen hospitals in the U.S. are charging more than ten times their total
costs for treatment (Table 13), and the average charge to cost ratio of the hospitals by the state
range from approximately 125% to 580% (National Nurse United, 2014). The patients with
higher out-of-pocket deductibles or no insurance, who cannot afford the cost of care, have
limited options—either to forgo medical care or be exposed to financial ruin.
72

The Price Depends on Who is Paying
List or "chargemaster" price

$2,844

Cash price

$695

UnitedHealthcare negotiated price

$1,990

Blue Cross negotiated price

$617

Aetna Negotiated price

$520

Cigna negotiated price

$341-$362

Medicare Rate

$335

Figure 9. One Test, Many Prices.*
*The table shows the price of MRI for the knee, hip or ankle, without contrast, at Oakwood Health care
System, Dearborn, Mich. as collected by PricingHealthcare.com - Adapted from (Beck, 2014).

Figure 10. Price Discrimination between the Providers*
*The table shows the actual transaction prices paid by a large New Jersey Health Insurer for a
colonoscopy in 2007 to various facilities where the procedure was performed. Adapted from (Reinhardt,
2011).
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Table 13. Charge to Cost Ratio*
List of Hospital

Charge to Cost Ratio

1. Meadowlands Hospital Medical Center, Secaucus, NJ

1,192%

2. Paul B. Hall Regional Medical Center, Paintsville, KY

1,186%

3. Orange Park Medical Center, Orange Park, FL

1,139%

4. North Okaloosa Medical Center, Crestview, FL

1,137%

5. Gadsden Regional Medical Center, Gadsden, AL

1,128%

6. Bayonne Medical Center, Bayonne, NJ

1,084%

7. Brooksville Regional Hospital, Brooksville, FL

1,083%

8. Heart of Florida Regional Medical Center, Davenport, FL

1,058%

9. Chestnut Hill Hospital, Philadelphia, PA

1,058%

10. Oak Hill Hospital, Spring Hill, FL

1,052%

*Adapted from NNU and IHSP: Top 10 Most Expensive Hospitals in the U.S. listed according to
the percentage of their charges relative to their costs
Historically, 90% of the reimbursements have come from insurance companies, so
patients have seldom worried about the price (Lutz, 2007). However, with the increase in high
deductible plans, the patients are paying more out of pocket (Hammer, 2006). With the intention
to help patients choose efficient providers for their care, legislation was introduced in 2009 to
mandate price transparency (Dafny & Cutler, 2011). Implicit in these policies lies the assumption
that reduction of governmental intervention would stimulate the healthcare sector to behave like
any other commerce marketplace, i.e., in a price-competitive manner and would result in costefficient medical care (J.C. Robinson, 1988). Needless to say, these changes have been slow to
appear because of the lack of meaningful information for the consumer to use, and because most
consumers still remain unaware of the price discrimination existing in the healthcare market
(GAO, 2011; Schleifer, 2015).
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With changes in the regulatory landscape, higher out-of-pocket costs, emphasis on
healthcare consumerism, and the advent of smart technology (cell phones, tablets, and wearable
technology) that provide access to information at our fingertips, price transparency in the
healthcare market should have arisen. Organizations such as Amazon, Airbnb, Uber, and
Expedia have delivered a shopping experience where consumers can compare and shop for the
best value for their money. For a meaningful change to take place in healthcare, incentives and
rewards have to be aligned across all stakeholders ( The patients, The providers, The payers,
The Policymakers), and they all will have to be on board (Cornett, 2007). The U.S. healthcare
system is due for an overhaul to a more price transparent system. Though multiple transparency
initiatives (by Medicare, private insurance companies, and the providers) are underway, and 35
states have passed price transparency regulations; yet there has been a minimal impact on price
transparency results (Bumpass & Samora, 2015; Sinaiko & Rosenthal, 2016).
Having conducted a literature review of the healthcare terrain above, in the next section, I
introduce my research motivation and my research question. This is followed by a description of
the research methodology used in my study and the findings from the perspective of the four
important stakeholders, the 4 Ps (The providers, The payers, The patients, and The
policymakers) in the healthcare landscape. In the discussion, I present an integrated view of the
stakeholders with a model that emerged for my analysis and the implications regarding price
transparency in healthcare.
Research Motivation
Healthcare price transparency has been a hot topic in the healthcare industry for a decade
now, but the tactic of creating price transparency to reduce healthcare spending has shown
modest results. Despite various price transparency tools available through insurance companies,
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private vendors, and state government, the utility remains low and the market continues to stay
opaque (Mehrotra et al., 2014; Rosenkrantz & Doshi, 2016; Sinaiko & Rosenthal, 2016). With
the advent of consumerism, healthcare is one of the few areas of commerce where consumers
agree to spend out of pocket for the service without knowing the actual price of the service. This
study aims to delve deeper into the factors that result in an opaque healthcare system and propose
an emergent theory or model to explain why the market has maintained its status quo on price
opacity. In response to these stated purposes, I propose the following research question:
Why is there a lack of price transparency for Healthcare Services across the U.S.
Healthcare System?
The focus of the research is on price transparency of non-emergency and shop-able
services.
Healthcare is a complex industry and like any other industry uses specific terminology.
During my research, I heard and came across a lot of terms, some which understood and some
not so much. I have added definitions of a few key terms that have been discussed in this paper
for reference (Appendix 8).
The impetus of the study also comes from my pilot phenomenological research study
conducted by interviewing seventeen patients who were waiting to be seen by a doctor at a
doctor’s office. The study revealed some interesting findings about why consumers do not shop
for prices in the healthcare market. Among the themes that emerged, these major ones surfaced:
•

Patients are unaware of the price variation and discriminations that exist between the
providers with the same insurance.

•

Historically patients have assumed that their health insurance plans would cover the cost.

•

Patients trust their physicians to make the right (health and cost) decision for them.

•

Patients observed that the physician and the staff are unaware of the cost of service.
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•

Patients believe that the pricing is all done by insurance companies and this pricing is
rigid.

•

Even though some transparency efforts are emerging, patients are unaware of the
resources that are increasingly available to compare healthcare prices.

•

Patients discern that the energy and time put into finding the prices not worth an effort.

•

Some patients are hesitant about discussing the cost of care with their doctor especially
when it comes to health (considered a taboo).
The interviewees from the pilot study described agony over the outrageous bills from the

hospitals both in emergency and non-emergency settings. In most cases, the patients called to
question the billed amount to put the price into perspective. These ‘after the fact’ bills leave the
patients stranded with no choice but to pay or have collection agencies aggravate them about
their bills (Riffkin, 2014).
Having researched the view of one major stakeholder, the patient, in the pilot study; the
logical next step was to take a comprehensive look at the industry and understand the perspective
of all the major stakeholder on price opacity in the healthcare system.
Research Methodology
My initial literature review found no evidence of theories that could explain the lack of
price transparency in healthcare. Though there is ample literature on healthcare price
transparency and opacity, there is no evidence of an exhaustive study investigating and
understanding the intricacies of the major stakeholders together. After reviewing various
methodologies, I felt that Grounded Theory Methodology (GTM) would be the best approach for
this domain. This methodology would allow me to have candid conversations with the
participants to delve deeper into interpreting the complexities in the multilayered and
multifaceted healthcare industry. Another reason for using Grounded Theory Methodology was
to come up with explanations and develop a model or a theory that is grounded in the data
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collected through the interviews of the industry leaders representing a significant stake in the
healthcare industry.
GTM guidelines, as outlined by Corbin and Strauss (2008), were followed starting with
data gathering. Open coding was done at the line by line and sometimes at a few lines and
paragraph level to incorporate the participant's idea. Open codes were aggregated by concepts to
create axial codes or categories. Initially, theoretical sampling was done to collect data and
information based on the core concept. I was seeking information on the price-opaque healthcare
system to understand all the factors and their relationships, co-dependencies, and boundaries
relevant to my core concept. This sampling led me to various areas/sectors in the healthcare
industry that provided me with a 360-degree view of the healthcare industry. While multiple
iterations of open and axial coding were being done, comparisons were also made across
different healthcare areas vis-à-vis the provider side, the payer side, the patient side, and the
policy side. The coding and interviewing were done until saturation was achieved. I stopped the
interview process when each segment of the healthcare industry (i.e., Stakeholders in each
segment) started giving me information that was redundant and stopped producing additional
codes. Finally, after saturation was achieved, selective coding was done to identify core
categories. Throughout the process, memo writing helped with narrating the codes in concrete
explanations and diagramming enables visual creation (Strauss & Corbin, 1994). The continuous
analysis along with constant comparison and memo writing led to the development of a relational
model that helps in explaining the phenomenon of price opacity in the healthcare market. (See
Figure 11.)
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Figure 11. Corbin and Strauss Grounded Theory Methodology
Participant Selection
An exhaustive selection of all the industry stakeholders was important for this study. I
wanted to understand the viewpoint of each stakeholder so that I could get a comprehensive
perception and understanding of the factors that are keeping the industry opaque. I recruited
industry executives (CEOs, COOs, CFOs, EVPs, SVPs, VPs, Executive and Senior Directors,
business owners, etc.) and professionals (consultants, physicians, researchers, academics,
journalists and lobbyist) who are the healthcare leaders in various organizations with knowledge,
expertise, and insights on the healthcare pricing and policy landscape. These executives were
categorized to represent the four main stakeholders (Table 14) in the healthcare industry, namely
the provider, the payer, the patient, and the policy side (the 4 Ps hereafter).
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Table 14. Participants in the 4 Ps
Patient Side
Number Provider Side
Number Payer Side
Consultants
4 Providers
14 Insurance
Journalist
2 Physician
4 Broker
Employers
4 Provider - Lobbyist
3 Benefit Advisor
Employer-Lobbyist
1 Hospital Associations
7 Healthcare Vendors
Consumer Advocate
4
Total Participants per
segment
15
28
Percentage of
Participant to the total
Participants
19%
36%

Number Policy Side
Number
5 Government, Policy
7
2 Academia
8
7
6

20

26%

15

TOTAL
PARTICIPANTS

19%
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The providers of healthcare services are doctors, nurses, nurse practitioners, physician
assistants, other healthcare professionals, hospitals, clinics, offices providing healthcare services
like imaging, medical labs, etc. For this research, I have grouped providers and their
representatives under ‘The provider side’ This side is represented by hospitals, group practices,
physicians, hospital lobbyists, and hospital associations. The provider side has vested interest in
the providers who deliver care.
The healthcare insurance companies are generally referred to as payers. The payer along
with other professions manages and administers plans and benefits. For this research, I have used
healthcare insurance companies and other professions such as brokers, benefits advisors and
healthcare vendors as ‘The payer side.’ This side acts as an intermediary between the patients
and the providers to meet the healthcare needs of consumers (patients, caregiver, employer who
provides healthcare to their employees) by assisting in and assessing their circumstances.
The patient side focuses on patients and consumers. These terms have also been used
interchangeably to represent specific meaning. Not all healthcare consumers (non-sick
consumers, parents, caretakers, etc.) are patients but all patients are consumers. Consumers
become patients when they enter a healthcare system for a service; but when healthy, they are no
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longer a patient but are still consumers. In this research, ‘The patient side’ is represented by
consumer advocates/ authors, journalist/reporters, consultants, employers, and employer
lobbyists. This side is the voice of the patients because it represents their concerns.
The policy in healthcare is state and the federal government. For this research ‘The policy
side’ is represented by thinktanks, researchers, academia and nonprofit research organizations
which influence policy and participate in creating changes in regulations. This side is continually
researching and writing in academic journals, assessing the current healthcare industry, and
educating the government on various issues in healthcare.
Table 14 shows the percentages of the 4 Ps to the total participants. Of all the
participants, 28 (36%) represented the provider side, 15 (19%) the patient side, 20 (26%) the
payer side, and 15 (19%) the policy side.
Many of the participants have experience in various sectors of healthcare. For example, a
participant on the provider side, with a total of 18 years, has been with the provider side for the
last eleven years and previously spent seven years representing the policy side. This cross
experience makes my study participants more attuned to different perspectives and enables them
to be more conscious of the complexities confronted by the other segments of healthcare. With a
total experience of 1,688 years and average experience of 22 years, most of these industry
leaders have been in healthcare long enough to reflect on the past and have a critical acumen to
glimpse into and anticipate the future.
Data Collection
The seventy-eight interviews (over the phone and in person) were planned and conducted
in small batches over the seven-month period (February–August). They were then transcribed
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and edited for correct content. The average interview was 65 minutes long with the longest one
being 168 minutes, resulting in 85 hours of interview data.
The semi-structured interview structure facilitated open discussion providing me an
opportunity to cross-question or clarify information to dig deeper into relevant topics. The
interviews were divided into three sections, and the participants were asked the same set of
questions:
•

In the brief (five minutes) first section, participants were requested to provide a short
description of the current role they play and or any past role they had played in healthcare
pricing.

•

The second section that typically lasted thirty to forty minutes asked questions about the
opacity in the healthcare system and their organization (if relevant)

•

The third and final section that typically lasted twenty-five to thirty minutes asked
questions about the direction of healthcare and the current the interviewee's perceptions
toward the consumer behavior.

Results
The 4 Ps – The Patient, The Provider, The Payer, and The Policy Side
The healthcare system, just like any other market, has a demand and a supply side. The
demand side is consumers/patients. The supply-side is the health delivery systems, the providers,
the hospitals, the doctors, the physical therapists, etc. The difference in a regular market vs.
healthcare is that it has a strong policy regulation and a payer side that act as a liaison between
the demand and the supply side (Figure 12).
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Figure 12. The 4 Ps in a Pod
The Provider Side: Health Delivery Systems and Their Representation
As mentioned above, the provider's side is represented by the healthcare delivery systems
and the groups with a vested interest for the providers and healthcare professionals.
The provider side and the industry.
Meaningless information. Because of increased healthcare spending, the changing
landscape is bringing all players into the limelight. With the blame game and the finger pointing,
the providers perceive that they have been criticized the most for high prices because they stand
to lose the most from price transparency (Fuse Brown, 2014). However, surprisingly, most of the
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provider side participants that I interviewed agree with the importance of price transparency but
caution that the price transparency information available is meaningless to the patient. There is a
hope that technology will make dissemination of information easier, but the information should
be simple, clear, understandable and relevant.
One of the many reasons for price opacity in healthcare: The price information available
to the consumer is not meaningful and does not provide relevant information for them to make
decisions. My participants are resistant to government mandating the publishing of prices that are
irrelevant to the consumer and do not help with their decision making.
•

Provider side – Physician 4: “Some providers will give you that information but it's not
really a price. It's really an estimate of your financial responsibility within the constraints
of your insurance. It's very difficult, even with as much press as price transparency gets,
every institution, every office seems to have some twists and contortions that make the
exercise very, very difficult.”

•

Provider side – Health system 8: “Putting up hospital charges and comparing them is
meaningless. Putting up actually payments by insurance companies is much more
meaningful. But that [ information] is protected under most circumstances as protected
contractual information. I think that's the sort of thing that should be open.”

•

Provider side - Hospital association 2: “All the healthcare system stakeholders are going
to have to figure out how to get the right information to the right people [consumers]
Knowing the prices, for example, the list price of a surgery is not necessarily meaningful.
What's meaningful for the consumer is knowing the immediate liability he [she] has.”
The provider power and market consolidation. The providers are aware that high

spending, high deductible health plans, media outcry, and government attention are bound to
significantly change the healthcare industry. Having to protect their territory and run their
businesses, they are ready for the change that might come their way. They are already involved
with mergers and acquisitions, integrating vertically to become health insurers and horizontally
by buying freestanding outpatient clinics. This benefits them in a few ways: First, they can have
a greater market presence and hence greater market share; Second, once they get the consumers
into their outpatient clinics, they can refer them for services within their network. Third, the
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integration through mergers and acquisitions can help them to create an integrated healthcare
system that will help the hospitals to increase efficiencies and at the same time provide a better
customer experience; Fourth, they can eliminate (to some extent) the competition in the market
to establish monopolies and oligopolies; Fifth, they can reduce the threat of competition hence
price transparency and hence the impact to their bottom line.
Market consolidation and market power of the providers (supplier) also leads to price
opacity. In a preemptive response to the changes that will be coming to the healthcare market,
the providers have begun consolidation and expansion effort for various reasons.
•

Provider side – Hospital association 3: “You can't say that when they're [hospitals or
healthcare delivery systems] consolidating it is for monopoly reasons. It's because they're
trying to build an integrated, care-delivery network. It is high quality, low cost because
ultimately, they're going to be accountable for total cost of care. They can't depend on
somebody else to be high quality and low cost. They need to build it. That's exactly why
CVS wants to have a payer.”

•

Provider side -Hospital association 6: “I think it's about acquisition. The larger you are,
you have [hospital or healthcare delivery systems] a great economy of the scale you could
reduce your cost, but I think that's one reason, I think another reason is you can
consolidate for instant, if you're trying to create a tertiary care center where you have
high-end surgery procedures. If you're larger you can start to funnel patients from other
facilities into your central system. Again, efficiency, I would say more of a gross
efficiency prospective.”

•

Provider side- Hospital association 5: “The market's changing for multiple reasons. It's
not just one. The complexity of care today is chewing up the small and solo practitioner.
They cannot manage all the infrastructure needed to run a modern system. They want the
world to stay fee-for-service because they could control their destiny. But in order to run
modern digital health information systems and in order to communicate and manage
complex enterprises that are interfacing and coordinating care, [they] need a lot of
infrastructure.”
Physicians’ lack of knowledge about prices. Physicians also do not want to discuss prices

with the patients because they perceive it belittles their profession. They get offended and
emphasize that discussing prices degrades their services and the selfless profession of being a
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physician. The other reason is that as a physician, they have not been involved in the price
discussion and are unaware of the high prices.
The physicians’ lack of knowledge about the prices and a lack of desire to discuss them
or to bring price as a part of total healthcare experience also leads to maintaining the status quo
of price opacity. The physicians discern that discussion about prices is not a part of their
profession.
•

Payer side - Insurance company 5: “I mean, doctors in general are just almost offended.
And they’re scientists, so they went to school and they were good in science, and they
became doctors. They don't want to be business owners. They don't want to be thought of
like a pizza shop, and they don't want to have to have prices and marketing” No, and our
providers don't have any reasons, I'm saying I don't think they understand.”

•

Provider side - Hospital system 13:“Our providers don't have any reasons [to hide prices],
I'm saying I don't think they understand. Our providers have very little interest in any
event [of creating price transparency] anyway.”

•

Patient side- Journalist 1: “You don't just have to say, "Oh, I'll pay it [a drug]," You can
call the doctor back and say, "Look, I just need a little liquid and antibiotics [ for a pink
eye]. Is there's something else you can give me?" and the doctor was like, "My God,
you're kidding. $300? That's insane. Here, you can take this." If people are made to feel
comfortable with that [calling the doctor] they will realize the doctors, when they
prescribe something that's very expensive, don't do it because they are going to make
money off of it. They're busy and it's very difficult to do everything that they need to do [
know the prices of product and services]. I don't think that there's ill intent here.”
The provider side and the payers.
Preservation of self-interest. The providers have a symbiotic relationship with the payer

(i.e., insurance companies) health plans. Both sides sit on the negotiating table, and both come
out a winner. The providers are able to give the desired amount of discount to the insurance
companies by increasing their prices on the chargemaster and still able to keep their price margin
and the insurance companies are able to get the desired percent discount. It is a win-win for both.
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All the stakeholders who benefit from the opaque healthcare system strive for the
protection of self-interest. There are different ways the providers and healthcare insurance
companies negotiate to protect their interests and still be synergetic.
•

Payer side – Insurance company 4: “The payers will try to get the hospital or the
physician to take the least amount of money possible for that service, as long as it is what
they call reasonable and customary. Which means as long as it's around what others in
the area are getting for this service or this procedure, we [payer] want to pay you the least
amount on that as we can. And so, it doesn't matter whether or not price transparency,
which is different than cost transparency. So, the cost transparency is being able to do
that knee replacement for $500 but charging $50,000, the price transparency is we can do
it for $500 but our charge or our price for doing it is $25,000, but if you have this
insurance, it's only going to be $10,000.”

•

Policy side – Academia 1 (He is on the board of a non-profit hospital): “There is a sort of
an unholy alliance between the hospitals and the insurance companies, commercial
insurance companies that they both play this game like that discount really means
something. In one board meeting I went into they said, "Well we're [the hospital] going to
have to raise our charges." I said, "Well why would you raise your charges. I mean we're
doing fine financially. And Medicare is generous in the payment for this. We're an
efficient operation. We've got plenty of capital. Why would you need to raise the
charges?" Well because [insurance company] wants a discount. Why would they want a
discount? They're getting the best price of anybody. They're getting the same price we
charge everybody, including the feds. They said, "No, they want a desired discount." So,
we raised the price to 50% above what we paid before and gave them a 30% discount and
they were happy. It makes no sense at all. This is where I first got really cynical about
insurance companies. Because they needed to show their small group clients that they
were actually saving them money. So, they had to show them that the discount was what
they negotiated from their hard-nosed position. In spite of the fact that they were actually
net paying 20% more than they would have otherwise. Made no sense. They were
happy”.
Contractual negotiation. On one side, the payers and the providers work hand-in-glove

whereas, on the other, a talk about price transparency starts the blame game. The providers argue
that insurance companies have all the information on prices as well as information on patient
benefits, so they should be the ones to publish prices. The insurances companies present a
counterclaim that the providers have price information, too, and they should provide it because
they are the first line of interaction between the patient and doctor. Moreover, the patients expect
all their questions to be answered when they meet the providers. The providers fight back
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because they do not have real-time information about the benefit plans. In reality, neither of them
wants the prices to be out because it is proprietary data for both; and if out, it can dampen their
abilities to negotiate prices.
The contractual negotiation protected by the anti-trust laws, motivation for protecting
their (providers and payers) individual interest, blaming the other are few other reasons for an
opaque healthcare. My participants (the provider and the payer side) blamed each other and the
confidentiality clause for price opacity in healthcare.
•

Provider side – Hospital association 2:” It's the payer's responsibility, the third-party
payer responsibility to make sure that either through the provider who gets the
information electronically from the payer or between the websites the payer has, that they
make people aware under what circumstances they would have to pay X.”

•

Payer side- Insurance company 4: “Hospitals don't want it [ share their information].
Hospitals would rather not have their information shown and shared about how much
they're charging for different services, because they know that will in most cases cause
for a change in behavior when it comes to the overall patient and where they're going”.

•

Patient side – Consumer advocate/Author 2: “The contracts that health insurers have with
healthcare providers require secrecy. That actually benefits both the provider and the
insurer, but not the patient, not the consumer because we don't have knowledge that we
should have about the deals that insurance companies strike with providers.”
The provider side and the policy.
Reluctance to invest resources on ineffectual causes. The providers are displeased with

the government. They do not welcome government intervention because they argue that the
government does not play fairly and intervenes without complete knowledge of how a change
may impact the healthcare market. This is the reason that the hospitals have the strongest
lobbying market.
The hospitals lack resources and the providers are unwilling to invest more capital in
something that might not work or have value. The provider side expressed their frustration with
high regulation cost.
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•

Provider side – Hospital association 4: “The resources [to create price transparency] but
who's going to be able to do all of this within a hospital and how many FTEs [full-time
employee] are they going to have to hire to devote to that. And when you just look at how
much they're already spending on regulatory burden. [We] did a study at the [ an
Association] and found that regulatory requirements associated with complying with
federal regulations account for approximately $1,200 of the cost for every hospital
admission.”

•

Provider side – Hospital system 7: “All this time, all the regulations that they put on
hospitals drive their cost up. If we want to get price down, we need to delete the amount
of regulations we have. Hospitals are too heavily regulated right now. It's ridiculous.
They have to hire staff just to deal with all the certifications and qualifications, and
surveys, and then follow up to surveys. They [have to be] survey by everybody. That's a
full-time job. It probably costs in the hospital [one full-time employee] with benefits up
to $100,000 a year, American College of Radiology comes in and surveys radiology. Oh,
wait a minute, do you have any nurses in here? Well, we're going to have to look at their
credentials because you know, there's regulations through the American Nurses
Association. Well, let's go over to this department, what regulations do we have here? We
have this, this and this, and then everybody has to do joint commission. And then
everybody has to pass the Florida department of public health. I mean, they're just
constantly, constantly regulated and being surveyed, and those regulations aren't free.
They impose regulations that require you to change staffing levels, change facilities. Add
doors, add sprinklers, add ... and that all costs. And somebody at the end of the day has to
pay that, or else that hospital closes. So that's why their costs are higher.”
Cost shifting. On the issue of price transparency, the providers are at with odds with the

government. They stress that the government tactics to create price transparency add no value to
the consumer but instead add another administrative burden on top of other regulations the
providers have to comply with. They feel that the government pays them below cost on Medicare
and Medicaid payments and thus they have to shift costs to the commercial insurance companies
so that they can have a decent bottom line to run the hospitals.
The providers remark that they are paid below cost for their Medicare and Medicaid
patients. Therefore, they have to cost shift to make up the difference by charging higher prices to
the commercial insurances. Price transparency would create a challenge to cost shift.
•

Provider side – Hospital system 10: “If you look at from the hospital and the State of
[Name of the state] 60% of my business is Medicare, 10% of my business is charity care,
and about 15% of my business is Medicaid. Medicaid pays a little bit less than Medicare
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does. For me, 85% of my business pays me less than cost, so I have to make money on
that 15% of my business, which is why you get that cost shift.”
•

Policy side – Nonprofit organization 5: “Everybody in the country loses money on
Medicaid. Most hospitals lose money on Medicare. And where do they make that up? On
the commercial insurance side. They have to charge more on the commercial insurance
side to make up for that and that is cost shift. What better way to describe that to the
community than say, "Hey, we have to charge more because we got a 20% Medicaid
burden. That [cost shifting] is probably one of the biggest challenges, of transparency is
that some hospitals have to make up for a massive indigent volume.”
Not on board with regulatory efforts. The government (CMS: Centers for Medicare and

Medicaid Services) has recently announced two initiatives to create transparency. Most states
that are participating are mandating that the hospitals publish their chargemaster prices.
Surprisingly, the providers with whom I talked did not mind creating price transparency. Instead,
they had concerns with the way price transparency is being ushered in. They claim that the ways
the government (both state and federal) is trying to create price transparency is just for media
attention. The second initiative led by the government is to publish the average prices of service
at the state and hospital level. Once again, the average prices do not provide any relevant
information to the consumer. These prices can be skewed depending on the type of market (a
market with high government subsidies like Medicare and Medicaid patients’ market will show
lower costs of a service, vs. a market with most commercial insurance companies). The average
price does not reflect the price a patient would pay out of pocket. Both initiatives are opposed by
the providers and the policymakers.
The providers perceive that the government is mandating hospital system to publish
irrelevant information and is meaningless for the patient. They are apprehensive about it and not
on board with the efforts made by the government to create price transparency.
•

Provider side – Hospital association 3: “Of these proposals [state and federal efforts for
price transparency] to mandate cost reports being public, that's a waste [publishing the
charges]. That's not going to do any good. It doesn't mean anything to anybody. It's a
wasted effort. I would oppose that. That is an unnecessary expense that means nothing to
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a person [because the patient or the insurance companies never pays these charges and
even if you pay of pocket you never pay those].”
•

Patient side – Consultant 4: “The Inpatient Prospective Payment rule that just came out
[May 2018]. They [Centers for Medicare and Medicaid Services] put in there that they're
interested in hospitals posting chargemaster data and regulating it, mandating that they
do. It’s a proposed rule but and people are going to probably lobby against it. You don't
know what's going to be finalized, so who knows, but they put it in there, and they're
using authority from the Affordable Care Act to be able to do that. But we'll see what
happens.”

•

Provider side – Hospital system 6: “State of [State] is going to hire a vendor, create some
pricing bundles. They would pull all of our hospital claim information and [ average
them] do pricing bundles for things like hip surgery, a knee surgery, and I think there
may have been a cardiac.” Another provider side from hospital association 1 mentioned
this database by saying: “The data that's available is like with the charge data and the
health charges have gotten convoluted, are more connected to Medicare than anything
else. So, I think that it's just a complex system and then there is a lot of data out
there…but there's no data to show what it costs.”
The provider side and the patients/consumers.
Unaware and uninformed consumers. The providers attribute to lack of price

transparency to consumer awareness and education. They discern that consumers have to be
responsible and take charge of their financial situation.
The consumers are unaware and uninformed of the price variation. According to the
provider side, the patients need to take more responsibility for health finance.
•

Policy side – Academia 8: “I think it's a combination of reasons. If you look at some
surveys that have come out, a research is being conducted, often patients don't know that
the information exists and they don't even know to consider it. Then, there's another
group that doesn't know where to find it.”

•

Provider side – Hospital system 4: “I think we've got the tools [for price transparency],
particularly down to the patient level. What I think is lacking is education and adoption.
So, whatever we could do to up that, to me, is going to be the big ... you know, that's the
game changer here. Folks have to understand. They have a responsibility to understand
what their healthcare costs. Like I said, I think our particular American society has been
educated to not have to do that”
Trust in physicians. The patients have great faith in physicians but not so much in the

hospital systems. They trust and regard the physicians and put them on pedestals and are
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reluctant to talk about prices with their physicians. They hesitate because they are ashamed of
giving an impression of frugality, that they are putting the money before their health.
Patients’ trust in their physician, results in patients blindly following their instructions
without asking any questions, let alone worry about the price.
•

Patient side – Employer 2: “A lot of people are like, "Well my doctor told me I had to go
over here and get that done, so I'm going to do over here and get that done." They don't
even think about, "Do I have to go over there? Or can I do something else? They trust
their doctors."

•

Payer side -Benefit advisor 1: “People will make choices for crazy reasons. I've been in
situations where it's like, "Look, if you go to this hospital, you have to get on a plane to
go to this hospital, but it's going to save the health plan [thousands of dollars], and the
outcome data shows that you have a much higher chance of survivability for this surgery
you're getting ready to have. Would you go to this other hospital?" They said, "No, I want
to stay here with my local doctor in the hospital."

•

Provider side – Hospital system 6: “We go to the doctor we like, and we go to the
hospital that the doctor tells us to go to, and we've left the decision to the doctor that we
trust and to the insurance company that's paying the bill. We never said, "Hey, this is
really my responsibility to sort this out, to shop doctors. I really should be looking at their
backgrounds and selecting one that's good for me. I should look at what they charge, and
maybe I should pick hospitals on other things like quality, and I haven't been doing that."
I think we've abdicated our role as a consumer because we've left it to the doctor we trust
and the insurance that's paying the bill, and that's it.”
The Payer Side: Healthcare Insurance Companies, Benefit Advisors and Vendors
The payer side is represented by healthcare insurance companies, brokers, and benefits

advisors and healthcare vendors. This is a side that assists the patient side (patients, healthcare
consumers, and employers) with the administration of, as well as benefits planning and decision
making for their healthcare needs. The insurance companies are referred to by other stakeholders
as the BUCAs (which stands for BlueCross Blue Shield; United; Cigna; Aetna or BUCAHs with
Humana included).
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The payer side and the industry.
Complex nature of healthcare. Consumers are not clamoring for price transparency but
the insurance companies, some providers, vendors, and some state website have tools for them to
use for price shopping. The utility of these tools remains low because of many reasons, one of
which is the complexity of the health information, the human body, and diseases. For a patient, it
is arduous to understand the key terms, biomechanisms, pharmacology, diseases, etc., that could
impact them. A vendor that sells medical management services to employers helps patients to
navigate through the healthcare episodes by providing disease management. They provide
advocacy on behalf of patients. The medical management is performed by independent doctors
and nurses who help the patient understand the disease, help them with the treatment options,
cost and quality matrices, etc.
Healthcare is complex and perplexing. The information is very confusing for the patient,
who when in need of healthcare, is in a weak and feeble state. They need handholding and
guidance at this stage.
•

Payer side – Vendor 6: “We have patients all the time who will call and say, "I need help
finding an in-network podiatrist." We say, "Okay, great. I can help you with that. Why do
you need to see a podiatrist?" They'll say, "My knee hurts." Well, you don't go to
podiatrist for knees, podiatrist is for feet. So, the whole medical jargon, lingo kind of
stuff will need someone, preferably a nurse or a doctor, someone to help them navigate
through that. So, we have medical interpreter.”

•

Payer side – Vendor 3: “Spending millions and millions of dollars on unnecessary
services you don't need. There's an alternative way to provide very, very healthy,
wonderful, rich health insurance benefits to your employees but you got to insert a
watchdog. That watchdog is medical management.”

•

Payer side – Benefit advisor 3: “[In the complex healthcare system] Consumers can pick
one MRI center or the other, but they're not going to be able to navigate the system for
pricing as it relates to surgical procedures because it's too complicated. You then have to
get engaged with pre-certification process. You have to coordinate the case management.
It's a complicated process, so what we do is have a healthcare navigator to help you
through the process, because it just gets to be too complicated without having a health
professional to help you navigate.”
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Payer power and market consolidation. The argument about who can and should publish
the prices is ongoing, but neither the providers nor the insurance companies want to do it. For the
insurance companies, putting the prices online would mean being out of business. Insurance
companies are a liaison to negotiate the prices of healthcare services in bulk for their members
(because they have strength in the number of members). If the negotiated prices are published,
the need the insurance companies will be eliminated. The market will come to equilibrium
through competition, and the role of the third party will be eliminated. Price transparency
threatens the purpose and very existence of insurance companies that are aware of the potential
shift in the market and are ready for the change. To avert the risk, they have started integrating
vertically. They are buying pharmacies, clinics, and nursing homes and have jumped into the
provider vertical. They are also now changing their role in servicing the industry to become
administrators of self-insured employer plans. Over time, the lines between the providers and
insurance companies will blur. Each stakeholder is trying to preserve its own interests by
positioning itself for the future. This dynamism in the healthcare market will change it in
unexpected ways.
The market consolidation and market power of the payers keep the market opaque. In
anticipation of the changes coming to the healthcare market, the insurance companies have
begun consolidation and expansion with other insurance companies. They have also started
venturing into the provider line of business in an effort to remain viable with the changes in the
healthcare market and to share the 80–85% of the share from the Medical Loss Ratio. As per the
Medical Loss Ratio (MLR), 80–85% of the premium dollars have to be spent on care. This
leaves the insurance companies with 15–20% of premium dollars for the administration of the
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health plans while still trying to make some profit. With the new wave of expansion insurance,
companies now are acquiring providers in order to get the 80–85% share.
•

Payer side – Vendor/Author 5: “These insurance companies would be out of business if
people did direct contracting, and they could figure out exactly what was being paid for
things[services]. But the health plans have a huge incentive to kind of stay in the middle
and keep things [prices] opaque and talk in terms of discounts from reasonable and
customary or discount the premiums to Medicare instead of just talking about plain old
prices”.

•

Payer side – Vendor 1: “So patients are not allowed to see the contracts that their health
plans have negotiated. Insurance companies and hospital organizations or medical
organizations have contracted confidentiality with one another on this. And the
agreement in that contract is to prevent anyone from scrutinizing or reviewing what the
exchange of revenue is going to look like for any particular service that the insurance
company's paying to the doctor. Because they want proprietary, that's their bread and
butter. That's their revenue source. And it's a revenue for both sides.”
Fear of change. Healthcare represents 18% of the GDP (KFF, 2017). The payers believe

that with the increase in healthcare spending, healthcare has become convoluted. It has become
too big to fail or change directions quickly. There are many stakeholders in and around the
industry, who have a vested interest in keeping the industry opaque and to perpetuate a status
quo.
Healthcare sector is 18% of the GDP and expected to grow to 20% by 2026. There are
many groups who have a vested interest in healthcare and its growth. Complete transparency can
dishevel the industry and cause havoc. Uncertainty and fear of change have kept the industry
opaque.
•

Payer side – Vendor 1: “When we say moving the Titanic, it's not necessarily moving the
Titanic. It's not really that difficult to move the Titanic or the industry. But what happens
is when we look at the industries and the way they're built, they're publicly traded
companies that are at the top of the healthcare food chain. They have a responsibility to
their shareholders. And if they disrupt themselves, there is a risk for stabilized revenue
stream, which would devalue them by making such an aggressive shift in change. It is a
requirement for the industry heads to maintain their financial portfolio with the level of
stability that keeps investors interested in them. It would also weaken them because they
would not be able to create the regulatory environment that they want to have that
protects entry of other people into the marketplace.”
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•

Payer side – Benefit advisor 4: “Healthcare itself has become too big to fail. There are so
many special interests that do not want to let it fail because now what it does is it causes
us to artificially prop up GDP growth. What would happen if 10% of our GDP [Gross
domestic product] evaporated overnight? That would be worse than 2008 [economic
collapse] that nearly caused a worldwide economic collapse. That's the other reason I
think it's going to be really hard to get that [full price transparency],”

•

Payer side – Benefit advisor 6: “Once it [healthcare] is transparent there's less ability to
hide money, make more money. The problem is people in America like to make money.
So, the more secretive it is, the more elusive it is the easier it is to make money. It's all
driven by profit.”
Misaligned incentives. With the growing concerns on high healthcare spending, there is a

strong motivation for finding ways to reduce it (Thorpe, 2005). In anticipation of any major
changes in healthcare, the insurance companies have started to adapt. They are venturing in
mergers and acquisition to move into the healthcare delivery side by acquiring clinics and other
facilities. They have also ventured out of just being an underwriter for healthcare service (their
current role, with higher risk) into becoming administrators of healthcare service, with minimal
risk. As per the Medical Loss Ratio (MLR), 80–85% of the premium dollars have to be spent on
care. This leaves the insurance companies with 15–20% of premium dollars for the
administration of the health plans while still trying to make some profit.
The incentive of the stakeholders is not aligned. Stakeholders are looking for ways to
maximize their profit and currently, there are no incentives for the stakeholders to create a
transparent market. Opacity and high prices are conducive to maximizing profit.
•

Payer side – Vendor 2: “The more recent strategy which is, insurance companies have
realized that the better way to make money is to actually become a provider of care and
focus on that 85 cents on the dollar, rather than just being an insurance company. There is
a huge movement of insurance companies now wanting to become providers of care
whether it’s a merger between Aetna or CVS. Whether it’s a merger between other
insurance company and other providers of care or organic growth. Like United Health is
doing with provider acquisitions. Everybody starts to understand that to make money
they need to be focused on those 85 cents to a dollar rather than on 15 cents and trying to
squeeze a cent more out of 15 cents that they have.”
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•

Payer side – Insurance company 1: “ASO is the Administrative Service Only contracts.
The insurance market on the commercial side is classified in two broader categories. One
is the fully insured, where the insurance company underwrites the policy and they own
the full risk. If somebody falls sick, then the insurance pays the bill. The other market is
called ASO which is administrative service only, wherein the big employers have a
policy for the employee, and that policy is an ASO policy, meaning that the employer has
contracted with [any insurance company], and this insurance company only charges the
Admin fee to administer the policy. The whole risk of paying my claim lies with my
employer.”
The payer side and the providers.
Profiteering and greed. As mentioned in the provider section, the payers and the

providers work in symbiosis. This love and hate relationship has resulted in finger-pointing and
quibbling on who is responsible for increased healthcare spending and an opaque industry.
The intrinsic motivation of profiteering and greed drives both the payers and the
providers and other industries (like medical devices, pharmaceuticals etc.) that benefit from an
opaque industry to keep the status quo.
•

Payer side – Insurance company 2: “I'll give you an example. In this example, the
hospital said to us, "Hey, we billed you for an inpatient stay," and this was for somebody
who was on a ventilator, "and you denied all of our charges for oxygen." I said, "Well,
yeah, I mean, oxygen is ... if somebody's on oxygen that's one thing. If they're on a
ventilator, the ventilator works with oxygen, so why would oxygen be separate?" They
said, "Well, if you're not going to pay for oxygen, we're going to gross up the charges for
room and board, and you're going to end up paying for it anyway. Even though you'll be
denying that line item, we're just going to gross up the charges for room and board."

•

Payer side -Vendor 2: “If you look at it somewhere in the middle from a corporate
segment there are stakeholders that would prefer the status quo versus folks who would
want to change it. The folks who get the benefit of this lack of transparency are obviously
providers that charge more of the services that are available in the market at a much
lower price. So that they enjoy the benefit of the lack of transparency. And they would
prefer that it stays the way it is right now.”
Lack of cost accounting for healthcare services. The payer side agrees with the provider

side that the government does not pay enough to the hospitals for the services under Medicare
and Medicaid. However, the payer side claims that hospitals have found an easy way to get out
of the predicament. Whenever the hospital’s bottom line is in jeopardy, instead of focusing on
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improving their efficiencies and or reducing cost, the hospital increases the prices through the
chargemaster.
The hospitals do not have a cost accounting system for the cost of services, their prices
are based on the chargemaster and they increase the prices of healthcare services without
understanding the underlying cost structure.
•

Payer side -Insurance company 1: “I meet with a lot of CFO's of hospitals, and when I
ask them what cost accounting measures they have, they look at you like ... dumb. Now,
the fact is, that you cannot run any organization without having a very clear handle on the
cost structure because that controls your profit line. But the fact is, the American system
is such that most of the hospitals are not for profit, they didn't have a focus to sustain or
make profit, and for that reason, most of them don't have a proper cost accounting
structure. In an ideal world, if I run the hospital, I should know that I have thousand
square feet of space for example and how much each of the square foot generates value
for me. Meaning that how much I get from the outpatient care, how much do I get from
the outpatient surgery, how much do I get for inpatient care, and so on and so forth. I put
on top of it the resource cost and then I say, 'this is the cost to do my services'. They
[Hospitals] don’t have cost accounting to tell them what the cost of the service is. In
balancing the overall book, without knowing the cost, they face two challenges. First, is
the uninsured population who comes and doesn’t pay and by law they [the hospitals] have
to treat them [the uninsured]. Second, is the government payment, the Medicare and
Medicaid payment are only a fraction of a dollar that they [hospitals]get on the services
that they provide. So, their overall costing goes back to the point where they have to
negotiate better rates [using the chargemaster] with the commercial payer, so that they at
least are sustainable [profitable].”

•

Payer side – Broker 1: “I think the delivery system [hospitals] has been reluctant to lift
the veil [ to become transparent] of what they charge and this whole idea of having this
chargemaster and the "retail fee" that is associated with their services, but in probably 70
to 80, if not 90% of the cases, they don't accept that retail fee. They accept a discounted
amount from a Blue Cross plan or an Aetna plan or whomever it might be because of this
negotiated discount. And there are these write off advantages that they have between
what they accept and what they charge. It's a very complex system, and I think
they've[hospitals] been very reluctant to open the door or the black box in that regard.”
The payer side and the policy.
Ineffective price transparency regulations. Insurance companies distrust the government

because they too feel that the government imposes mandates that are not well thought through.
An example given was of EMR (electronic medical records). The government had mandated that
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all the providers had to have the patient records in an electronic format in order to make them
accessible to anyone in real-time. All the providers complied and had all the records in electronic
format, but the problem remains that the records cannot be shared over different platforms
because of combability issues and the information is still not accessible real-time to the front-line
staff, physicians, etc. One of the benefit advisors from the payer side ridiculed by saying that
“EMR is just a glorified filing cabinet.” The payer side recognizes that the federal and state
government are making an effort toward price transparency but believe it is not adequate to
change the system.
Though healthcare is a highly regulated market, strong and meaningful price transparency
regulations have not been proposed. Weak healthcare price transparency regulations have kept
the industry opaque. The regulations are well intended but not well thought through, thus leading
to erroneous outcomes.
•

Payer side- Benefit advisor 4: “I'm not going to rely on the federal government to do that
[create price transparency]. I'm not going to rely on Amazon and Jeff Bezos and
Berkshire Hathaway and Warren Buffet, JP Morgan, and all those guys, to solve it either
Because they're all tied to the stock market. Again, go back and take a look at it. The
problem is that there's too much money and that actually creating change would be too
disruptive to the market”.

•

Payer side – Insurance company 4: “Legislators aren't going to require it [price
transparency] because you have some sides that give money from physicians and you
have some sides that get money from insurance companies, or associations. So, in order
to continue to get re-elected, they will make sure that they maintain their autonomy
towards decision, or ambivalence towards decision-making yet talk on stump speech
about how they want to make sure that it's done differently so that they can continue to
get re-elected.”
Apprehension of government-led initiatives- governments’ lack of awareness causes

consensus and interoperability problems. The payer side believes that poorly-conceived
regulations passed by the government can have unintended consequences. A common example
sighted is of the Medical Loss Ratio (MLR). As discussed above, it states that at least 80–85% of
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the total premium dollars should be spent for medical care and the remainder for administrative
purposes. The intentions were clear that medical care would benefit in quality and payers would
be able to create efficiency by managing the remaining 15–20% of the premium dollars.
Uncertainty of the government led initiatives has led the stakeholders to believe that the
regulation is not well thought through. The consensus of the stakeholders is that government
though quick to pass mandates, the lack of awareness rarely understand the intricacies of the
healthcare market. On top of this, there is no governing body overseeing the consistency to
provided consensus and interoperability. This has weakened the trust of the payers, the providers,
patients and policymakers on the government. Consequently, any initiatives led by the
government are also met with suspicion and caution.
•

Payer side- Benefit advisor 6: “Let me ask you a question. What's bigger, what percent of
a million dollars or four percent of a billion dollars? I think that was an unintended
consequence. It doesn't take a genius to figure that out and it should have been realized
before it was put into the law. The intent of the law was to limit the profits of the
insurance company, but what they inadvertently did was they completely misaligned the
incentives of the insurance company and the employer and now they're directly at odds
with each other. Now, insurance company and staff they found ways to maximize profit
and do what they need to do to make the most amount of money possible.”

•

Payer Side – Vendor 3: “Who is the governing body [for healthcare price transparency]?
There's no governing body in healthcare to say, "Okay, let's create a system that talks to
each other and let's have these ... " Like an IT project management. There's nobody, so
everybody does their own things and that's why they [ the systems] don't talk [ are not
compatible with each other].”

•

Payer Side – Broker 2: “You have a lot of regulation based on geography and political
alignment. So, many times those understandings of what that should mean are incomplete
because the definition or the process of managing that is defined differently by the
organization that is trying to put in the regulation.”
The payer side and the patients/consumers.
Patients not the direct purchasers. Historically, the payer side has protected patients by

making purchasing decisions and protecting them from financial consequences and at the same
time making them insensitive to the prices (Austin & Gravelle, 2007). In healthcare, unlike other
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markets, a third party (the insurance companies) is paying for the services being consumed by
the patient.
Another reason for price opacity in healthcare is that patients are not the direct purchasers
and are insulated from the healthcare prices because of the presence of a third party, the
healthcare insurance companies. Thus, insurance companies reduce patients’ sensitivities to
healthcare prices.
•

Payer side – Insurance company 3: “Moral hazard is just created by the end user, or at
least historically with the lack of not having been in the game creates a situation where
you don't have the two direct parties having to interact with each other. There's a whole
lot of other unnecessary complexities that have taken over this system that the hospitals
and other some individuals providers have taken advantage of and are really used to their
advantage.”

•

Payer side – Benefit advisor 6: “Hospitals have the bargaining power because they're
negotiating with someone that doesn't actually foot the bill. They're negotiating with the
insurance company, so they have complete bargaining power.”

•

Patient side – Consultant 3: “I think because for so long we've been in really good health
plans. We've had HMOs, we've had PPOs. You might not have had to get authorization,
even. "I need to go to the dermatologist, so if it's not costing me anything, or if it's
costing me very little, it's $10 for a copay, wow, I'm not going to pay much attention to
that.”
Quality transparency. My participants emphasized the need for quality transparency

along with or instead of price transparency. The impetus to push quality is because patients do
not care about price as much as quality. The emphasis has been on providing both price and
quality tools in tandem to give the consumer resources to find comprehensive transparency and a
better value (better quality at a lower price).
Patients value the need for quality over price. The price transparency tools have no value
for them because they prefer quality over price, this keeps the system opaque.
•

Payer side – Benefit advisor 3: “You can get some limited transparency out in the
marketplace, otherwise, number organizations like Healthcare Bluebook, Castlight and
even some of the carrier tools that will give you some limited pricing around things like
MRIs, radiology, lab, but nobody gives you transparency by doctor around quality ratings
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or by a hospital around quality ratings and that's really the most important, because in
healthcare, unlike anything that I know of, there's an inverse relationship between cost
and quality.”
•

Payer side- Vendor/Author 6: “What you find is the highest quality facilities are typically
the lowest cost, which is the biggest challenge for us to get patients to understand.
American consumers think that the highest quality is always the most expensive because
that's how it is in every industry except healthcare... [this] kind of consumer buying
attitude doesn't hold true with healthcare. That the providers who do the highest volume
of the procedure usually do it much faster, easier, smoother, have fewer complications.
Because they do such a high volume the cost is lower.”
Absence of accurate and reliable price transparency tools. The insurance companies

have spent money and resources to create price transparency tools for consumers but have seen
insignificant consumer interest and usage. These tools have limited impact because they are not
reliable or efficient. They do not allow a universal search and are just bound to the insurance
network, only the enrollees in the insurance plan can access the tools, the tools are not accurate,
and most people remain unaware of these tools.
The absence of accurate and reliable tools for transparency is another factor why
transparency tools are pervasive. These tools though available do not provide meaningful
information so their usage is limited.
•

Patient side – Consultant 1: “Those things [price transparency tools on insurance
company’s website] don't work very well. People don't know how to use it, and they have
very low adoption rates. So, even though we have more price transparency than we've
had in the past, we still don't have good ways for people to access price transparency. I
think that's another barrier.”

•

Payer side – Broker 1: “There just haven't been the tools to do any kind of research. You
can't [search for ]MRI with or without contrast ..you can't ask [research] on what's it
going to cost me if I get an x-ray instead, or based on my benefits and my employer plan
or if I buy it on my own, what's my out of pocket going to be, and or is there someplace
better to go?"
Consumer skepticism. Another reason that consumers do not use the transparency tool is

that they distrust anyone (insurance companies and employers) who directs them to a lower cost
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provider. They feel they are entitled to go anywhere and that the insurance companies and/or
employers may have a financial motivation to direct them to go to a lower cost provider.
Consumer doubt towards the price transparency tools and initiatives impede the progress
towards transparency. Consumers do not trust the tools provided by insurance companies or
employers. Consumers believe they are being led to lower cost providers for financial gain of the
insurance companies and/or employer.
•

Policy side - Academia 4: “They[patients] think that the insurers are too self-interested.
The third-party payer has a greater interest in price transparency so is always sending
them[patients] to the cheapest provider. That's exactly why the patient doesn't trust the
third-party payer as a source of information. My insurer is always going to tell me to go
to [XYZ] City Hospital even if that's not the best choice for me. [This] would be the
fear.”

•

Payer Side – Vendor 4: “We did more detailed data [survey] on them. They had about
30,000 employees, a large insurance firm. And what we learned is that the employees
distrusted the idea they were being directed to lower cost providers. They thought there
was more in it for the employers was for them.”
The Patient Side: The Consumer Advocates, Journalists, and Employers
The patient side is represented by groups that have first-hand knowledge about

consumers and who represent their collective voice and their interests. The group consists of
consumer advocates/authors, journalist/reporters, consultants, employers who pay for
employees’ health insurance, and employer lobbyists.
High deductible plans have severe health and financial implications for patients. Research
shows that a major impact of the high deductible plans is that patients are foregoing care because
the prices are impacting them financially. Despite their anger and frustration, there is very little
evidence that a majority of them are shopping for healthcare services. Moreover, those who
shop, do not always follow through or are not satisfied with their shopping for various reasons.
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The patient side and the industry.
Healthcare not an economic transaction. Despite the high deductible plans, patients are
not shopping. The complexity is in part a barrier for them. Most of them are not sure what they
are buying or what they should buy (and if that service is right for them) and if they are sure then
they are not sure what they are getting for their money when they shop for healthcare services.
Are they getting everything they need or are there other parts to getting a total service and are
there alternatives? These and many other questions are difficult for a patient to answer while
shopping. This inhibits their shopping propensity and thus most of the patient healthcare is not an
economic transaction.
•

Patient side – Consumer advocate/ Author 2: It's hard [shopping]. It's not easy, and you
don't have any certainty that you're making a good decision. Even if you are quite
educated, and adept, and computer savvy, it's not easy. I don't know if that can change.

•

Policy side – Academia 4: “The records of people's use of decision support tools and so
on is pretty mixed. You want somebody else to pay for and to worry about the economic
implications of their medical care. They really do. People do not want to view their
healthcare as a normal economic transaction even though in some ways it is.”
Intricacies in healthcare and information asymmetry. As mentioned above, despite their

high deductible plans, they are not shopping. This lack of shopping, even when the patients have
to pay out of pocket, can be attributed to many things including consumer priority, preference,
the industry’s complexity, and fragmentation. Some of the complexity like not being
knowledgeable about health condition is inherent to healthcare but other complexities like lack
of standardization in products and services, fragmentation of care, opacity at numerous levels
etc. causes confusion.
For a consumer, being a patient is intimidating enough. To top that off the added
intricacies in healthcare makes it more challenging for them to maneuver through. The stress of
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making the right decision, while handling other complexities in healthcare is enough to create
anguish that adds up to the health sufferings.
•

Patient side - Consumer advocate/Author 2: “I worked in healthcare for a long time. I'm
pretty well-educated. I am now old enough to be in Medicare. But when I was looking at
making a decision … it's bewildering. You don't really know if you're making a good
decision. Healthcare is extraordinarily complex, even without pricing being a factor.”

•

Policy side – Academia 3: “There is information asymmetry in healthcare. The seller
knows a lot more than the consumer. Consumers are not shopping for healthcare prices
because it’s too complicated for them, they don’t have time, do not understand the
daunting system, don’t know where to find information, they are hesitant to ask for
prices, unsure if they are making the right decision, they are not organized.”

•

Patient side – Consultant 1: “You've got benefit designs, and there are provider contracts
and all this stuff. You've got different lines of business. You've got HMO versus PPO.
You've got Medicare versus Medicaid versus commercial insurance. You've got group
insurance, individual insurance. You've got the high deductible plans and out of pocket
maximums and co-pays and deductibles. There's just ... It's really complex.”
Fragmentation in healthcare. The healthcare industry is very fragmented. There are

numerous layers to provide and manage the care of a patient. It starts from employer and
insurance companies providing insurance to inpatient visits, outpatient visits, physician visits,
pharmacies, laboratories, imaging centers, physical therapies, occupation therapies, nursing
homes proving healthcare services; to brokers, benefit managers, third-party administrators
helping the employer; to third party vendors who help the employer with certain sections of
healthcare for example like quality vendors (create websites to help the employees find quality
providers) price transparency vendors (create websites to help the employees find better prices
providers), reference-based pricing vendors (vendors who help employers negotiate referencebased prices) , medical management vendors (these vendors focus on medical management,
utilization management, and disease management), wellness vendors (vendors who focus on the
wellness and prescreening for the employees), etc. Though each sector or layer of healthcare is
vital and has its own role in the healthcare industry, this has led to fragmentation. The
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fragmented healthcare system creates complexity because it is difficult to add price transparency
to each layer for a coordinated care experience.
•

Patient side – Consumer advocate 4: “Our healthcare system broadly is causing problems
because we have an incredibly fragmented healthcare system. It's very hard to introduce
transparency in a way that covers all of those different parts of the healthcare system in
the same way. There are also parts of the healthcare system that frankly don't want
transparency. It's better for them not to have people understand exactly how much it costs
for a band-aid when it costs $1,000. That would bring a lot more of an uproar than having
it buried within a bill that people don't really understand.”

•

Provider side- Hospital association 3: the system is so fragmented and truly not
competitive because you basically have everybody out there optimizing, profiting as
much as they can for themselves. Now, they're [ some providers] moving to actually
organizing care delivery to compete for the patient.”
The patient side and the provider.
Patient and provider relationship: Trust and barriers. Patients tend to have faith and trust

in their physicians. They follow their instructions, do as they are told, and most of the time do
not ask questions. Consumers are hesitant to discuss the prices because of shyness, culture, or
hesitance. Some patients do not ask because they do not want the physician to think that they are
cheap and worry more about the price than health.
Patients do not shop for prices because they trust their physicians and do as they are told.
There are social and cultural barriers that prevent patients to shop and discuss the prices with
their physicians.
•

Patient side – Journalist 1: “We want to have people talk about price in healthcare. A lot
of people are very reticent about doing this. They don't want to look like they're being
cheap. They don't want their doctor to give them what they think is an inferior treatment
because, you know, Americans tend to equate cost with quality when it comes to
healthcare even though there's abundant evidence that that is not the case.”

•

Patient side – Consultant 4:” Now that's harder to imagine that consumers will change
their behavior because you build relationships with your physicians, so even if you hear
that they're not as good, people will stay because they have a relationship.”

•

Policy side – Academia 4: We want to trust that person. We want to find someone that we
believe is excellent and then we really don't want to bargain with that person and dicker
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with him over the price. I don't know how it is in other societies, but I think that's a pretty
fundamental issue.
•

Payer side – Vendor 2: “That's generally in our minds, that fear of not being healthy for
your loved ones drives you to not think about money at that point in time.”
The patient side and the payer.
Too many payers. The lack of price transparency begins with choosing a health plan. The

options for payer plans are often too complicated. There are too many payers, that have different
networks, different plans, and then different benefit packages under the plans (Figure 13). There
is no way to compare the cost of services under each plan because of the huge number of
possibilities.
The multi-payer systems contribute to the complexity, which makes transparency even
more challenging.
•

Patient side – Consultant 4: “There are tons of plans, and there's just so much variation.
So how does the provider, to be fair to the provider, how do they even begin to display
the prices because if you have Plan A, Aetna Plan B ... and then they probably have
hundreds of plans they accept, especially if you're a big hospital, and it all varies. And so
it's just the system we've created because we don't have a rate.”

•

Provider – Hospital association 5: “The fact that we have a multi-payer, multi-contract
competitive marketplace where there is, you have disincentives for creating price
transparency in the market.”
The decision of choosing a payer is based on the coverage and if the patient’s physician is

in the network. Historically, the patient has been shielded from the prices in healthcare because
they are not directly paying the provider. It has been seen that when patients are not using their
own money, they are insensitive to the price and once they know they will meet their out of
pocket deductible, they might over-utilize the services. The patients are angry and frustrated
about the high deductibles and resent having to pay a substantial amount for healthcare service
out of pocket. Their resentment can be seen in the remark a consumer advocate made when I
referred to the insurance companies as payers: “They don’t pay for anything; the consumers and
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employers are the actual payers who share the burden either through premiums or out-of-pocket
deductible.”

Figure 13. Too Many Insurance Companies – Too Many Configurations
Patients want the price transparency tools to be meaningful and easy to use and believe
the current tools are rudimentary (as discussed under “Absence of Accurate and Reliable Price
Transparency Tools”). Patients do not trust their insurance companies (as discussed under
“Consumer Skepticism”). They feel whenever the insurance companies have a financial
motivation to lead the patients to a lower cost provider.
In-network limitations. Patients feel restricted by their network. They are quite aware that
going out of network can have profound financial implication as they in most would not be
covered. So, the patients have assumed they have limited shopping opportunities.
Most patients do not shop for healthcare because they have to be in the network under
their health plan as a part of the insurance network.
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•

Patient side- Employer lobbyist 1: “A lot of people are in the wrong plan and don't shop
around or don't have the information at their fingertips to make a better plan selection.
So, they end up paying more.”

•

Patient side- Employer 1: “Well, generally they're not [ shopping], because most
consumers are grouped in with a group plan from their employer. Many organizations
offer a single plan, and that's it.”
The patient side on policy.
Role of government: A debate on single payer. The patient side (along with the payer and

the provider) has less faith in policy. Even though most consumers do not shop, many of them,
especially the self-funded employers, have taken sides on the role of government in healthcare.
Some feel that government intervention is necessary to crack down on the issue of price
transparency, with the implication is to reduce the total healthcare spending. While some
strongly disagree with government’s intervention to socialize healthcare, they understand that the
efforts to make consumer shop through high deductible healthcare plans did not work.
Patient side feels that we are at an impasse to reduce healthcare spending. Some believe
that it is time to move in socialize healthcare while some believe there is still time to fix the
healthcare system without having the government intervene.
•

Patient side – Journalist 1: “I used to be a whole lot more sanguine about hopes that we
could fix the problems. Now I don't know how you would unless there's a really strong
regulator, who can actually do something and who is actually privy to a lot of information
that is secret and considered. The insurance system certainly has its flaws, but it's the
system that we have. But, short of single payer, I don't know how you have perfect price
transparency. Like I said, our system isn't great, but it's a system at least, and people rely
on it. So, I don't know what to do about that.”

•

Payer side- Vendor 2:” I'm not quite sure politically how real a single player model is.
And in the future of where we as a capitalistic country tend to focus in on our benefits of
a capitalistic society. I don't know how real as a single-payer model. “
A patient’s world.
A patient being on the demand side of the equation and spending more out-of-pocket, has

the most to gain with price transparency. Figure 14 shows the path for a patient who intends to
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shop. The first step is to know whether the service is an inpatient or an outpatient service. The
ability to shop for inpatient services is minimal entirely because of how services are priced. A
Fee-for-Service (hereafter referred as FFS) pricing for inpatient service charges a patient for all
the services and products utilized while the patient is admitted (including physician fee,
anesthesia, room rental, supplies like gloves, sutures, oxygen, etc.). For a patient, it is difficult to
comprehend the list and know with any degree of certainty whether a particular product or
service was necessary or not. Hence, shopping for inpatient services is next to impossible.
Having said that, it is easier and possible to shop for outpatient services if a patient is aware of
what kind of service is he is looking to get. For example: to get an x-ray, a patient should know if
the x-ray is with or without contrasts, details about their insurance, deductible, benefits plan, etc.
The next step to shop is to have an awareness that there is price variation in healthcare services.
Once the awareness is there, the next step is to know where and how to shop (website, phone
call). If the process to get the information is easy (finding the medical or CPT codes for a
service, calling the clinic and insurance company and being held on the phone is not ease of use).
Then, the last step is to decide whether the information received during this process was
meaningful and informative. If such a shopping experience is good, a patient may enter the
decision loop again depending on other factors that are important at the time. Most patients exit
the loop or do not shop because shopping for healthcare services is difficult, time-consuming,
and provides them information that is either difficult to understand or is meaningless.
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Figure 14. To Shop or Not to Shop

Price generally not a part of decision making. With all the conversation of price
transparency, it has been noticed that consumers quite often do not bring up price as a part of
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their decision making. They have numerous other factors that they worry about and price is just
one subset of numerous other decision factors
•

Payer side – Benefit advisor 6: “We had a culture for 30 or 40 years where the cost didn't
matter and that allowed the cost the balloon even faster. Now, the biggest challenge is
these high deductible plans is that in theory, these would have resulted in people become
a better consumer because they'll have more skin in the game, but they're [people] so
used to not thinking about costs.”

•

Patient side – Consultant 4: “We clamor, as consumers, for pricing on certain things. I
want to know what Amazon's going to charge me for whatever thing I'm buying. People
don't clamor for healthcare prices. They just don't, and it makes sense.”

•

Policy side – Academia 6: The consumer had almost no interest in knowing the price that
somebody else was paying for. And even as deductibles went higher, very often, still did
not dawn on the consumer that prices varied.
Patients do not shop. Most of the patients do not think about price when making

healthcare pricing decisions this is evident because even the high deductible plans, have not
resulted in the reduction of healthcare spending because patients are not shopping, and all the
four sides concur (Fernandopulle, 2015; Park, 2006).
Patients are not shopping for healthcare services will continue to keep the system opaque
no matter what initiatives or efforts are made to create transparency.
•

Provider side – Health system 11: “I don't think there's a lot of that going on.”

•

Payer side – Vendor 4: “Minimal impact [of shopping].”

•

Patient side – Journalist 1:” I think most of the studies show that they're not.”

•

Policy side – Academia 8: “There's not very much evidence for patients shopping based
on price.”
My interviews also highlighted things other than price that take a priority for a patient in

the decision making when getting a healthcare service. Figure 15 shows various factors that
could be of precedence to a patient. As is evident from Figure 15, price is just one of the many
factors used in making a healthcare decision.
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Figure 15. Inside the Mind of a Patient -Where is Waldo (Price)?
The Policy Side- The Policymakers and the Influencers
The policy side is represented by researchers, academics, non-profit organizations, and
think-tanks who educate the general public and government on important healthcare issues. This
side has a significant influence on policy because they are the subject matter experts. They are
coming up with ideas and products to optimize healthcare, though not all are popular or
successful.
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In recent years, healthcare spending has escalated. High deductible plans were created in
an effort to reduce healthcare spending (Durand et al., 2015). With consumers spending more out
of pocket, the need for price transparency in the healthcare system is imperative. Policymakers
presumed that the high deductible plans would incentivize consumers to shop for better prices in
healthcare services, thus creating competition, and eventually reduce the healthcare spending
(Semigran, Gourevitch, Sinaiko, Cowling, & Mehrotra, 2017) (Figure 16).

Figure 16. High Deductible Health Plans & Price Transparency – A Function of Healthcare
Spending
Single payer approach to reduce healthcare spending. The assumed effect of high
deductible plans was that patients would shop because they are now spending more out of
pocket. This would in turn help with reducing the overall healthcare spending. Since the
consumers are not shopping (as discussed under “The Patient Side”), the overall spending
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continues to grow, the healthcare industry is concerned that if nothing is done soon to curb the
spending, single payers might be the only solution to get the spending under control. Single
payer is one of the approaches and not all seem to be in favor.
Single payer has its advantages and disadvantages. On the pros, government intervention
will bring in economies of scale, single administrator that could cut cost and hence healthcare
spending. But, on the cons, the industry is worried about the impact on health, quality of care,
innovations, and competition.
•

Provider side- Health system 14: “if costs continue to rise at the pace that they are, the
government might end up going towards the single payer type system which I think is not
going to work either.”

•

Payer side – Vendor 6: “I think that those who are proponents of single payer don't really
understand what they're asking for. UK, which has one of the longest histories of singlepayer systems, has major problems with access to care. I don't know that the American
public is going to tolerate that.”

•

Payer side – Vendor 3: “I do not want socialized medicine. I want medicine to be
competitive as hell.”
Moving away from fee-for-service (FFS). High deductible plans and price transparency

do not seem to be bringing down healthcare spending. To achieve this goal, there are other
approaches being considered and proposed within the industry. One such proposal is to change
the ways the providers are getting paid for the healthcare services they provide. These payment
reform propose to move FFS model (where they charge for each and every product and service
utilized while taking care of a patient) to more value-based care, incorporating bundled payments
(services where a single price is quoted as a bundle; for example, tonsillectomy, hysterectomy,
knee replacement, open heart surgery).
•

Policy side -Nonprofit organization - 1: “The medical-industrial complex does not want
people to understand what it does and to get them to compete. That's where the episode of
care comes in because it allows you to structure healthcare delivery in terms of defined
products. Now, that's something that people can understand. I'll give you a little example
that you'll immediately grasp. Imagine if you needed to buy a dishwasher, but instead of
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Whirlpool and Bosch putting these dishwashers out for a price, what you see is the parts
list, a couple hundred parts. Then, this insurance has a discounted fee-for-service
scheduled, somehow you have to assemble that all together in your head as a product.
What an episode of care model does is to build contracts around these discreet lines of
services that makes sense to consumers.”
•

Payer side – Benefit advisor 4: “When anything gets this complicated [referring to FFS] t
gets expensive because of all the administration. Doctors are spending six hours of their
day inputting numbers into a financial reporting system, so they could bill. That's
something to think about. So, if we can take them off the table and just say, "You can do
all of that in one hour a day [bundled payment], that's a pretty good time to have better
outcomes in healthcare.”
Moving towards bundled services. Changing the payment system toward bundled care

would change the way healthcare is paid for and create a more intuitive approach to healthcare
services. This approach is easily understood by the consumers who have always thought of
healthcare in terms of episodes and not as a list of parts (as when billed by FFS). Bundled
payment comes in various forms of risk sharing. It could be risk and profit sharing between
insurance companies and the providers and alternatively, hospitals might want to take all the
risks so that they can keep all the profits. Early adoption of bundles services like knee and hip
replacement have been seen in the contractual agreements between hospitals and insurance
companies.
•

Provider side- Health system 12: “Bundle payment and risk scores say that if you're a 62year-old male with hypertension, diabetes, obesity, your risk score is going to be
significantly higher than a 24-year-old male with a normal BMI and the cost of care for
that normal male and the cost of care for that 62-year-old male, is going to be based on
that risk score.”

•

Provider side – Health system 8: “We like the idea of bundled services, again, with the
proper identification of those patients. But, we have worked with some of the insurance
companies to implement those. That's the good news. The bad news is, is that most of the
insurance companies' systems are not geared to doing that.”

•

Payer side – Insurance company 5: “The negotiation on bundled services is mutual. The
health plan may approach a provider and say, “We have a new bundle. If you're
interested, we'd like to do this.” And the hospital might say anything from, “We have no
experience in that. We're not ready,” to, “We want to do that. We want to do that, but we
want to take full risk,” and they negotiate. Or the hospital may come to the payer, saying,
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“We have 10 new lines of service that we've created bundles and we're ready to deal.” So,
it's a back-and-forth.”
Reference-based pricing. Another approach that is seen increasingly, especially in
California and the Midwest, is reference-based pricing. Reference-based pricing can be done
with help of reference-based-pricing vendors without the need of a network. There are many
healthcare vendors using this technique of paying the provider a certain percent of Medicare.
This approach uses Medicare prices for service as a reference point, and vendors negotiate some
percentage on top of that (for example 140% of a Medicare price). This approach is based on a
premise that employers will save on healthcare by paying the providers based on the Medicare
payments. The approach has seen mixed results.
•

Policy side – Academia 6: “That [use of reference-based-pricing] was really an enormous
change in the right direction. It was a big change because it was an acknowledgment that
pricing mattered.”

•

Policy side – Nonprofit organization 3: “Really ambitious employers could set up or
demand reference pricing, or some other way to leverage it in their negotiations with
providers.”
The participants discussed other approaches to manage healthcare spending and creating

a transparent healthcare for the patient. Few of the other approaches that were discussed are
Direct Primary Care (DPC), tele-health etc. These alternative practices are making inroads to
creating a better, accessible, economical, competitive and value-based healthcare system.
Integration across the Ps
The 4 Ps discussed are interwoven among themselves. Each of the P’s not only has its
own set of complexities but also influences and impact the other P’s by the virtue of co-existing
in one industry. Each one has its own preferences and perceptions that influence the others
positively or negatively.
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In my interviews with all the 4 Ps, multiple factors impacting price transparency were
revealed. Most of them have been addressed above under the headings “The Provider side,” “the
Payer side,” “the Patient side,” and “the Policy side.” Integrating the various factors shows many
the moving parts and complexities in the healthcare system. Figure 17 shows the factors based on
each stakeholder. Each of these factors manifests its complexity throughout the industry.

Figure 17. Factors Impacting Price Transparency in the Healthcare System
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In my attempt to understand the lack of price transparency by studying the 4 Ps, I was
able to discern 2 Ps in one pod and 2 Ps in another—each reflecting their ideas and motivations.
This divides the industry into two halves with each stakeholder with diametrically opposed drive
and impetus.
“Who Cares…?” – A Story about the Patients and the Providers
The supply and demand sides of the equation are the ones who are least interested in
creating price transparency. The supply side, for obvious reasons, has the least interest in
creating price transparency because it impacts their bottom line and lets out all the secret ways
they generate profit. The provider side is mostly unaware of the increased out-of-pocket prices
that the patients have to pay. In most cases, physicians are unaware of the prices of service that
the hospital charges the patients. Figure 18 shows the two main Ps: the supply and demand and
statement of “Who Cares?”
The demand side, the patients, stand to gain the most from price transparency, especially
when they have high-out-of-pocket deductibles. The patients who are fully insured do not care
because they are playing with house money and have little motivation to shop. The patients with
high deductibles have been shown to delay care but still not shop for better healthcare prices
(Fuse Brown, 2015; Riffkin, 2014). The reason starts from the macro to micro in that order: The
complexity of the healthcare, asymmetric information, historic behavior where insurance covered
all the cost, opaque billing, cultural concerns, type of insurance, benefit design, network,
deductibles, copays, coinsurances, support system, the provider, trust in physician, physical
health, co-morbidities, clarity of diagnoses, appropriateness of service, understanding of their
condition, course of treatment, awareness, education, value, quality, price proximity of care,
convenience, time, motivation and many more. These reasons are also reflected in Figure 15.
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With so many combinations and priority level, where is the price is like saying “Where is
Waldo?” The price is lost in a whole host of other factors that might be preferable to consider
over price.

Who Cares…?

Figure 18. Two Ps in a Pod - Who Cares…?
Demand – The patients. The patients do not care a lot about price transparency because
of many reasons discussed above including the reason that historically they have never done it
and that price is the last thing on their mind when they are looking for healthcare options.
•

Patient side – Consumer advocate/Author 2: “We're all so darn busy. Because that's just
one more thing that people are asked to do. A lot of places don't feel that they are able to
do that or know where to go to get it. Our concern that, if they see that one hospital has a
lower price than another, maybe the quality is not so good.”
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•

Patient side – Consultant 2: It’s [ not shopping for healthcare] been built into our culture
for so long that it's a hard thing to change. It's just taken for granted

•

Payer side – Benefit advisor 6: “They figure it's just so expensive that what good is going
to be saving a couple hundred bucks anyway. I'm going to meet my out of pocket and my
deductible.”
Supply – The providers.
The providers rather not have price transparency because the opacity reduces competition

and gives them ample opportunities to make a profit.
•

Patient side – Consultant 4: “I worked at [a hospital] for a number of years, and I loved
them ... but they've been sitting on the outside. The largest for-profit chain is sitting on
the outside, not really engaging in these models because number one, they make money
off fee-for-service, and number two, I just feel like there's a set of hospitals that are going
to ride that gravy train until it's really out.”

•

Patient side – Employer 2: “I think most providers don't want people to know how much
they're charging, because then the game's up, right? I just think they're money hungry. In
certain circumstances, I'm not saying all providers, but I've seen it. I've seen it over 900%
upcharge on items. That's crazy.”

•

Payer side – Vendor 3: “The key factor in affecting pricing transparency is greed. That's
the number one thing impacting it is greed across the board.”
…Maybe We Do! – A Story about Payer and Policy Influencers
When the two most important players in the game are not interested in playing, should

the game even be played? Maybe it should because it is not about the players but the game itself.
The other 2 Ps in the pod are payer side and the policy side. These two collectives are
making efforts through value-based bundled care and reference-based-pricing to reduce
healthcare spending. The issue of price transparency might remain or fade away if the high
deductible plans go away as a result of certain payment reforms. However, these two P sides are
making significant strides to address the bigger picture. There are many reforms that are in the
pipeline or waiting for adoption. Figure 19 shows the 2 Ps who are planning to change the
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healthcare landscape by making payment reforms, that will eventually result in reduced
healthcare spending.

Figure 19. Two Ps in a Pod …Maybe We Do!
Both policymakers/influencers and payer are trying to usher in payment reforms that will
change the healthcare system for better. They are using various strategies that will reduce
healthcare spending and create comprehensive transparency that included price, quality and
service transparency. These reforms focus on reducing the complexity of the payment system to
make it simpler and intuitive to understand.
•

Policy side – Nonprofit organization 1: “What an episode of care model [bundled model]
does is to build contracts around these discreet lines of services that makes sense to
consumers. Once you study this stuff, I hope you've come to understand that ordinary
people have always thought about healthcare in terms of episodes. It's just that the
American system, which I can speak to most in-depth, simply doesn't respond that way to
them. You see all these transparency tools and high-deductible plans, and I'm telling
people for years, "No, that won't get it done at all."

•

Patient side – Consultant 4: “It just all depends what we end up doing with this payment
system. I think if we stick with fee-for-service, you're going to see more of it [ the need
for price transparency]. I think if we move outside of fee-for-service, it [ price
transparency] becomes less important.”
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•

Provider side – Hospital association 3: “We have advocated the payment reform, we'll
continue to advocate the payment reform, and you will never get price transparency, true
price transparency, until you change the payment model.”

•

Payer side: Insurance company – 5: “If I'm going to have a knee replacement, there's
going to be an anesthesiology bill, a surgeon bill, a facility charge from the hospital. All
of those things needed to be put together into a bundle so that you could show somebody,
“Your real cost for a knee replacement here is going the be this. Bundled care and taking
the data and making it more intelligible, is useful to a consumer to what they're really
going to spend.”
Playing the Game
Given these many different levels of motivation, the strategy for the game varies

considerably. Same are satisfied with maintaining the status quo as seen above with the patients
and the providers. Some are trying to change old, deep-rooted system to create a new, fresh,
intuitive, accessible and affordable healthcare system as can be seen with policy
makers/influencers and payers.
Some continue to play the game as is.
The patients and the providers. Changes in the healthcare system had a minimal impact
on the patients and the providers. Though patients should have been the most affected by high
deductible plans, they consider it to be a part of the change that they will have to deal with. With
many price transparency tools, they have chosen just to consider high deductible as collateral
damage and carry on with their regular practice of buying healthcare. Providers also do not care
about price transparency because being transparent creates publicity of their practices to charge
and this can lead to unintended consequences that might not be good for their reputation. Some
quotes expressing this attitude can be seen under the topic “Who cares?” Both the sides are
continuing with their practices of finding services (patients) and providing services (providers)
regardless of the changes in the industry.
•

Payer side – Benefit advisor 4: “I think ignorance is bliss. We've always been taught that
our insurance company's going to pay for it. In fact you go to your doctor and you say,
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"How much is this going to cost?" They say, "Oh, don't worry. Your insurance company
covers it."
•

Payer side- Vendor 4: “Time and time and time again we see it [ price transparency] just
doesn't work and it actually has a negative intimate impact. I'll say it again. People
associate higher cost providers with higher quality. Transparency is bogus. The providers
are completely aware of it too. They are not the least bit scared about healthcare
transparency.”

•

Payer side – Vendor 5: “I am at a A rated hospital here. My odds of infection here, maybe
they're 10 times higher here than they are in [hospital B, which is far but cheaper], but
that means they're 1% instead of 21%. I mean, I can live with that.”
Some make do with short-term solutions.
Payers and policymakers/influencers. To reduce healthcare spending, the policy side

developed high deductible health plans. The assumption was that since consumers will be
spending out of pocket, they will shop for better-priced services resulting in reduced healthcare
spending. The payer side that includes insurance companies, benefits advisors, vendors and
brokers tried to help the employers and patients reduce the cost of their healthcare by creating
transparency tools for the patients to shop. Both the payers and the policy side have come up
with quick solutions to help the patient side. These short-term solutions did not work because
patients are still not shopping for healthcare services.
•

Patient side – Consultant 4: “Oh, they're giving points and rebates to the consumer at the
front end. And they get creative, and they solve the problem, but doesn’t really solve the
problem. [ An insurance company] completely backed away from spending any more
money on doing price transparency tools”

•

Policy side – Academia 1: “The assumption is that if everybody knew the price and were
transparent, if all the prices were out there, then it'd be like a normal consumer market.
People would be able to select among the options. And then we'd have competition and
you keep the price, and the cost down. That's the obvious assumption here. The problem
is that healthcare doesn't work that way for a whole variety of reasons.”

•

Payer side – Vendor 3: “We have a number of vendors that attempted to make it into the
market a few years ago, called transparency vendors. They died out.”

•

Payer side – Vendor 4: “Because I've had firsthand experience of members and large
employers I've worked with and they are not using it. [price transparency tools].”
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Others find sustainable solutions.
Payers and policymakers/influencers. With the short terms solutions not having the
desired results, policymakers and payers are looking for sustainable and systematic solutions to
tackle the problem of healthcare spending. The focus seems to be on payment reforms that are
considered necessary to reduce healthcare spending and create a comprehensive transparency.
Bundled payments is a concept that has gained acceptance but the whole payment system will
need to transform to optimally process these bundles.
•

Policy side -Academia 1: “We've done this [ bundled payments] for a long time in
maternity. We have most companies to bundle them pre and postpartum stuff about
maternity all in one package. So, the obstetrician gets one fee and then the hospital gets
one fee. We're doing that now with knees and a few other things.

•

Policy side -Academia 5: “They're doing some contracts with insurers for bundled
payments, which, generally, I believe is a positive step. These bundled payment contracts
usually are shared savings. Bundled payment contracts will involve a benchmark and a
sharing of savings or losses, based on performance.

•

Payer side – Benefit advisor 2: “Over at Hospital [X] clients save 50 to 70% from having
direct contracted these bundle payments of surgery.”

•

Payer side- Broker 1: “Bundled payment integrates quality requirements with financial
need and creating a payment structure that doesn't break the bank for the payer, it also
allows the provider to continue to deliver the kind of care they need to and enhance the
member experience and leverage technology to their own benefit.”
Some go overboard with the strategies.
Payers. Some of the long-term strategies to reduce healthcare spending and address price

transparency have backfired. Reference-based-pricing though initially picked up some traction, is
getting resistance from the providers because they are not getting paid enough. This has resulted
in some court cases and has caused friction between the employers and the providers.
•

The Provider side – Health system 14: “And that's a problem with the reference-based
pricing world is that they get pushed back from provider. There are some legal issues. A
lot of times when you're not paying your providers and facilities enough, they'll push
back and add a CPT code for this, or up for extra charge.”
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•

Payer side – Benefits advisor 2: “Reference-based pricing has its own challenges but is it
better than what's in place? I would say it depends on who you talk to. [ providers are
fighting back]”

•

Payer side – Vendor 3: “They [provider] didn’t agree with reference-based pricing. They
fought back, and that ultimately hurt the employer.”

Discussion
Quite often, a quick view creates a perception that might not tell the whole story. I did
this research to understand the factors that impact price transparency by talking to the major
stakeholders who are a big part of the industry. I still feel very unsure about how much I have
been able to discern and interpret because I have barely scratched the surface during my
research. I have learned that analyzing things in silos masks the complexities that are inherently
important.
Each of the 4 Ps is examined independently to show intricacies that increase
tremendously in numerous directions when all the P’s are studied together. The complexities in
the industry are profound and create a network effect where even a small change can have a large
impact. Each side (the patient side, the provider side, the payer side, and the policy side) with its
preferred direction, cannot move quickly because of the complexities that interconnect them. The
findings from this research give an exhaustive view of the healthcare industry thus reinforces the
use of grounded theory methodology to understand entanglement in the complex healthcare
market. The far-reaching and deep-rooted impact of all four sides is clearly understood went
these sides are examined together.
A study of the healthcare field shows that price transparency today cannot be sufficiently
achieved. Transparency must extend beyond price transparency to also encompass quality,
services, satisfaction, treatment options etc. The underlying payment systems, the motivation of
stakeholders especially the consumers and the variability in multiple factors are too complex to
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be solved with a simple solution. The findings from analyzing the 4 Ps lead me to create a
“Transparency Action Theory” presented in Figure 20. The theory states that the actions or
solutions to create transparency are dictated by the complexity in a system and the time in hand.
There are four approaches under this theory: Ain’t Broken–Don’t Fix-it, Band-aid, Fix-it,
Overkill approach.

Figure 20. Transparency Action Theory
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Ain’t Broken- Don’t Fix-it Approach
With a perception that the healthcare system has less complexity, the patients and the
providers are slightly inclined towards the idea of “Who Cares…?” Both these stakeholders are
not worried about price transparency. The providers really don’t care because opacity is the best
way for them to keep prices unreasonably high. On the other hand, consumers who should care
about their out-of-pocket deductibles do not shop for numerous reasons (Figure 8). Some of the
quotes under “Who Cares?” and “Some continue to play the game” show that patients trust their
providers, do not consider price as an important factor because they equate high price to better
quality. It has also been observed that historically consumers have displayed insensitivity to
prices because they were insulated by the insurance companies. Though the insulation has
depleted since the patients are paying more out of pocket, their attitude and philosophy of not
worrying about prices in healthcare still remain.
The 2 Ps in the pod “Who cares…?” continue to move along with little concern about the
changes in the industry. They continue with their traditional shopping habits and have not made
any substantial changes in the way they shop (the patients) or price the services (the providers).
That is why one of the participants said that ignorance is bliss. For both the patients and the
providers in the present time, the industry “Ain’t Broken” so they are not voicing any concerns
to fix it.
In this “Ain’t Broken-Don’t fix it” approach, the stakeholders understand that the system
has relatively less complexity but are content with the way it is at the present time and want to
maintain the status quo. They are amenable to the certainty in the system and do not want to
disturb or change the dynamics. The benefit of such an approach is that the stakeholders who like
the state of equilibrium, stay stable in the situation without the commotion in the system. Though
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this approach does not add value, it does not deplete any resources of the system either. The
major disadvantage of this approach is that it prevents growth and innovation and keeps the
system at a stagnation point.
Band-aid Approach
During the advent of high deductible plans, there was an urgency in the healthcare market
to create tools that would help the consumer shop for services. Media attention and government
focus on high healthcare spending created an urgency that led the payers and policymakers to
come up with quick-fix or a band-aid solution that at the time seemed rational. It was assumed
that with high out-of-pocket deductibles, and having more skin in the game, the consumers
would be more cognizant of the price. They would want to shop for better prices and hence need
tools and incentives. In this frenzy to create resources, insurance companies, state and federal
agencies and even third-party vendors started investing to create the best software tools for price
transparency.
The 2 Ps in the pod “Maybe we do,” who want to change the industry, thought that
creating tools and providing incentives to use them, would change consumers behavior that
would lead to a competitive market. Unfortunately, the price transparency initiatives did not
produce the desired results and it soon became clear that very few consumers were shopping for
healthcare services. We can see in the quotes from the section “Some make do with short-term
solutions” many solutions to push the consumer to shop, failed. Many price transparency vendors
went out of business and insurance companies stopped investing money on transparency
resources. The rebates and points provided by the employers to their employees as an incentive
to shop were ineffective as well.
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The “Band-aid” approach is called so because it is a quick and dirty way to address an
urgent circumstance as a stop loss. The solutions are not thought through well, but on the
surface, they look rational and viable. The stakeholders understand that the system has greater
complexity, but with limited time and resources, this approach is the best way to solve a
problem. The benefit of such an approach is that it has a quick turnaround and buys time to find
better solutions while doing some damage control. The major drawback for this approach is that
it does not address the underlying problem and can create unintended consequences. For
example, the Medical Loss Ratio (MLR) policy. The intentions were good, but it was a quick fix
to create efficiencies on the payer end (with only having to spend 15 cents of a dollar) and to
improve quality and services on the provider end (with having to 85 cents of a dollar). This
policy created misaligned incentives on two levels. First, the payer had now the incentive to
increase the cost of healthcare to have a bigger base for the 15%. Second, the insurance
companies started to expand on the provider side to gain a portion of the 85%.
Fix-it Approach
The outcomes of the low utility of price transparency tools made some policymakers and
payers realize that getting the patients to shop by adding a financial responsibility on their
shoulders or giving them incentives is not the answer to reducing the total healthcare spending.
They had to think about long-term solutions. They had time on their side during which they
could do research to find better solutions. They realized that unlike other industries, they could
not depend on the demand side (patients) to reduce healthcare spending. Their solution would
come from the supply side. The prices of healthcare services have been going up because there is
no cost accounting method to tell the providers the real cost of their service. Healthcare payment
systems use contractual negotiations between the providers and the payers. These contractual
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agreements were built on the premise that the prices of services would never need to be
transparent. This perpetuated the high cost of services. The result is that today, we have a system
that is too complex and convoluted to ever become transparent.
The 2 Ps in the pod “Maybe we do” realized that the “Band-aid” approach did not work,
so they continue to seek ways to solve the problem of high healthcare spending. They have
proposed many reforms including payment reforms that are designed to result in comprehensive
transparency (price, quality, service, treatment etc.). The concept of bundled payments treats an
episode as a bundle and prices it based on the risk rather than charging for every service and
supply to treat that episode. As seen under the sections “Maybe we do” and “Others find
sustainable solutions” bundled payments help with integrated care, enhances customer
experience, promotes cost savings and creates an incentive for the provider to provide better
service and performance.
For the “Fix-it” approach, the stakeholders recognize that the system has greater
complexity, so they try to address it with solutions that are well researched, tried and tested. To
add to their advantage, these stakeholders also have the time by their side to analyze, research
and experiment with different options. This approach is for long-term, sustainable solutions that
add value to an organization. This approach addresses the underlying problem because it dives
deep to identify the root cause. This approach is important for multifaceted problems that could
have a number of complicated factors causing trouble. The major drawbacks of this approach it
that it takes time and needs commitment and patience.
Overkill Approach
Some approaches like reference-based pricing became quite successful in reducing
employers’ healthcare expenses. This success provided opportunities for a number of vendors to
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jump in the healthcare market and provide this expertise to many employers. As this approach
started to come to fruition. benefitting the employers in reducing cost, many providers felt
alienated. The providers perceive that they are already underpaid for Medicare and Medicaid
patients and hence they have to cost shift to the commercial market to maintain a healthy bottom
line. With reference-based pricing, the providers are paid a certain percent on top of Medicare
price, but it is not as much as they would have been paid with a commercial insurance. So,
though they are making some profit, it is not enough, and they resent being undercut by
reference-based pricing vendors (and employers being represented by them).
Reference-based pricing yielded encouraging results but its overuse by the payers in an
attempt to save money for the employers by cutting the profit margins of the providers resulted
in the providers feeling marginalized and hence resisting the approach. A good solution became
an overkill when used in excess and when the vendors become overzealous with the solution’s
success. As we can see from quotes in “Some go overboard with the strategies” that the
providers are fighting back to the reference-based pricing either by adding additional code for a
medical service or procedure to the bill or by fighting legal battles with the employers. This has
resulted in some employers being skeptical about the reference-based pricing.
An “Overkill Approach” is good for trial and error solutions. This approach is good for
trying out different methods in a relatively lesser complex environment where only a few factors
are being considered. Reference-based pricing could have been a great solution if other variables
like being marginalized by Medicare, treating the uninsured and surviving in the highly regulated
industry did not hurt the provider. The ‘Overkill Approach’ can be used for a multifaceted
problem setting, working on a single facet to understand its complexities. This approach can
actually highlight specific problems by breaking a complex industry in silos and overusing
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certain techniques to understand the boundaries and limits of that area. The major drawbacks of
this approach are that it can create unintended consequences and make some stakeholders
resentful.
Conclusion
Various initiatives and efforts have been made in the industry to motivate consumers to
be financially savvy patients. Almost all healthcare organizations including insurance companies,
hospitals, state and federal agencies, employers through the third-party vendors and private thirdparty vendors have created some kind of price transparency tools to guide the consumers
(Appold, 2016; Dafny & Cutler, 2011; Hammer, 2006). Despite making the tools pervasive, their
utility remains low, and the market continues to stay opaque (Mehrotra et al., 2014; Rosenkrantz
& Doshi, 2016; Sinaiko & Rosenthal, 2016). The limelight on price transparency came about
when high deductible plans were created in an effort to reduce the overall healthcare spending.
Though the literature has not been fully synthesized on the effect of high deductible plans on
total spending, initial studies show they are unlikely to have an impact on the total healthcare
spending (Fernandopulle, 2015; Park, 2006).
When examining the healthcare industry, we need to move past the simplified narrative
created by single-sided studies. They obscure the complex issues and cause our perspective to go
awry. A simplified lens can blind us to the complexities in healthcare and skew our
understanding. We have to move away from the perception that healthcare is inflexible and a
monolithic domain. Instead, we should look into deconstructing the complex healthcare system
layer by layer to find meaningful solutions to solving the problem of healthcare spending.
Most patients do not shop for healthcare services because of their personal priorities and
complexity in the information. In most cases, patients who shop for healthcare do not know what
133

they are buying or getting. The complex payment model of the healthcare system was built on
the premise of not needing to be transparent. It adds to the complexities in healthcare and makes
price transparency very difficult to comprehend. Even the industry experts have admitted during
the research process that even they have not been able to understand the healthcare in its fullest
because of its complexities. With lukewarm results for the utility of price transparency tools, it
has gone down in the priority list to become a minuscule issue and is not on the radar of hospital
associations, policymakers, think tanks, and payers. On the surface, the concept of price
transparency seems simple, but on talking to all four stakeholder groups the intricacies and
complexities in healthcare have become visible. In the current state of healthcare, any kind of
price transparency ushered will be meaningless. It will create frustrations, confusions and a
waste of valuable resources and at the end, it will still be too complicated for the patients to
understand and use.
The main concern of the industry remains rising healthcare spending. As an industry, we
should stop talking about the healthcare price transparency as it is today and start focusing our
resources on bigger and better things like making healthcare simpler through direct primary care,
payment reforms, population health, telemedicine and artificial intelligence in medicine that can
bring down healthcare spending. Payment reforms are the new buzz in the market, and once
again there are associated with vast expectations of reducing healthcare spending and bringing
comprehensive transparency (not just price but also quality and service). Healthcare is going
through trial and error phase and will eventually find a way to create a market that is better than
anyone ever expected. Like a phoenix, healthcare will rise from the ashes of despair and will be
more beautiful and efficient than ever!
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Appendix 1: IRB Exemption

January 23, 2018
Gurlivleen Ahuja
College of Business Administration
Tampa, FL 33612
RE:
IRB#:

Not Human Subjects Research Determination
Pro00033667

Title:

Lack of Price Transparency in U.S. Health Care System

Dear Ms. Ahuja:
The Institutional Review Board (IRB) has reviewed your application. The study activities do not
involve collection of data from the subjects, but rather information and opinions about industry and
company practices. As such, the activities do not meet the definition of human subject research
under USF IRB policy, and USF IRB approval and oversight are therefore not required.
While not requiring USF IRB approval and oversight, your study activities should be conducted in
a manner that is consistent with the ethical principles of your profession. If the scope of your project
changes in the future, please contact the IRB for further guidance.
If you will be obtaining consent to conduct your study activities, please remove any references to
"research" and do not include the assigned Protocol Number or USF IRB contact information.
If your study activities involve collection or use of health information, please note that there may be
requirements under the HIPAA Privacy Rule that apply. For further information, please contact a
HIPAA Program administrator at (813) 974-5638.
Sincerely,

John Schinka, Ph.D.,
Chairperson USF Institutional
Review Board
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Appendix 2: IRB Letter

Informed Consent to Participate in Research

You are being asked to take part in a research study. Research studies include only people who choose to
take part. This document is called an informed consent form. Please read this information carefully and
take your time making your decision. Ask the researcher or study staff to discuss this consent form with
you, please ask him/her to explain any words or information you do not clearly understand. The nature of
the study, risks, inconveniences, discomforts, and other important information about the study are listed
below.
We are asking you to take part in a research study called:
Lack of Price Transparency in U.S. Health Care System
The person who oversees this research study is Gurlivleen (Minnie) Ahuja. This person is called the
Principal Investigator. However, other research staff may be involved and can act on behalf of the person
in charge. She is being guided in this research by Prof. Jung Chul Park.
The research will be conducted at any site of your preference where you are comfortable to participate in
an interview as a part of this research within the University of South Florida.
Purpose of the study
The purpose of this study is to explore the price opacity in the U.S. healthcare system. The prices of a
service can vary widely at the same provider because of the type of insurance or with different providers
even with the same insurance. It has been seen that consumers are not aware of this price variance
because prices are not transparent. A patient generally finds out about the cost of care after the service has
been consumed. The research aims to understand, the factors and causes that result in the lack of price
transparency in healthcare. The study will also explore the opportunities and conditions that can create a
price transparent marketplace. The study excludes emergency services.
With the increase in high deductible insurances, the consumers pay most of the healthcare cost from out
of pocket. Despite this, the market has been slow to move towards price transparency. I would like to
explore why healthcare is an area of commerce where patients cannot compare the cost of service.
The study aims to develop a theory, model, or explanation about the lack of price transparency in the
healthcare system. The research will be conducted via academic research, trade journals, and popular
press along with an interview with experts in healthcare pricing field to understand the industry better.
I would like to conduct an interview with you at your convenience and follow up with you at an
appropriate time as needed, to seek your insights and expert commentary about the industry and your
organization, focusing specifically on price transparency in healthcare to inform the goals of this research.
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Why are you being asked to take part?
I am asking you to participate in this research study because of your understanding of the healthcare
market and your insights into the healthcare pricing field. I feel that I can learn from your expertise. You
are eligible for this research based on the participant inclusion criteria provided below:
•
•
•
•

Your profession exposes (exposed) you to the healthcare field
You have an understanding of how healthcare pricing works in your organization
You can speak expertly on the price opacity in the healthcare market
You work in the United States

Study Procedures:
If you take part in this study, you will be asked to provide a personal artifact (examples: resume,
LinkedIn profile, professional or personal website, news article, essay, biography or other published
interviews about you) that will help provide background information about you. You can opt out of
providing this personal artifact by informing the principal investigator and indicating your wishes on the
last page of this consent form. Should you provide a personal artifact, you should know that no
identifiable information such as your name, age, gender, or your employer’s/organization’s names (past or
present) will be revealed in the data analysis and subsequent report coming out of this research. Only the
principal investigator will have access to your artifacts.
You will also be asked to participate in an interview which will take approximately 60-90 minutes.
During the interviews, you will be asked to elaborate on price transparency in the healthcare industry and
your organization. Along with your expert opinion, you can provide documents that can help with the
research. These documents could include but are not limited to official documents, reports, news articles,
and other published essays or interviews etc. Your interview will be scheduled at any date, time, and
place that is convenient for you. You can expect the interviews to be scheduled any day between February
and May 2018. Advanced notice and a consent form will be provided at least one weeks prior to
scheduling your interview session.
The interviews will be audio-recorded. The recordings will be downloaded and stored in a secure
password protected cloud server. The principal investigator will send the recordings in a secure electronic
file to a designated transcriber. There will be only two individuals who have access to the audio
recordings - the principal investigator and a transcriber unless you consent to share these recordings for
future academic or professional learning purposes such as in classroom or conference presentations.
Please see options for providing permission or no permission to share recordings on the last page of this
consent form.
Once the recordings are transcribed, there will be a maximum of three individuals who have access to the
interview transcripts – the principal investigator, a second coder, and an optional third coder that the
principal investigator designates to help establish the reliability of data analysis. For most transcripts, the
third coder will be requested only as a backup in the absence of the second coder. During initial reading
and analysis of transcripts, you may be asked follow-up questions to clarify information that you gave
during the actual interview.
Names, gender, the age of study participants, and names of past or present employers/organizations will
not be included in the analysis or any of the discussions. The analysis will be anonymized, and the data
will be analyzed in an aggregated fashion ensuring the anonymity of individuals. In coding and analysis
of data, a secure master list will be stored in a separate folder in a password protected secure cloud server.
Only the principal investigator will have access to this master’s list. These recordings will be maintained
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for five years from the date that the Final Report of this research is submitted after which they will be
deleted from the secure cloud server. You have the right to review and delete recordings.
Total Number of Participants
About forty individuals (or until a saturation point is reached) will take part in this study at USF.
Alternatives / Voluntary Participation / Withdrawal
You do not have to participate in this research. You can stop participating at any time for any reason.
Benefits
You will receive no benefit(s) by participating in this research study. Your contribution will add rigor to
the research, and your insights and knowledge will be valuable to the research. Others may benefit in the
future from the information we find in this study that leads to the advancement of our knowledge.
Risks or Discomfort
This research is considered to be minimal risk. That means that the risks associated with this study are the
same as what you face every day. There are no known additional risks to those who take part in this study.
Compensation
You will receive no payment or other compensation for taking part in this study.
Costs
It will not cost you anything to take part in the study.
Privacy and Confidentiality
We will keep your study records private and confidential. Certain people may need to see your study
records. Anyone who looks at your records must keep them confidential. These individuals include:
•

The research team, including the Principal Investigator, the transcriber, the coder, dissertation
committee and research staff.

•

University people who need to know more about the study, and individuals who provide
oversight to ensure that we are doing the study in the right way. Staff who have oversight
responsibilities for this study, including staff in USF Research Integrity and Compliance.

•

Any agency of the federal, state, or local government that regulates this research. Office for
Human Research Protection (OHRP)

We may publish what we learn from this study. If we do, we will not include your name. We will not
publish anything that would let people know who you are unless you provide permission to do so.
You can get the answers to your questions, concerns, or complaints
If you have any questions, concerns or complaints about this study, or experience an unanticipated
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Consent to Take Part in this Research Study
I freely give my consent to take part in this study. I understand that by signing this form, I agree to take
part in research. I have received a copy of this form to take with me.
_____________________________________________
Signature of Person Taking Part in Study

____________
Date

_____________________________________________
Printed Name of Person Taking Part in Study
I am also indicating my consent (or no consent) to provide my personal artifacts such as a resume,
LinkedIn profile, professional or personal website, news article, essay, biography or other published
interviews about myself.
 Yes, I will provide my personal artifacts as requested.
 No, I opt out of providing my personal artifacts as requested.
Additionally, I am providing (or not providing) my permission to share the audio/video recordings of my
interview for future uses intended for academic or professional learning purposes such as in classroom,
conference or online presentations:
 Yes, I agree to share audio recordings of my interview.
 No, I do not agree with sharing audio recordings of my interview.
Statement of Person Obtaining Informed Consent
I have carefully explained to the person taking part in the study what he or she can expect from their
participation. I confirm that this research subject speaks the language that was used to explain this
research and is receiving an informed consent form in their primary language. This research subject has
provided legally effective informed consent.
_________________________________________________
Signature of Person obtaining Informed Consent
_________________________________________________
Printed Name of Person Obtaining Informed Consent
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___________
Date

Appendix 3: 300-Character Count Invite
Dear [Name],
I am pursuing my doctorate dissertation on healthcare price transparency & am interviewing healthcare
pricing executives for their insights. I know you are busy but feel that your feedback will add value to my
research (all personal info is kept confidential). Hoping to connect.
Thanks
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Appendix 4: Information/ Introduction to the Research

Price Transparency in Healthcare
A letter of Introduction
Purpose of the study
The purpose of this study is to explore the price opacity in the U.S. healthcare system. The prices of a
service can vary widely at the same provider because of the type of insurance (Figure A) or with different
providers even with the same insurance (Figure B). It has been seen that consumers are not aware of this
price variance because prices are not transparent. A patient generally finds out about the cost of care after
the service has been consumed. The research aims to understand, the factors and causes that result in the
lack of price transparency in healthcare. The study will also explore the opportunities and conditions that
can create a price transparent marketplace. The study excludes emergency services.
With the increase in high deductible insurances, the consumers pay most of the healthcare cost from out
of pocket. Despite this, the market has been slow to move towards price transparency. I would like to
explore why healthcare is an area of commerce where patients do not have the ability to compare the cost
of service.
The study aims to develop a theory, model, or explanation about the lack of price transparency in the
healthcare system. The research will be conducted via academic research, trade journals, and popular
press along with an interview with experts in healthcare pricing field to understand the industry better.
I would like to conduct an interview with you at your convenience and follow up with you at an
appropriate time as needed, to seek your insights and expert commentary about the industry and your
organization, focusing specifically on price transparency in healthcare to inform the goals of this research.

Why are you being asked to take part?
I am asking you to participate in this research study because of your understanding of the healthcare
market and your insights into the healthcare pricing field. I feel that I can learn from your expertise. You
are eligible for this research based on the participant inclusion criteria provided below:
•
•
•
•

Your profession exposes (exposed) you to the healthcare field
You have an understanding of how healthcare pricing works in your organization
You can speak expertly on the price opacity in the healthcare market
You work in the United States

What to expect
You will be asked to participate in an interview which will take approximately 60 minutes. During the
interview, you will be asked to talk and elaborate on price transparency in the healthcare industry and
your organization. Along with your expert opinion, you can provide documents that can help with the
research. These documents could include but are not limited to official documents, reports, news articles,
and other published essays or interviews etc. Your interview will be scheduled at any date, time, and
place that is convenient for you. You can expect the interviews to be scheduled between February and
May 2018. Advanced notice and a consent form will be provided at least one weeks prior to scheduling
your interview session. I may contact you with follow-up or clarifying questions via an agreed upon
format after the interview has concluded.
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Your contributions will be very valuable to the research. It will not only help me to complete my
dissertation but also add rigor to the research and make it purposeful through your insights and
knowledge.
Figure A: One Test, Many Prices
Adapted from (Beck, 2014)
The figure shows the cost of MRI for the knee, hip or ankle, without contrast, at Oakwood Health Care
System, Dearborn, MI as collected by PricingHealthcare.com
The cost depends on who is paying
List or "chargemaster" price
Cash price
UnitedHealthcare negotiated price
Blue Cross negotiated price
Aetna Negotiated price
Cigna negotiated price
Medicare Rate

$2,844
$695
$1,990
$617
$520
$341-$362
$335

Figure B: Price variation between providers
Adapted from (Reinhardt, 2011)
The figure shows the cost Actual Transaction Prices Paid by Large New Jersey Health Insurer for a
Colonoscopy, By Facility Where Procedure Was Performed, 2007

Contact Information:
If you have any additional questions on the research, please contact
Principal Investigator: Minnie Ahuja

Cell: 216-235-9840
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Email: miniahuja@aol.com

Appendix 5: LinkedIn, Non-LinkedIn and Total Enrollment Stats
Total Interviewing Stats
Activity
Approx. Number
Reached out to
550
Responded back
88
Interviewed
78
LinkedIn Stats
Reached out
500
Denied
50
No response
275
Accepted
175
Responded
88
Interviewed
50
Non LinkedIn Interview Stat
Reached out
50
Responded
40
Interviewed
28
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Appendix 6: Questionnaire
Interview Question

Names, gender, age of study participants, and names of past or present employers/organizations will not be
included in the analysis or any of the discussions. The analysis will be anonymized, and the data will be
analyzed in an aggregated fashion ensuring the anonymity of individuals.

The research aims to understand, the factors and causes that result in price opacity in
healthcare. The study will also explore the opportunities and conditions that can create a price
transparent marketplace. The study aims to develop a theory, model, or explanation about the
lack of price transparency in the healthcare system. The study excludes emergency services.
The questions that it is trying to address:
RQ: Why is there a lack of price transparency for Healthcare Services across the U.S. Health Care
System?
Potential Interview Questions – all questions pertain to non-emergency services/procedures
Demographic Questions
•
•
•
•
•
•

How long have you been at this company/job?
What is your current position here?
How long have you been in this position?
Tell me a little about what you do?
How does this relate to pricing?
How many years have you been exposed to healthcare pricing information?

General Industry Questions
•
•
•
•
•
•
•

How important do you think price transparency is in healthcare?
Why do you hold this opinion about the importance of price transparency?
What direction is the healthcare industry taking towards with price transparency?
What are the key factors that are impacting price transparency in healthcare?
o Probe on these factors
What are the pros and cons of price transparency in healthcare?
What stakeholders will price transparency help and hurt?
In virtually any area of commerce, consumers know the price (or have an estimate) of
things they intend to purchase beforehand, except healthcare (Reinhardt, 2014). Do you
agree with this statement?
a) What are the factors that result in price opacity in the healthcare industry?
b) What are the key barriers and challenges the U.S. Health Care System has
faced in providing price transparency?
Past, present future
c) What steps/actions have been taken by the industry to create price
transparency?
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d) What are other steps/actions is the industry taking to create price transparency
in healthcare?
e) What are other steps/actions that the industry can/should take to create price
transparency in healthcare?
Organization specific questions
•
•

•

What role does your organization play in creating price transparency in the healthcare
system?
What is your organization’s approach to healthcare price transparency?
 Does the organization have any have policies about healthcare
transparency?
a) What factors dictate/dictated your direction?
b) How is your organization impacted with what the competition is doing regarding
price transparency?
c) What steps/actions has your organization taken to create price transparency in
healthcare?
d) What steps/actions is your organization currently taking to create price
transparency in healthcare?
e) What steps/actions should your organization take to create price transparency in
healthcare?
f) What tools do you need (or have used) to implement price transparency?
What do you think the healthcare market will look like in 10 years regarding price
transparency?

Consumer Questions (if not covered)
•
•
•
•
•
•
•

How are consumers responding to increases in out-of-pocket deductibles/health costs?
How are consumers shopping for the best prices in healthcare?
How does ease of access to information on cell phone mobility play in pricing
transparency?
Which areas/ services within Healthcare are consumers seeking pricing information for?
Which services in healthcare are/will become price elastic?
Which services are/will remain price inelastic?
How can the industry afford not to provide consistent price transparency for select or all
services with current changes such as high deductible and access to information?
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Appendix 7: List of Participants with their Titles, Type, Total Years of Experience in
Healthcare and in different Sectors
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Appendix 7 (cont’d.)
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Appendix 7 (cont’d.)
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Appendix 7 (cont’d.)
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Appendix 8: Concepts and Definitions of Some Commonly Used Key Terms
•

Chargemaster: A hospital price list of all goods and services /procedures performed in the hospital.

•

Coinsurance: The percentage of costs paid by the patient for a covered healthcare service, after the
deductible requirement is met (Greene, 2015).

•

Copayment or copay: A fixed dollar amount paid by the patient for a covered healthcare service after
the deductible has been paid by the patient. Copays can vary for different services within the same
plan, like drugs, lab tests, and visits to specialists. Generally, plans with lower monthly premiums
have higher copayments. Plans with higher monthly premiums usually have lower copayment
(Greene, 2015).

•

Fee-For-Service: A method in which physicians and other healthcare providers are paid for each
service performed (Greene, 2015).

•

Health Insurance: A contract between healthcare consumer and the health insurer to pay some or all
of the healthcare costs in exchange for a premium that is paid by the consumer (Greene, 2015).

•

Health plan or benefit plans are the plans offered by healthcare insurance companies. Plans differ
based on your premium, deductible, co-payment, co-insurance, network, etc.

•

Healthcare delivery system: A facility or group of facilities that provide healthcare services. It could
be a single hospital, clinic, or a chain/group of hospitals and affiliated outpatient clinics.

•

Healthcare Price Opacity: Nonexistence of healthcare price transparency.

•

Healthcare Services: Services, tests, and procedures are interchangeably used to represent the
healthcare received from the providers.

•

High Deductible Health Plan: The IRS defines these health plans as plans with deductible of at least
$1,350 for an individual or $2,700 for a family. The premium of these plans is based on the
deductible; higher the deductible lowers the monthly premium. A patient has to pay the deductible
before the insurance kicks in (Greene, 2015).

•

Inpatient services: Healthcare services care that you get when you are admitted to a healthcare
facility, like a hospital or skilled nursing facility as an inpatient (Greene, 2015).

•

Out-of-pocket deductible: The amount paid by the patient for covered healthcare services before the
insurance plan starts to pay (Greene, 2015).

•

Outpatient services: Healthcare services care that you get when you go to a healthcare facility, get the
services and leave within hours. You are not admitted overnight and you do not stay in the facility.

•

Price of a Service: The price that a consumer has to pay for healthcare services. Price is a function of
the type of insurance or the design of the insurance benefit plan that the consumer has. The
deductible, copayment, and coinsurance determine how much a patient pays and how much
healthcare insurance pays for a healthcare service.
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